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Abstract 
 
Organophosphorus (OP) self-poisoning is a major global public health problem 
resulting in over 200,000 deaths each year with a case fatality of 15-30%. Early 
medical management consists of effective resuscitation and targeted antidote therapy.  
 
This thesis argued that health services research and rural doctor training could be used 
to improve the medical management of OP poisoning in a resource limited rural Sri 
Lankan setting, where the delivery of critical care is limited by a lack of diagnostic tests 
and resuscitation skills. Research investigating the use of AChE in guiding clinical 
management, and research that measured the effectiveness of rural resuscitation 
training, were the two streams of research that were the founding pillars of the thesis. 
These two elements were linked together through a conceptual framework of 
knowledge translation, each operating at different points in the continuum of evidence 
being translated into practice.  
 
An AChE POC test (Test-mate ChE) was demonstrated to provide accurate and 
reliable results in acute OP poisoning when compared with a reference laboratory. A 
survey based analysis of clinician’s knowledge, attitudes and practices found that most 
doctors valued the test, but also surprisingly found that doctors who were more 
experienced with AChE valued the test less. Low proportions valued the test in 
guidance of acute poisoning management (e.g. to direct oxime therapy and early 
discharge).  
 
A systematic review highlighted a lack of supporting primary evidence for the use of 
AChE in relation to oxime use and discharge decisions. Advice on interpretation of 
AChE and caution about pitfalls in measurement were also lacking.  These areas need 
to be addressed to optimise provision of AChE POC devices.   
 
iv 
A train-the-trainer (TTT) model of resuscitation education was effective in improving 
resuscitation knowledge and skills in rural peripheral hospital doctors, and 
improvements in most components were sustained for 12 weeks. This demonstrated 
the effectiveness of using non-specialist doctors to conduct peer-led advanced life 
support (ALS) training in a low resource peripheral hospital setting, using objective 
knowledge and skills endpoints according to standardized metrics.   
 
A systematic review of resuscitation of OP poisoning found no texts solely focused on 
acute initial management. An ‘OP specific’ ALS guideline was proposed based on 
consistent literature recommendations highlighting the importance of rapid 
atropinisation (doubling dose regimen) to be delivered simultaneous with immediate 
airway, breathing and circulation management. Other antidotes such as oximes should 
not be in the ALS guidelines.  
 
A participatory action research approach was used to address practical problems 
through close engagement with health services and local training systems. The 
experience from both streams of research showed that such strategies were integral to 
the completion of the studies employed in the low resource rural setting. The thesis 
demonstrated health services research and training could be used to close the 
evidence-practice gap, and may have a role in the improvement of the medical 
management of OP poisoning. Future research should investigate clinical endpoints 
associated with the use of AChE in guiding OP poisoning management, the 
development of decision rules offering practical guidance in measurement and 
interpretation of AChE, the evaluation of OP specific ALS guidelines, and the 
sustainability rural resuscitation training programs.  
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A strategy for hope in the face of death… 
 
 
It was quarter past midnight, when I was standing in the intensive care unit (ICU) for a 400-bed 
secondary referral hospital enjoying some momentary air-conditioned respite from the outside 
tropical heat.  After an evening of trawling the medical wards checking on patients in clinical 
studies, and supervising research assistants who carried out the data collection, the ICU was my 
last stop before retiring for the night. Out of the 6 ventilated beds in the unit, 3 were occupied 
by intubated and mechanically ventilated organophosphorus (OP) poisoned patients who had 
ingested pesticides through a variety of impulsive acts.  
 
The first patient was a 40 year-old female who had recovered from 3 cardiac arrests within the 
preceding 2 hours, and was on an infusion of inotropes (cardiovascular drugs) that seemed to be 
helping her maintain a blood pressure enough to keep her alive. I asked the doctor, who was 
about 3 years out of medical school in seniority, whether this particular patient would be 
receiving oxime therapy. Oximes are an antidote whose use is controversial in the management 
of OP poisoning. His answer was that it depended upon the Consultant who was looking after 
the patient because there were no clear protocols on its use, and no means to measure its 
effectiveness.  
 
This patient had been admitted on a day where she would get oximes, and I wondered to 
myself, “was it going to be important in this patient? Would it make a difference? Will the 
inotrope infusion make a difference to her survival? Or will she arrest again no matter what we 
do?” 
 
 “Perhaps an acetylcholinesterase (AChE) level, if available, could be helpful in guiding this 
difficult decision”, I quietly thought to myself as I watched this motionless lady lie helplessly 
connected to an artificial ventilator through a breathing tube. AChE is a biomarker that can 
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give an indication of both the levels of poisoning and the effectiveness of oxime therapy, and the 
portable field kit that I had chosen to study could measure it.  
 
In the next bed lay another intubated patient, a 26 year-old male, who was bare-chested, and 
donning a sarong for cover of his bottom half. His attire was entirely appropriate as ICU was 
still not “cold” despite being cooler due to the air conditioned, a welcome change from the 
humid heat that was present outside and in the regular ward setting. This man had been in the 
ICU for 2 weeks and was being treated for aspiration pneumonia rather than the direct toxic 
effect of the poison, which had long since left his body.  
 
I found out about the circumstance of this patient’s admission, upon further inquiry from my 
ICU night doctor friend, and learned that he was transferred from a peripheral hospital with an 
unprotected airway, despite having a stomach full of pesticides and alcohol. He was close to 
having a respiratory arrest upon arrival in the secondary referral hospital. This junior ICU 
doctor was quite frustrated when explaining this scenario to me. He said he often received 
patients from peripheral hospitals, who had travelled for up to 2 hours in the back of an 
ambulance without nurse or paramedic, and that it was common for the patients to have not 
received the adequate initial advanced life support and airway protection prior to transfer.  
 
It was easy to be critical of the doctors in the periphery but I wondered if the problem was more 
complex than it seemed on the surface? I had learned from a colleague’s local research that 
primary care doctors in the peripheral hospitals were professionally isolated and found it hard to 
access training. I had observed a lack of training in resuscitation for junior doctors even in the 
larger referral centres, and thought resuscitation education must be even more scarce in the 
periphery.  
 
“Surely, there must be something that can be done to address this problem?” I reflected, 
wondering about a research intervention that could provide resuscitation training to the 
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peripheral hospital doctor population, but that hopeful thought would have to wait for another 
day as at that moment I still had a ward round to complete.  
  
Finally, the last patient whose observations were collected on my routine ICU visit, was a 20 
year-old female who had been distressed about a relationship that had ended, providing her 
with an additional stressor that contributed to her drinking poison that night. She was 
resuscitated in the ward and had come to ICU intubated like the other two patients.  
 
“What would be her fate?” I wondered, whilst my mind slowed a little, already full of a heap of 
unanswered clinical questions about improving health care systems that could perhaps lead to 
improved care in these critically ill poisoned patients.  “Would she also receive oxime therapy?”, 
I continued to ponder,  “And if so, is there evidence to distinguish whether this was the best 
therapy for her right now?”, “If she arrested again, what would be the best treatment for her in 
that moment – do we even know?”. 
 
Such questions kept rapidly appearing, but the strategies to find some of the answers would form 
much more slowly, over the months, and even years to come. All I knew at that moment was 
that this patient was too young to die; and if something was possible make a positive difference 
in some small way, then we had to at least try… 
 
 
 
 
 
 
 
 
The following thesis is dedicated to the pesticide poisoned patients and their families, 
and to the medical staff that have been entrusted with their care.  
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Preface – Introduction and aims of thesis 
 
Self-poisoning is a major worldwide public health problem, resulting in over 300,000 
deaths annually. Organophosphorus (OP) pesticides are the most common agents 
accounting for approximately 200,000 deaths each year in Asia(1-3). Case fatality is 
between 15-30% with current best practice, but there has been limited research 
dedicated to reducing the mortality and morbidity of this condition.  
 
The high case fatality is multifactorial and has been linked to several factors including 
the toxicity of the pesticide, the quality of medical treatment and a lack of resources in 
the region where the practice of self poisoning is prevalent(4). Early medical 
management that includes effective resuscitation and targeted antidote therapy is often 
lacking(5). My research aimed to demonstrate that health services research and 
training were two important vehicles that could act to close the evidence to practice 
gap and thereby improve the medical management of OP poisoning.  
 
I used the conceptual framework of translational research, also known as “knowledge 
translation”(6), to link together two streams of research that addressed the topic of OP 
poisoning management, which may otherwise appear unrelated. These streams 
consisted of research investigating the use of AChE in guiding clinical management, 
and research that measured the effectiveness of resuscitation training in a rural setting. 
Both streams tested strategies focused on improving medical management of a single 
condition, OP poisoning, with an overarching goal of reducing mortality and morbidity.  
 
The different studies operate at different stages of the continuum in the translation of 
evidence into practice, as summarized in Figure 1. This diagram also highlights how 
both research topics, AChE and Resuscitation, represent more than one of the three 
component’s that have been described as integral to the process of knowledge 
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Figure 1  Schema of a translational research model for closing the evidence-to-practice gap. 
Shows the contribution of individual chapters to different steps in the process of evidence being translated into practice. Schema based on a figure by 
Lang et al.(8) and adapted according to Arnold et al.(6). 
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Translation; knowledge synthesis, exchange and application (6, 7). 
 
Peripheral hospitals are frequently the first point of contact with health services for OP 
poisoned patients. Half of my research focused on exploring an educational strategy in 
this setting, and the other half addressed a deficiency in laboratory facilities at 
secondary referral hospitals by providing biomarkers of OP poisoning through point-of-
care (POC) testing. Specifically, I evaluated the effectiveness of a train-the-trainer 
(TTT) model of resuscitation education for peripheral hospital doctors, and I studied the 
validity of an acetylcholinesterase (AChE) POC test in acute OP poisoning, as well as 
the effect its results have on the knowledge, attitudes and practice of treating clinicians 
at secondary referral hospitals. 
 
Both projects address a gap in the translation of existing knowledge, and 
recommendations into practice, and each targets aspects of an underdeveloped 
emergency and critical care service for acutely poisoned OP patients in resource 
limited rural hospital settings.  
 
Origin of research projects and details of fieldwork  
Before I embarked on the path of higher degree research through the Australian 
National University, I was an Emergency Medicine specialist-in-training working in an 
urban emergency department in Wellington, New Zealand. I had an interest in medical 
education and research, and this background combined with my discovery of specific 
on-the-ground deficiencies in the Sri Lankan rural health services led me to the current 
research projects. The South Asian Clinical Toxicology Research Collaboration 
(SACTRC; www.sactrc.org) is a research collaboration whose objective is to reduce 
mortality from poisoning through capacity building research that utilises a range of 
strategies. Working through SACTRC’s infrastructure I conducted my research entirely 
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in Sri Lanka owing to the high prevalence of OP poisoning and consequent burden of 
disease.    
 
The clinical research was conducted at hospitals in the North Central Province, the 
largest province in Sri Lanka. Employment is largely in agriculture and consequently 
agrochemicals such as OP pesticides are widely available. The POC testing research 
was based at the two larger referral hospitals located in the cities of Anuradhapura and 
town of Polonnaruwa, (Figure 2), and the resuscitation training work was conducted at 
smaller peripheral hospitals throughout the province. For the purpose of the argument 
presented in this thesis, these two referral hospitals were both considered as central 
“rural” hospitals because their health services shared similar resource constraints, in 
terms of resuscitation and laboratory facilities, when compared to the larger cities 
located in Sri Lanka’s commercial centres such as Kandy or Colombo. The research 
office was in a collaborating local university, University of Peradeniya, which was 
located close to Kandy, the second largest city in Sri Lanka. 
 
My aim whilst working with SACTRC in Sri Lanka was to find practical ways of 
addressing the challenge of improving the medical management of OP poisoning and 
to participate in organizational change whilst conducting research. Thus the research 
strategy I employed could be considered a form of participatory action research(9, 10).  
At the same time both the introduction of the POC test, and study of the TTT education 
model had characteristics of complex interventions(11); such as engagement with the 
local health service, and having more than one phase of development and evaluation 
for some interventions. 
 
The research methodology I used was adapted to the health care setting where my 
fieldwork took place. At these hospitals there was a general lack of research culture, a 
paucity of methodical note taking or audit, and lack of familiarity or acceptance of the 
benefits of coordinated research such as randomized studies. These rural hospitals are 
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Figure 2  Map of Sri Lanka showing the 
location of central and peripheral hospitals in 
the north central province(12).  
Sri Lanka is an Island nation of 64,000 square 
kilometers, and a population of 21 million people. 
It is a low to middle income country with an 
annual income of USD $5,500 per capita, and life 
expectancy of 71 years for men and 78 years for 
women(13). The figure highlights the North 
Central Province, and the inset shows the 
distribution of central and peripheral hospitals. 
The two central referral hospitals are marked with 
shaded circles and inner dot. The remaining 
hospitals vary in size from larger peripheral 
hospitals (marked with a shaded circle), to small 
peripheral hospitals and peripheral units (shown 
as black dots).  
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focused on delivering clinical care to very high volumes of patients with limited 
infrastructure.   
Gap in emergency and critical care training in rural hospitals  
The Postgraduate Institute of Medicine (PGIM) coordinates postgraduate training in all 
accredited specialties in Sri Lanka (including medicine, surgery, paediatrics and 
obstetrics and gynaecology). At the time I embarked on my fieldwork in 2006 there 
were no dedicated qualifications for intensivists or emergency physicians. This left a 
void in the provision of critical care, and particularly in the realm of resuscitation 
training and supervision. This situation is compounded by the fact that only a low 
proportion (less than 20%) of medical graduates undertake any postgraduate training, 
and these people are concentrated in urban hospitals. There are very few, or no, 
doctors undergoing postgraduate specialist training in peripheral rural hospitals where 
pesticide poisoned patients generally first present. From 2006 to 2010, during which 
time my fieldwork was conducted, no national resuscitation training programs or ad hoc 
resuscitation training was available in the peripheral hospitals. Since then Sri Lanka 
has experienced advances in the nationwide Emergency Medicine strategy that 
includes an active Emergency Medicine specialist training program, which was 
launched in 2013(14). These developments would suggest an increased access to 
resuscitation training for the small number of doctors who were training in Emergency 
Medicine, in the large urban centres where specialist training occurs. However, despite 
such advances in the large urban centres where specialist training occurs, a national 
resuscitation training program was still absent for the peripheral hospitals at the time 
this thesis was published.  
Resource limitations in emergency and critical care service provision   
Resource limitations in rural areas have a strong impact on the emergency care of OP 
poisoned patients. In referral hospitals, laboratory tests are not commonly used. 
Patients are diagnosed and managed largely based on clinical findings. Access to 
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basic tests (biochemistry, haematology) is very limited.  There is no laboratory 
accreditation enforcement so the quality of results can be unreliable.  
 
There are limited numbers of intensive care beds, with the largest (1600 bed) 
secondary referral hospitals only having 8-10 ventilated beds within their medical 
intensive care unit (ICU). 
 
Nurse and doctor to patient ratios are much lower than in western countries. It is not 
uncommon for a large referral hospital to only have two consultant physicians 
managing up to 200 patients each. Furthermore, the same consultant physicians are in 
charge of the medical ICU and the care of ventilated patients. Most of the middle tier 
doctors, senior house officers (SHO’s), who are responsible for delivery of patient care 
and supervising intern doctors are between 3-4 years post graduation. They also all 
have heavy clinical loads. Primary hospitals range in size from central dispensary units 
without inpatient facilities that are manned by a single doctor, to larger base hospitals 
with more than ten doctors. Such hospitals do not have specialist-trained doctors, and 
there is a limited infrastructure for training. Often the nearest training may occur 
several hours away and an inability for doctors at these locations to obtain leave from 
clinical duties leads to professional isolation(15).  
 
‘Participatory action research’ - framework for methods used 
 
This research also has many features of participatory action research (PAR) which 
involves collective, self reflective inquiry that researchers and participants undertake, 
so that they can understand and improve upon the practices in which they participate 
(9, 16). The reflective process is directly linked to action, influenced by the 
understanding of history, culture, and local context and is embedded in social 
relationships. The process of PAR should be empowering and lead to people having 
increased control over their lives(9). PAR is a growing field that is noted to be of 
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particular value in the problems affecting low income countries, and in addressing the 
10:90 gap, a term highlighting that only 10% of research funds are addressing 90% of 
the global disease burden(9, 16-18). Another term for PAR that is seen in the literature 
is community based participatory research (CBPR)(16). 
 
The studies I carried out were reflective of this approach on many levels including the 
conduct of research through collaboration and development of partnerships with local 
authorities, development of sustaining and trusting community-researcher 
relationships, the assessment of barriers to achieving better health, and the 
dissemination of findings to practice and policy. Reflections on the use of these type of 
methods will be addressed in the final chapter.   
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Chapter outline 
 
The challenge of improving the medical management of OP poisoning in a resource 
limited rural setting is evaluated through interventional studies, and systematic reviews 
that form the chapters of this thesis. The chapters have been conventionally ordered 
with the background and systematic reviews at the beginning, followed by the 
description of experimental work. However, the research was undertaken in a different 
order, which is outlined below.   
 
The thesis starts with a review of the management of OP poisoning (Chapter 1) which 
describes how effective resuscitation, and targeted antidote therapy, are the accepted 
cornerstones of acute management in the incidence of severe OP poisoning. 
Improvements in these two aspects of medical management are the basis for the two 
streams of intervention, acetylcholinesterase (AChE) POC testing, and rural 
resuscitation training, which is the focus of the remainder of the thesis.   
 
The first half of the research assesses the introduction of an acetylcholinesterase POC 
test (Test-mate ChE 460) designed in North America for occupational use in the 
surveillance of agricultural workers rather than for use in the setting of severe OP self-
poisoning.  The POC Test-mate machine is first validated in this population (Chapter 
4). Thereafter the change in knowledge, attitude and practice of clinicians with 
exposure to seeing AChE test results was studied, with the expectation that the 
introduction of this widely recommended test may improve all three (Chapter 5). It 
became clear after the analysis of this study that interpretation of AChE results was not 
straightforward. Thus, I conducted a detailed systematic review of the literature on the 
range of specific recommendations for the use of AChE in the management of OP 
poisoning, and the degree such recommendations were backed up by evidence 
(Chapter 2).  
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The second stream of research was related to advance life support (ALS). I observed 
preventable poor outcomes in OP poisoned patients that were largely due to poor 
resuscitation. Frequently such results were observed in transferred patients who had 
been inadequately resuscitated at the peripheral hospitals where they first presented. I 
also observed a lack of practical training and supervision in resuscitation. This 
motivated me to carry out some pilot training work using mannequins, video technology 
and scenarios that led to shifts in ALS knowledge and skills. This pilot work is what 
inspired my study that evaluated the effectiveness of a train-the-trainer (TTT) model of 
resuscitation in peripheral hospital doctors (Chapter 6). It also addressed the shortage 
of specialist trainers through the use of peripheral hospital doctors to run peer-led 
resuscitation education workshops.  
 
In the context of doing general advanced life support training, it became apparent that 
specific OP ALS guidelines might more directly address the challenge of resuscitation 
in the context of OP poisoning. Thus, I conducted a systematic review (Chapter 3) that 
identifies which components are broadly accepted, and the sequence in which 
antidotes should be recommended, and this was incorporated into an OP specific ALS 
guideline. The TTT study described in Chapter 6 did not test the proposed guideline 
because the first step was to find out whether a “model” of training for rural hospitals 
was feasible and effective in teaching a previously validated guideline such as 
standard ALS.   
 
Chapter 7 summarizes the contributions, strengths and weaknesses of the thesis and 
outlines suggestions for future research and policy changes relating to AChE POC 
testing, and resuscitation training for OP poisoned patients.  
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Chapter 1: Overview of organophosphorus pesticide 
poisoning     
 
 
Published: This chapter has been published as a book chapter in an emergency 
medicine instructional text. 
 
 
Citation: Rajapakse BN, Buckley NA. Organophosphorus and carbamate agents. In: 
David SS, Brown A, Nelson B, Banerjee A, Anantharaman V, editors. Textbook Of 
Emergency Medicine: Lippincott Williams & Wilkins; 2011. p. 2113-21. 
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Highlights 
 
1) Anticholinesterase pesticides including organophosphorus (OP) compounds 
and carbamates are highly toxic insecticides requiring emergency 
management. 
2) They are responsible for over 200,000 deaths annually worldwide. Most follow 
deliberate self-poisoning and occur in the developing world. 
3) The primary toxic mechanism is inhibition of neuronal acetylcholinesterase that 
causes an acute cholinergic crisis and results in parasympathetic effects such 
as diarrhoea, urination, miosis, bronchorrhoea, emesis, lacrimation and 
salivation (DUMBELS). It can also cause cardiac effects such as brady- or 
tachycardia, and hyper- or hypotension, neuromuscular junction blockade and 
coma. 
4)  Initial management includes resuscitation (airway, breathing and circulation), 
oxygen, IV fluids, large doses of atropine, and oximes. 
5) Measurement of biomarkers such as red blood cell acetylcholinesterase (RBC-
AChE) and plasma cholinesterase (PChE) may guide management including 
when to start, continue and stop oxime therapy.  
6) Ongoing reassessment of respiratory status including the need for endotracheal 
intubation, and for atropine is essential to avoid morbidity.  
7) The delayed onset of respiratory failure due to the ‘intermediate syndrome’ up 
to 5 days later mandates prolonged careful observation.  
8) Carbamates are similar to OPs but have a more rapid onset and the inhibition of 
AChE is reversible. There is thus no benefit from the use of oximes.  
9) There is a large variation in case-fatality for OP from <2% to >30% and with 
carbamates from 2% to 10%.  
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Introduction 
Organophosphorus (OP) compounds and carbamates belong to the group of 
anticholinesterase drugs and are amongst the most widely used insecticides. 
Organophosphates are esters of phosphoric acid and are the active ingredients of 
many insecticides. Examples include parathion, malathion, chlorpyrifos, dichlorvos, etc. 
Accidental or suicidal exposure can cause life-threatening poisoning (19). The 
management of severe toxicity is the focus of this chapter because of its relevance to 
the field of emergency medicine.  
 
OPs are extremely toxic chemicals that present with a myriad of clinical problems in 
poisoning which lead to difficulties in management. Oral ingestion in cases of 
deliberate self harm may involve doses 100-1000 fold greater than occupational 
exposure. 
 
Anticholinesterase pesticides are a heterogenous class of agents with over 100 OP 
compounds and over 20 carbamates in use.  There is marked variation in toxicological 
manifestations and severity, which makes risk assessment and management more 
complex(3, 19). It is best to consider all oral poisonings with anticholinesterase agents 
as being potentially life threatening (20).  
 
Certain OP anticholinesterases have been developed as chemical warfare agents such 
as GA [tabun], GB [sarin], and GD [soman]. These are extremely toxic to humans and 
have a rapid onset of effects with more severe CNS manifestations. They have 
occasionally been used in recent times in warfare and terrorist attacks, but clinical 
experience and research are limited(19, 21).  
 
Carbamates are similar to OP in mechanism, presentation and treatment. They feature 
the carbamate ester functional group. Examples include aldicarb, carbofuran, 
fenoxycarb, carbaryl , ethienocarb, and fenobucarb. Carbamates have been regarded 
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as less toxic because of their reversible binding to acetylcholinesterase (AChE).  
Although the duration of toxicity is thus shorter, the onset is rapid and many have a 
comparable case-fatality to OP compounds(22).  
Epidemiology 
Anticholinesterase poisoning is most common in rural areas of the developing world, 
where as per the WHO estimates, millions of people are affected annually(1). In Asia 
alone 200,000 deaths per year result from intentional ingestion of OP compounds, with 
an estimated case fatality of 15-30%(1-3, 5). While much less common in the 
developed world, OP poisoning remains significant and still accounts for a substantial 
proportion of severe poisonings, with comparable case fatality rates(23).  
Pathophysiology 
Toxicodynamics,,
Anticholinesterase pesticides inhibit esterase enzymes, especially acetylcholinesterase 
in synapses (AChE) and on red blood cell membranes (RBC-AChE), and 
butyrylcholinesterase in plasma, which is sometimes referred to as ‘plasma 
cholinesterase’ (PChE).  
 
Inhibition of neuronal AChE prevents hydrolysis of the neurotransmitter acetylcholine 
(ACh) leading to its accumulation in both sympathetic and parasympathetic synapses 
(Figure 1-1). The initial effects predominate in the parasympathetic nervous system 
producing a range of clinical features known as the “acute cholinergic crisis”. These 
cholinergic features generally respond to high-dose atropine as they are due to action 
at the muscarinic Ach receptor. ACh accumulation also leads to central nervous 
system effects, sympathetic nervous system effects and neuromuscular junction 
blockade that are due to action on the nicotinic Ach receptor and these effects do not 
respond to atropine treatment. The exact combination of these different clinical 
features varies greatly depending on the particular OP compound. 
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Figure 1-1  Mechanism of organophosphorus (OP) poisoning- showing the three 
main reactions that occur; 1) reversible inhibition 2) reactivation and 3) 
irreversible inhibition (‘ageing’). 
Modified and reproduced with permission from Emergency Medicine Australasia 
2000;12:22-37(24)  
 
OP-inhibited neuronal AChE sometimes undergoes reactivation restoring normal 
function. This occurs at a slow rate spontaneously, or it can be catalysed by oximes 
(see Figure 1-1). However a proportion of inhibited AChE also undergoes irreversible 
inhibition, a process known as ‘ageing’. Aged AChE cannot be regenerated even with 
oxime therapy. New enzyme needs to be synthesised to restore function if a significant 
proportion of the AChE becomes aged. The extent to which induced or spontaneous 
reactivation occurs is determined by the chemical structure of the OP. The half-life of 
ageing also depends on this and ranges from minutes to 33 hours(25).  
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Toxicokinetics,,
Absorption**
All organophosphates are rapidly absorbed from the small intestine. Peak 
concentrations occur within a few hours after oral ingestion. Absorption after dermal 
exposure is slower and highly dependent on formulation. 
Distribution**
Organophosphates are a diverse group of compounds with a wide range of lipid/water 
solubility characteristics and have variable, but usually large, volumes of distribution 
(Vd). 
Metabolism2*Elimination**
Most OP are metabolised in the liver to more active metabolites (–thions are converted 
to –oxons). These “pro–” poisons such as parathion, fenthion and chlorpyrifos are 
usually highly lipid soluble and are eliminated slowly from fat. The slow conversion of 
these substances may lead to delayed and/or prolonged cholinesterase inhibition. A 
range of enzymes may be involved in detoxifying reactions such as Cytochrome P450 
(CYP450). A major route of elimination of the active oxon is through OP hydrolases 
such as paraoxonase(26).   
 
Clinical Features  
Four clinical syndromes are described in OP poisoning(26)  
1) Acute cholinergic crisis (the most common) – see Table 1-1  
2) Subacute proximal muscle weakness (‘Intermediate syndrome’) 
3) OP induced delayed neuropathy (OPIDN) 
4) Chronic OP induced neuropsychiatric disorder (COPIND) 
17 
 
Table 1-1  Clinical syndromes and manifestations of anticholinesterase poisoning  
(Table modified from (20, 27-30) . 
 
* Exception is highly fat soluble OPs such as fenthion which initially present with mild features abut have severe features after the first 24 hours(32) 
Clinical syndrome Onset of 
symptoms 
    Clinical Manifestations Lab investigations or special tests 
 
Muscarinic features Nicotinic features Central nervous 
system 
RBC-AChE 
(Normal taken as 
31.4 U/g Hb) 
 
PChE 
(Normal greater 
than 3200 IU/mL) 
 
Acute 
cholinergic 
syndrome 
(severity) 
 
Spectrum 
of 
features 
 
Immediately 
(peak onset 
usually by 6 
hours)* 
 
Parasympathetic activity 
 
Diarrhoea  
Urination 
Miosis 
Bronchorrhea 
Emesis 
Lacrimation 
Salivation  
(also bradycardia and 
bronchospasm) 
 
Fasciculations 
Muscle weakness  
Paralysis) 
Respiratory failure  
 
Sympathetic activity 
 
Mydriasis 
Tachycardia and Hypertension 
 
Confusion  
Agitation 
Decreased level of 
consciousness (LOC) 
Respiratory failure 
Seizures 
 
(Muscarinic and 
Nicotinic) 
 
Normal (>75%) 
 
 
Mild inhibition (30-
75%) 
 
 
Moderate 
inhibition  
(10-29%)  
 
 
Reduced levels 
simply confirm 
exposure.   
 
Severe 
Features 
 
Hypotension and bradycardia (or less commonly tachycardia) 
Dyspnoea, bronchial secretions and wheeze.  
Decreased tidal volume with paradoxical breathing 
Respiratory failure requiring ventilation 
Coma and seizures 
 
Severe inhibition  
(<10%)  
 
 
Intermediate Syndrome 
(IMS) 
 
24-96 hours  
 
Resolving 
 
Classically presents with 
respiratory muscle weakness 
often requiring intubation and 
mechanical ventilation for a 
period of time.  Neck muscle, 
bulbar and proximal limb muscle 
weakness. 
 
No consistent 
findings in CNS   
 
RBC-AChE and PChE likely to be 
persistently low. 
Repetitive Nerve Stimulation (RNS) 
findings – “Decrement-increment”  and 
“Severe decrement” patterns(31)   
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Acute Cholinergic Crisis 
This crisis consists of muscarinic, nicotinic and central nervous system (CNS) features 
of anticholinesterase poisoning as shown in Table 1-1. Symptoms occur rapidly usually 
within 4-6 hours of exposure.  In severe cases, life threatening respiratory failure 
develops rapidly due to excessive lung secretions and bronchospasm (muscarinic 
receptors); decreased level of consciousness (CNS effect involving both muscarinic 
and nicotinic receptors), and respiratory muscle paralysis (nicotinic receptors).  
 
Cardiovascular effects include bradycardia or tachycardia, hypotension or 
hypertension, ventricular arrhythmias, and cardiac arrest. Gastrointestinal tract (GIT) 
effects include vomiting and diarrhoea.  
 
Intermediate Syndrome  
This was described in 1987 as the delayed onset of severe muscle weakness 
(including respiratory muscle paralysis) occurring from day 2 onwards after patients 
had made an initial recovery(33). It is characterized by proximal truncal muscle 
weakness, neck weakness and sometimes bulbar palsy, classically occurring 1-4 days 
after poisoning and after resolution of the initial cholinergic crisis(34).  
 
This delayed onset of weakness can catch inexperienced clinical staff unawares and is 
a major cause of preventable death from OP poisoning. While the classical description 
is recognised, it is clear that the syndrome of delayed muscle weakness has a wide 
spectrum of severity ranging from sub-clinical to severe, and may occur with or without 
recovery from cholinergic effects, earlier or later than 24-96 hours(31).  
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Differential Diagnosis  
The classical presentation of OP poisoning with muscle fasciculation, pinpoint pupils, 
decreased level of consciousness and respiratory signs poses few diagnostic 
challenges, with the most pathognomic sign being muscle fasciculations, most easily 
observed on the tongue. A decreased PChE or RBC-AChE confirms the diagnosis.  
 
When there is no clear exposure history to anticholinesterase pesticides and the 
presentation is less than typical, the differential diagnosis is wide and will depend on 
the main symptom complex being exhibited. A patient with predominant dyspnoea, 
bronchorrhoea and wheeze may be mistaken as having cardiogenic pulmonary 
oedema or asthma(35). A patient with predominant CNS features and respiratory 
complications may be assumed to have a primary CNS problem and aspiration. 
Patients with profuse diarrhoea and vomiting may be mistaken to have gastrointestinal 
pathology. Other substances with overlapping manifestations such as clonidine, 
opioids, antipsychotic drugs, and chlorphenoxy herbicides should also be considered in 
a patient with an unknown poisoning.  
  
Investigations 
Biomarkers*of*exposure*
When available PChE and RBC-AChE measurements are useful in clinical 
management.  Both RBC-AChE and PChE have a wide normal range, and 
approximately 1:2000 normal individuals have no detectable PChE. PChE activity does 
not relate to the severity of poisoning, but is used as a sensitive marker of exposure to 
OP and to confirm the diagnosis. RBC-AChE correlates well with synaptic AChE 
function and is therefore a reasonably good marker of severity (see Figure 1-2). A 
major issue regarding the use of both RBC-AChE and PChE in clinical management of 
OP is the lack of availability of the tests. Bedside AChE detection kits are likely to 
become more widely available in the future management of acute poisoning. 
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Figure 1-2  Interpretation of biomarkers used in the management of 
anticholinesterase poisoned patients.   
(a) and (b) An increase in red blood cell acetylcholinesterase (RBC-AChE) activity after 
each bolus dose of pralidoxime. Continued ongoing response suggests that ongoing 
therapy may have been beneficial in the patient shown in (b). The late decline in 
activity in both cases is likely to be due to ‘aging’. (c) Rapid spontaneous reactivation of 
RBC-AChE in acute carbamate poisoning, where no oxime were given. A more gradual 
regeneration of plasma cholinesterase (PChE) is also noted (data from author (36)). 
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RBC-AChE  
RBC-AChE activity may be a useful guide to therapy in a number of different ways.  
Reduced activity (<75% of the lower limit of normal range) confirms the diagnosis of 
anticholinesterase poisoning.  The extent of depression roughly correlates with clinical 
severity (RBC AChE only) and less than 10% of normal activity is usually associated 
with severe toxicity(27). RBC-AChE activity may be used to monitor the therapeutic 
effects of pralidoxime, as the RBC-AChE activity should increase if the oximes are 
effective (see Figure 1-2a).  
  
Monitoring RBC-AChE activity can also suggest whether it is reasonable to stop 
oximes as RBC-AChE activity will fall rapidly over 6 to 12 hours once the oximes are 
stopped if there are still anticholinesterases present. If this is observed oximes can 
then be restarted as long as reactivation is continuing to occur (see Figure 1-2b). 
 
PChE  
PChE levels can indicate when there is no more anticholinesterase present as the 
PChE will steadily rise back to normal at the rate of 5-10% per day after the OP is 
eliminated(37). More rapid rates of recovery of both RBC-AChE and PChE  activity 
suggests reversible inhibition that is seen with carbamate poisoning (see Figure 1-2c).  
 
Despite the above notes there are many pitfalls in the use of biomarkers(3, 38). Whilst 
they can be helpful, the use of atropine and oximes in the management of 
anticholinesterase pesticide poisoning should be based primarily on clinical features. 
Investigations should play a secondary role in aiding clinical decision making. 
  
22 
 
Other*useful*investigations*and*measurements*
ECG– QT prolongation may occur, and both brady and tachyarrhythmia may be 
present. All patients with moderate to severe poisoning should be monitored on a 
cardiac monitor. 
 
Chest Radiograph– This should be done in all severe poisonings, as aspiration 
pneumonia, possibly due to the hydrocarbons in the formulation, is common. 
 
Arterial Blood Gas Analysis– It is indicated in severe poisoning to monitor respiratory 
function and to check for respiratory failure.  
 
Spirometry– Serial measurements of forced vital capacity or tidal volume are a method 
of detecting early respiratory muscle dysfunction 
 
Nerve conduction studies– Repetitive nerve stimulation studies are of most value in 
monitoring for the Intermediate Syndrome, as they show parallel changes with 
progressive muscle weakness(31).  A change from a decrement–increment pattern to 
progressive or severe decrements indicates severe weakness and that respiratory 
failure is usually imminent(31, 34).   
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Criteria for Diagnosis  
 
The finding of pinpoint pupils following agricultural exposure or a history of pesticide 
ingestion should raise suspicions of anticholinesterase poisoning. Widespread muscle 
fasciculation is pathognomonic in this setting. There is often a strong odour which may 
be due to hydrocarbon solvents. Other features of an acute cholinergic crisis 
DUMBELS (see Table 1-1) also aid in the diagnosis. Where doubt exists, the diagnosis 
may be confirmed by either a decreased RBC-AChE or PChE activity, although early 
emergency management must not wait for these tests.  
 
Treatment 
Principles*of*Therapy*
Therapy involves rapid resuscitation of the patient with oxygen, IV fluids, atropine, and 
sometimes an oxime acetylcholinesterase reactivator. See Table 1-2 for a summary of 
antidote use in treating anticholinesterase poisoning. 
 
Summary*of*Management*(see*also*Table*1@2)*(3,*5,*19,*22,*26,*35,*37,*39,*40)**
o Check airway, breathing and circulation. Place the patient in the lateral position with 
the head down. Provide high flow oxygen and perform endotracheal intubation if 
the patient’s airway or breathing is compromised. 
 
o Obtain IV access and give  
o 1-3 mg of atropine IV as a bolus, increase as required using a ‘doubling 
dose’ regime followed by an infusion(41) (see Table 1-2)  
o IV infusion of 0.9% normal saline to keep the systolic blood pressure above 
80 mmHg and urine output > 0.5 mL/kg/h 
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o If severe signs of poisoning are still present then give pralidoxime chloride 1-2g (or 
obidoxime 250 mg) intravenously over 20-30 min through a second IV cannula. 
Follow with pralidoxime of 0.5 g/h, (or obidoxime 30 mg/hr).  
 
o Re-assess atropine requirement  
o Continue with a doubling dose regimen if further boluses of atropine are 
required and titrate therapy to clinical response (improvement of 
bradycardia, hypotension, secretions and bronchorrhoea) (41). Assess for 
atropine toxicity which commonly present as delirium and tachycardia (42). 
o Where only some of the endpoints of atropinisation are achieved then the 
potential benefits should be weighed against the risks of giving further 
atropine boluses. Eg: A patient with resolved bradycardia who still had 
bronchorrhoea after atropine therapy may reach a point where further 
atropine doesn’t improve lung signs further (here other causes of 
bronchorrhoea such as aspiration must be considered) (5).  
o Severe hypotension may benefit from vasopressors, providing adequate 
fluid resuscitation has been given. 
 
o The need for, and duration of, continuing oxime infusions are controversial. 
Consider stopping oximes if atropine requirements are low and the patient is not 
intubated; or if there is an increase in PChE. The RBC-AChE can be monitored 
after stopping oximes.  If there is a fall in activity and worsening of symptoms, then 
the oximes may be recommenced (see Figure 1-2).  
 
o Treat agitation with adequate sedation using IV benzodiazepines such as diazepam 
0.1-0.2 mg/kg, or midazolam 0.05-0.1 mg/kg.  
o Physical restraints should be avoided for agitation as severe, life-
threatening hyperthermia may be provoked.  
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o Seizures should be treated with IV benzodiazepines such as diazepam 0.1-
0.2 mg/kg, or midazolam 0.05-0.1 mg/kg.  
o Benzodiazepines may also improve the central control of respiration, 
paradoxically improving respiratory function preventing the need for 
endotracheal intubation. 
  
o Ongoing frequent monitoring to: 
o Assess for a recurrence of an acute cholinergic crisis requiring further 
atropine. Such recurrences are most common with highly fat-soluble OP 
such as fenthion, where acute symptoms may occur up to 2-3 days 
following ingestion. 
o Review respiratory function. Intubation and mechanical ventilation are 
indicated if a patient’s tidal volume is below 5 mL/kg or vital capacity is 
below 15 mL/kg; if there are paradoxical or disordered diaphragmatic 
movements, or if apnoeic spells occur; or if the PaO2 <60 mmHg despite 
supplemental oxygen. 
o Monitor strength of muscle power, particularly neck flexion. The 
Intermediate Syndrome may develop 1-4 days after resolution of the acute 
cholinergic crisis, and manifest with proximal muscle weakness, neck 
weakness, and bulbar palsy. These indicate a high risk of respiratory failure, 
which may require intubation and ongoing ventilation in ICU.  
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Table 1-2  Antidotes for poisoning with anticholinesterase insecticides  
(Table modified from (5, 22)) 
 
Class of antidote Specific 
antidote 
Dose and administration Goal of 
Antidote 
Endpoints to titrate antidote Toxicity of Antidote Levels of 
evidence* 
for use 
 
Anti-muscarinic Atropine 
 
(others include 
glycopyrronium 
bromide and 
hyoscine 
methobromide – 
not discussed) 
Initially 1-3mg IV for adults.  
Re-assess in 5 min and double dose if 
endpoints have not been achieved.  
 
Continue doubling the dose every 3-5 min 
until endpoints of atropinisation are 
achieved.  
 
Large total doses may be necessary but 
usually not more than 25 to 75 mg.  
 
Follow on with 10-20% of the loading dose 
per hour as an infusion  
 
To reverse 
features of 
muscarinic 
overactivity. 
HR > 80/min 
Systolic BP > 80 mmHg 
Clear chest 
Dry axillae 
 
 
Delirium Hyperthermia  
Ileus 
Likely to be of 
benefit 
Oximes 
(acetylcholinesterase 
re-activator) 
Pralidoxime 
chloride  
IV loading dose 30 mg/kg over 20-30 min, 
followed by an infusion of 8 mg/kg/hr 
 
Thus in 60-70 kg adult =  2g followed by 500 
mg/hr infusion 
To prevent 
muscle 
weakness and 
respiratory 
failure 
(nicotinic 
features) 
Administer oxime infusion until 
either:- 
 
Clinical recovery (decreased or 
negligible atropine requirement) 
 
PChE starts to increase 
 
Serial RBC-AChE shows a lack of 
increase in response to oximes, 
or maintenance of RBC-AChE 
level after stopping oximes 
 
 
Vomiting 
Tachycardia & diastolic 
Hypertension (noted 
particularly when bolus given 
too rapidly)(39) 
 
Unknown 
effectiveness 
Obidoxime IV loading dose of 4mg/kg 
 
(followed by infusion of 750mg/day)  
 Unknown 
effectiveness 
Benzodiazepines Diazepam, 
lorazepam, or 
midazolam 
 
0.1-0.2 mg/kg (increments of 5-10 mg) to 
achieve endpoints. 
 
Or lorazepam 0.07 mg/kg up to 4 mg, or 
midazolam 0.05-0.1 mg/kg (increments of 
2.5-5 mg) 
To treat 
seizure activity 
and offer 
moderate 
sedation 
Control of seizures and sedation Decreased level of 
consciousness and respiratory 
depression. However 
paradoxically improved 
respiratory status has been 
noted in recommended doses 
of antidote 
Likely to be 
beneficial 
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Intubation)and)ICU)Management)
There should be a low threshold for early endotracheal intubation in OP poisoning (see 
above guidelines), as a high proportion of patients will need definitive airway 
management (43). In a series of 376 OP poisoned patients treated in a rural hospital in 
Sri Lanka, 24% of patients were intubated. Of these, 58% were intubated within the 
first 2 hours of admission, however, these patients usually did not require extended 
ventilation (32). In contrast those patients who were intubated after 24 hours usually 
required prolonged ventilation.  
 
In low resource settings, factors such as lack of ICU beds make the management of 
severe cases of poisoning challenging, including the decision if and when to intubate. 
However, delayed intubation in the patient with a compromised airway results in 
greater morbidity from airway complications. Failure to protect the airway early may 
also result in hypoxic brain injury and aspiration pneumonitis, with a longer stay in the 
ICU and greater secondary morbidity and mortality.  
 
Extubation can be difficult in OP poisoned patients owing to slow recovery of 
respiratory muscle function.  Re-intubation is frequently required so patients should be 
closely monitored for the first 12 hours after extubation. Ideally before extubation, 
patients should no longer require atropine or oxygen, be conscious and the tidal 
volume and neck muscle power should be improving.     
Carbamates)
The management for carbamates is the same as above except that oximes are not 
indicated. The clinical course is usually shorter; and delayed or prolonged respiratory 
failure is much less common. 
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Other)antidotes)
A number of other antidotes have been suggested largely based on small research 
series to improve the mortality and morbidity in OP poisoning. These include the use of 
fresh frozen plasma, magnesium, clonidine, and bicarbonate. Current data on these 
antidotes does not support their routine use. 
Decontamination)
Decontamination should only be performed after initial resuscitation is underway, 
including the use of atropine. Contaminated clothing should be removed, but should 
not compromise care.  
 
Gastric lavage is not supported by good evidence. It should not be performed until 
patients have been stabilised and the airway is protected with an endotracheal tube. 
Forced emesis also has no evidence supporting its use and has a high risk of 
increasing respiratory complications(44). It should be abandoned. Activated charcoal is 
not indicated. A recent large randomised controlled trial including 1310 patients with 
anticholinesterase poisoning showed no benefit on mortality or any other outcome from 
use of activated charcoal(45).  
Nosocomial)Poisoning))
Hundreds of thousands of patients with severe OP poisoning are seen by health care 
workers across Asia. Most workers use no special precautions other than gloves and 
gowns, and no cases of nosocomial (or secondary) poisoning with significantly reduced 
RBC-AChE activity have been reported anywhere in the world.  A recent consensus 
statement for Australian emergency departments concluded there was negligible risk of 
nosocomial poisoning in those treating OP poisoned patients if universal precautions 
such as the wearing of gloves, gowns and masks are used(46). 
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Prognosis 
The overall in-hospital case-fatality for OP poisoning is around 15%(3). However, the 
prognosis varies considerably with different OP, with case-fatality ranging from <2% to 
>30%. For example, in one large series the case-fatality for poisoning by chlorpyrifos, 
fenthion and dimethoate was 8%, 16% and 23% respectively(47). The case-fatality for 
each agent is approximately double when patients are symptomatic. There is less data 
on the case-fatality for the carbamates, however, one large cohort study showed 
similarly contrasting rates for carbofuran (2%) and carbosulfan (10%).  
Prevention  
Restriction of pesticides is important as self-poisoning is associated with ease of 
access to pesticides, particularly in rural parts of many developing countries in Asia. 
Significant decreases in mortality from pesticide poisoning have resulted following bans 
on the most highly toxic OP pesticides(48).  
Controversies 
The use of pralidoxime in OP poisoning  
 
• Oximes were discovered in the 1950s and consistently showed benefit with pre-
treatment (single dose) in animal studies. 
• Cohort and RCT studies however have shown contradictory results(25, 49, 50). 
• It is likely that oximes will benefit some patients at some dose and duration, but 
that they may also sometimes cause significant and serious adverse 
effects(50).  
• The 2000 WHO recommendations on dosing pre-date the most recent trials 
(see Treatment)(24). Further studies are therefore required to identify which 
patients will benefit, and what is the optimal dosing regimen. 
• Serial measurements of RBC-AChE may be useful to better titrate oximes dose 
to response. 
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Chapter 2: A systematic comparison of 
recommendations for the measurement of 
acetylcholinesterase in acute organophosphorus 
pesticide poisoning 
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Abstract 
 
Context: The measurement of the AChE biomarker has been suggested to be able to 
potentially assist in management of organophosphorus pesticide (OP) poisoning 
through confirmation of diagnosis and severity, guidance of oxime therapy (through 
provision of a titrateable endpoint to therapy), and patient discharge decisions. Despite 
improvements in access to the test in the last decade, there is still no published 
consensus statement giving unequivocal guidance on the use of AChE in the 
management of acute OP poisoning. 
 
Objective: The study aim was to answer to what extent there is a consensus on where 
AChE is recommended in the management of OP poisoning, and what specific 
parameters have been provided to guide AChE, through a review the literature using a 
systematic approach. 
 
Methods: 
Data sources - Review articles, book chapters and electronic resources were included 
in our source list.  
Study selection - Google scholar and Pubmed search engines were used to identify 
texts that focused on management recommendations for acute OP pesticide poisoning 
published between 2008 and 2013. Articles with an environmental focus on 
environmental poisoning, nerve agents, or chronic exposure were excluded.  The 
source list was supplemented by other relevant toxicological and emergency medicine 
texts that have been used in similar published reviews.  
 
Data extraction: We asked the literature 59 questions relating to recommendations for 
AChE in a range of situations and also recorded whether texts were citing literature in 
covering these topics.  
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Results: 27 texts (6 review articles, 15 book chapters, 6 monographs from online 
resources) providing recommendations for the management of acute OP poisoning 
were identified. 26/27 recommended the measurement of AChE in OP poisoning, and 
the majority of these recommendations were in the context of confirmation of diagnosis 
(23/27). The test was less widely recommended in the context of guiding oxime therapy 
(14/27), and patient discharge (6/27). Potential pitfalls were not covered widely (6/27) 
despite original evidence existing and being cited in a minority of this group. Specific 
cut-off points or reference values for AChE were lacking across the range of topics 
explored.  
 
Conclusions: This review identified two key gaps in the recommendations for AChE in 
the management of OP poisoning. The first gap surrounds a lack of primary evidence 
reporting specific guidelines for the use of AChE in relation to oxime use and discharge 
decisions, and the impact of the use of AChE on clinical outcomes. Better evidence, 
may help to reduce variation in guidelines, and improve the management of OP 
poisoning. 
 
The second was that existing evidence on pitfalls in measurement and interpretations 
are not widely covered in texts. Such preventable errors need to be highlighted 
routinely.  
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Background  
Organophosphorus pesticide (OP) self-poisoning is a significant global public health 
problem leading to 200,000 deaths each year in South Asia alone(1, 2, 51).  
 
Acetylcholinesterase (AChE) is an intermediate biomarker of OP poisoning that has 
been studied from the time that OP poisoning was first reported.  The measurement of 
this enzyme to assist in management of OP poisoning is often recommended in both 
Emergency Medicine and Toxicology textbooks (37, 52-55). Its potential roles have 
been discussed in the following broad areas;-  
 
1) confirmation of diagnosis and severity  
2) guidance of oxime therapy, and  
3) patient discharge decisions.  
 
However, some texts also note that there are many pitfalls to the measurement of 
AChE in practice, and that interpretation of AChE can be complex. Laboratory facilities 
are often unable to provide clinicians with results in a timely fashion, particularly in low-
income Asian countries where there is a high incidence of poisoning. Point-of-care 
AChE testing may partially solve this problem(56).  
 
There is no published consensus statement giving clear unequivocal guidance to 
clinicians on the use of AChE in the management of acute OP poisoning. The purpose 
of the current review, using a systematic approach, is to answer to what extent there is 
a consensus on a) where AChE is recommended in the management of OP poisoning, 
and b) what specific parameters have been provided to guide AChE. 
 
We are specifically interested in the strength and breadth of recommendation, and 
practical guidance that the literature provides regarding its use in the areas of 
confirmation of diagnosis and severity, guidance of oxime therapy, and patient 
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discharge decisions. Secondarily we are interested how the pitfalls of measurement, 
and the challenges with interpretation of AChE results are described in the literature 
when recommendations are present.  
 
Methods 
We performed a systematic literature review using google scholar searching for articles 
published between 2008 and 2013 that focused on the management of acute OP 
poisoning using the following search terms;- 
 
(organophosphate OR organophosphorus OR anticholinesterase) AND 
(poisoning OR toxicology) AND (treatment or management) AND (review OR 
book)  
 
A secondary search was made using PubMed searching for the same keywords but 
limited to review articles only.  
 
We were interested in management of patients who had been poisoned as a result of 
pesticide ingestion, so we specifically excluded texts that focused on nerve agents or 
chemical warfare, environmental exposures or animals, or that did not have any 
recommendations toward “management”.  
 
We limited the search to the last 5 years (2008 – 2013), and references that had a 
minimum citation index of 2 citations per year for review articles (for articles published 
before 2013), or at least 1 citation per year for book chapters (published before 2011), 
and we set this distinction on the rationale that text book chapters are less likely to be 
cited than articles.  
 
Major texts of Toxicology and Emergency medicine, handbooks and electronic 
resources were added to the source list as such resources have the potential to 
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significantly impact on medical care. The electronic resources included commonly 
accessed internet based resources such as UpToDate, and eMedicine. We followed a 
similar methodological approach that used in a comparative review of 
recommendations for a different component of OP poisoning management(41). 
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Figure 2-1  Search strategy for inclusion of texts in this review 
Pubmed 
Search Terms
(organophosphorus or 
organophosphate or 
anticholinesterase) and 
(poisoning or toxicology) 
and (treatment or 
management)
Limitations
Human, English, Review, 
Last 5 years publication 
(2008-2013)
77 results
Title review and/or abstract 
review
5 Review articles identified
(3 already identified from 
google search)
Google Scholar 
Search Terms
(organophosphorus or 
organophosphate or 
anticholinesterase) and 
(poisoning or toxicology) 
and (treatment or 
management)
Limitations
Human, English, Review, 
Last 5 years publication 
(2008 - 2013)
653 hits, 14 relevant
Title review and/or text 
review 
6 articles meet criteria;- 
• 3 book chapter
• 3 review articles
26
Related OP poisoning 
management reviews
33 texts in source list from 
Eddleston et al. (2004) 
List updated and expanded to 
28 current texts by Conner et 
al. (2013)
Source list limited to study 
criteria. Excluded following;- 
> 5 years  -      3
not focus -       7
canʼt access -  3
15 texts remaining from 
Connor et al. source list
1 updated version from 
Eddleston et al. (not included 
in Conner et al.)
Other supplementary texts
Other Book Chapters and 
Online resources that meet 
inclusion criteria
16
327 Texts
• 6 Reviews
• 15 Book chapters
• 6 Online resources  
Inclusion
• Clinical management 
focus 
• Acute poisoning
• Pesticide (not nerve gas)
• Current literature 
(Publication last 5 years)
Exclusion
• Non clinically focussed 
• No management 
instruction
• Environmental focus
• Chronic exposure focus
• Nerve agent texts
• Publication < 2008
• Non English language 
Selection criteria 
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The list of supplementary texts was guided by previously published literature reviews 
on aspects of OP poisoning management(41, 57). A diagram outlining the search 
strategy is shown in Figure 2-1.  
 
We asked the literature 59 specific questions relating to information about 5 domains 
covering a range of issues relevant to AChE recommendations in OP poisoning. These 
questions were constructed by a consensus amongst experts in the field. The broad 
domains of inquiry included recommendations for AChE in confirming diagnosis and 
assessing severity of OP poisoning, guiding oxime therapy and patient discharge, and 
pitfalls in measurement and collection, as well as difficulties in interpretation of assay 
results (Table 2-1).  We also recorded for each specific point that was covered, 
whether the various texts cited the scientific literature, and the number of citations 
quoted if more than one source was referenced.    
 
Results 
Table 2-1 lists 27 texts (3, 58-83) that were analysed to answer the research 
questions.  This includes of 15 book chapters, 6 review articles, and 6 monographs 
from online databases.  
 
Our search strategy identified a total of 304 hits on Google Scholar, 59 review articles 
from a Pubmed search, and 36 texts from other published clinical reviews on OP 
poisoning from the search terms used, but the list was refined to the final 27 texts 
based on selection criteria outlined in Figure 2-1. The majority of texts were excluded 
because of their focus on basic science or non-clinical aspects of the pharmacology of 
OP poisoning, environmental poisoning or poisoning by nerve agents. 
 
Almost all the texts (26/27) recommended the measurement of AChE for some aspect 
of OP poisoning management. Most recommended measurement of the assay in the  
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Figure 2-2  Coverage of topics on AChE recommendations for guiding clinical 
management  
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context of confirmation of diagnosis (23/27), and it was less frequently mentioned in the 
context of guidance of oxime therapy (14/27), and patient discharge (6/27) (Figure 2-2). 
The potential pitfalls of measurement of AChE were not widely covered, for example, 
caution about incorrect collection technique was only mention in 6/27 texts (Figure 2-
3).  
 
Specific cut-off points or reference values were lacking across the range of topics 
explored. Specific values were provided in less than half (11/23) the texts that 
recommended AChE for diagnosis, and in 1 out of the 6 texts that recommended it for 
discharge. Of the 13 texts that suggested AChE could be used to guide oxime therapy 
none provided specific values to guide clinical decisions (Figure 2-2).   
 
AChE biochemistry was variably covered. Some points, such as the distinction 
between RBC-AChE and PChE (25/27) were made by nearly all the texts. However, 
other details that were more focused on the clinical application of these biomarkers, 
such as PChE being a less specific marker of poisoning (6/27), were only covered in a 
minority of texts (Figure 2-3). 
Citation of scientific literature  
There was a large variation amongst texts in how often information was supported by 
citation. The total number of citations per text varied from 0 to 37 in relation to the 59 
review questions (Figure 2-4a). On average the review articles were more likely to cite 
the literature having a median of 4.5 citations per text, than book reviews or online 
resources where there was median of 1 citations per text (see Figure 2-4b). However, 
variation was also noted within all subgroups of review articles, textbook chapters and 
online monographs, where there were 1 or 2 outliers who quoted much more literature 
than average. It was also noted that citations for recommendations varied by topic. 
The proportion of recommendations with citations supporting pitfalls of measurement of 
AChE was almost double (33%) that for use of AChE in diagnosis, oxime therapy and 
discharge (17% each) (Figure 2-4c). 
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Figure 2-3  Coverage of topics on AChE biochemistry and pitfalls in 
measurement and interpretation of assays 
 
41 
 
 
 
Figure 2-4  Evaluation of citations quoted in chapter on OP poisoning, showing 
a) the total number of citations per text, b) the number of citations by type of 
text, and c) the proportion of recommendations for different domains of OP 
poisoning that refer to evidence. 
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Table 2-1  Coverage of topics related to recommendations of 
AChE measurement in OP poisoning management and 
frequency of citations to literature by different texts.   
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Google citation ( u = unavailable) 263 70 1 39 53 u 3 90 12 3 u u u u u u u u u u u u u u u u u
Overall 1 Recommend checking AChE level (in general) 1 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
2 AChE recommended for confirming Diagnosis 1 0 0 -1 2 0 2 0 0 0 -1 0 0 0 0 0 0 0 0 0 -1 0 0 0 -1 0 0
3  - Specific cut-off values -1 -1 0 0 -1 -1 1 -1 -1 0 -1 0 0 0 -1 -1 3 -1 0 -1 -1 2 0 -1 -1 -1 -1
4 AChE ranges for poisoning severity 2 -1 0 1 -1 -1 1 -1 -1 0 0 0 -1 0 0 -1 3 -1 0 -1 -1 2 0 -1 -1 -1 -1
5 Severity of poisoning correlated with symptoms 2 -1 0 -1 -1 -1 -1 -1 -1 0 0 0 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 0 -1 -1 -1 -1
6 Distinction between AChE and PChE made 2 0 0 0 0 -1 0 1 0 0 0 0 0 0 0 0 4 0 0 0 -1 1 0 0 0 0 0
7 RBC-AChE and PChE are only "markers" of OP poisoning 0 0 -1 0 0 -1 1 0 0 0 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 0 -1 -1 -1 -1 -1
8 PChE more sensitive marker of exposure 1 0 1 -1 -1 1 -1 -1 -1 -1 -1 -1 0 -1 0 -1 4 -1 0 -1 -1 1 0 -1 0 -1 -1
9 PChE is less specific for exposure -1 -1 4 -1 -1 -1 1 0 -1 -1 -1 0 0 -1 -1 -1 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1
10 PChE doesn't give information about poisoning severity 0 0 -1 -1 -1 1 -1 -1 0 -1 -1 -1 -1 -1 0 -1 4 1 0 -1 -1 0 1 -1 0 1 -1
11 Increasing PChE can indicate no more OP is present 0 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1 -1 0 0 -1 1 -1 1 -1 -1 -1 -1 -1 -1 -1 -1
12 PChE test can be used to provide prognostic information -1 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
13 RBC-AChE more reflects nervous tissue AChE 0 0 -1 -1 1 -1 1 0 0 -1 -1 -1 0 -1 -1 0 0 -1 0 -1 -1 1 -1 0 -1 -1 -1
14 RBC-AChE more reflects severity 2 0 -1 0 2 -1 -1 -1 -1 -1 -1 0 0 -1 0 -1 0 -1 0 -1 -1 1 0 -1 0 0 -1
15 RBC-AChE is a less useful marker after ageing 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
16 RBC-AChE levels take longer to return to baseline than PChE 0 -1 -1 -1 -1 -1 1 -1 -1 0 -1 0 0 -1 0 0 -1 0 -1 -1 -1 2 -1 -1 -1 -1 -1
17 Caution about incorrect collection technique 1 -1 -1 -1 -1 -1 2 -1 -1 -1 0 0 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
18 Temperature is a factor - PChE activity 1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
19 Ex-vivo mentioned for RBC-AChE 0 -1 -1 -1 -1 0 2 -1 -1 -1 -1 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
20 Room temperature can influence ex-vivo reactions 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
21 Cooling and dilution decreasing ex-vivo reactivation 0 -1 -1 -1 -1 0 2 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 1 -1 -1
22 Normal range in PChE is "assay dependent" 1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1
23 Advice about normal ranges for RBC-AChE 0 -1 -1 -1 -1 -1 0 -1 -1 0 0 0 -1 -1 -1 -1 2 0 -1 -1 -1 0 0 0 -1 -1 -1
24 Actual values for normal ranges for RBC-AChE 0 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
25 Advice about normal ranges for PChE -1 -1 -1 -1 -1 -1 1 1 0 0 -1 0 -1 -1 -1 -1 2 0 -1 -1 -1 0 0 0 0 -1 -1
26 Actual values for normal ranges for PChE -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1
27 Other factors affect normal range of RBC-AChE AChE -1 -1 -1 -1 -1 -1 2 -1 -1 0 0 -1 0 -1 -1 -1 -1 0 -1 -1 -1 1 -1 0 -1 -1 -1
28 Other factors normal range of PChE -1 -1 -1 -1 -1 -1 2 -1 -1 0 0 -1 0 -1 -1 -1 -1 0 -1 -1 -1 1 -1 0 -1 -1 -1
29 Mention specific pitfall(s) of interpretation (AChE) 0 0 -1 -1 1 1 0 0 1 0 -1 0 0 -1 -1 -1 4 -1 2 -1 -1 0 -1 -1 0 -1 -1
30  - Specifies pitfall for RBC-AChE 0 0 -1 -1 -1 0 0 -1 -1 1 -1 -1 -1 -1 -1 0 4 -1 -1 -1 -1 1 -1 -1 0 -1 -1
31  - Specifies pitfall for PChE 0 1 -1 -1 -1 -1 0 1 1 0 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1
32 False negative due to high baseline -1 0 -1 -1 -1 -1 1 1 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 1 -1 -1 -1 0 -1
33 False positive in RBC-AChE (not 100% specific) -1 -1 -1 -1 -1 -1 1 -1 -1 0 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 4 -1 -1 -1 -1 -1
34 Describe the variability of different OP agents -1 -1 -1 -1 -1 -1 1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 4 -1 -1 -1 -1 -1
35 AChE can guide oxime therapy -1 -1 4 -1 -1 -1 4 -1 -1 -1 -1 0 -1 0 0 0 0 0 0 -1 -1 0 0 0 0 0 -1
36 AChE should be measured if on oxime therapy -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 0 -1 -1 0 -1 -1 -1 -1 0 -1 0 -1 -1
37 Specifies RBC-AChE 0 -1 -1 -1 -1 -1 4 -1 -1 -1 -1 0 -1 0 0 -1 0 -1 0 -1 -1 0 0 0 0 0 -1
38 Specifies PChE -1 -1 -1 -1 -1 -1 4 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 -1 -1 -1 -1
39 Reactivation with oximes provides a guide to ageing 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 2 -1 -1 0 -1 1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1
40 AChE used to decide on starting oxime therapy -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
41 AChE measurement to be taken before starting PAM -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 0 0 0 -1 -1 -1
42 AChE before and after bolus dosing -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 0 -1 -1 -1
43 AChE measurement during oxime Rx -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 -1 -1 0 -1 -1 -1 0 0 -1 0 -1
44 AChE after stopping oximes -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
45 Guide to frequency of checking AChE in oxime therapy -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
46 How to interpret AChE in oxime therapy -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 0 0 0 -1 -1 0 -1 -1 -1 0 -1
47 Advised oxime Rx effective if RBC-AChE increases -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 0 0 0 -1 -1 -1 -1 -1 -1 -1 -1
48 Amount of increase specified -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
49 RBC-AChE can indicate when oximes are ineffective -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
50 AChE can indicate when to stop oximes -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 -1 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1
51 Distinguishes PChE and RBC-AChE -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 0 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
52 General information -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 -1 1 -1 0 -1 -1 0 -1 -1 -1 -1 -1
53 Specific cut-off points -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
54 States time period over which to monitor AChE -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
55 Recommend checking AChE level (in general) -1 -1 -1 -1 -1 0 0 -1 -1 -1 -1 -1 -1 -1 -1 0 1 -1 -1 -1 -1 0 0 -1 -1 -1 -1
56 AChE recommended for confirming Dx -1 -1 -1 -1 -1 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
57 Specific cut-off values -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1
58 AChE ranges for poisoning severity -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1
59 Severity of poisoning correlated with symptoms -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Colour Key - number of citations per recommendation
No recommendation
Recommendation without citation
x Recommendation with "x" number of citations
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Discussion  
There was a general agreement that AChE assay could help with diagnosis and should 
be ordered if available. However, the test is less likely to be practically useful in this 
situation because a diagnosis of OP poisoning is most often made without difficulty on 
the basis of history and clinical features. AChE is only likely to be helpful when there is 
a diagnostic challenge(73), such as with co-ingestion with other substances, or in 
paediatric populations when the diagnosis could be more elusive(84), and even in such 
situations the common lengthy delay to obtain results may limit its usefulness.   
 
Both oxime therapy, and discharge decisions are areas of OP poisoning management 
that can be complex, and one where a biomarker could be of great benefit. We 
paradoxically noted that texts much more frequently mentioned AChE’s potential to 
guide diagnosis and severity than mentioned its role in guiding oxime therapy or patient 
discharge (despite the much greater potential for improvement in clinical outcomes in 
the latter situations). Also only a minority (2/27) of the texts cited evidence 
recommending the measurement of AChE in the context of oxime therapy(59, 63). This 
likely reflects a lack of primary literature to support such recommendations. Similarly, 
only 1 of the 6 recommendations for use of AChE in discharge decisions referenced 
literature in support of this suggestion (73).  
 
Discharge decisions can be complex in OP poisoning with a proportion of poisonings 
from fat soluble OP agents having a delayed onset of cholinergic symptoms(47), up to 
2 days following the initial presentation.  Delayed respiratory failure (e.g. intermediate 
syndrome) may occur up to 96 hours following initial cholinergic symptoms (32, 47).  
 
There was also a lack of incorporation of evidence into recommendations noted, in 
particular with regard to the pitfalls of AChE collection, measurement and 
interpretation, where only a minority of texts provided citation for original articles. For 
example, an original study by Worek et al(85) highlighted that ex-vivo reactions could 
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lead to inaccurate measurements, but was only cited by 1 text(63) out of the 5 that 
described this phenomenon.   
 
Whilst some aspects of basic science of AChE were covered relatively widely amongst 
the texts, including the differentiation of RBC-AChE and PChE, only a few texts (6/27) 
highlighted the clinical relevance of some of these features, such as that increasing 
PChE may indicate that OP has been largely eliminated (3, 37, 63, 69, 73, 75).  
 
A common theme that was noted across all the different domains of question was the 
lack of specific values of AChE that were quoted in text. The lack of a detailed 
explanation of interpretation the complexity is likely to limit the utility of the advice 
(even if the principle is sound).   For example, the approach outlined above in regard to 
rising PChE needs to be further clinically evaluated to provide specific values that are 
sufficiently sensitive to exclude ongoing poisoning. 
 
Specific values were quoted for diagnosis, and severity, however, there was some 
variation in the exact cut-offs suggested for diagnosis, and different levels of severity. 
For example, the threshold for diagnosis varied between <90% and  <50% (59) of 
normal RBC-AChE. The format of reporting the test and values also varied between 
texts with some discussing only one of the two biomarkers (RBC-AChE and PChE) and 
even a few that were unclear as to which cholinesterase test was referred to. 
Correlations of values with symptoms and management implications such as “patients 
with less than 10% of normal red-cell AChE activity had grossly deranged muscle 
function and needed high doses of atropine”(3) was only occasionally  provided.  
 
No text that suggested increasing AChE indicated effectiveness of oxime therapy 
provided specific values or details on the extent of increase that was required. 
Supporting material was limited to two texts that simply showed an illustrative case of 
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the expected behavior of AChE levels with oximes(3, 75). This highlights the need for 
more research to guide the use of AChE in assessing oxime response.  
 
Few texts covered the many pitfalls in interpretation. For example, the significant 
variation in normal ranges for PChE and to a lesser degree RBC-AChE was highlighted 
in only a minority of texts. 
    
To our knowledge, no reviews have previously examined the literature 
recommendations for use of AChE in OP poisoning management. However, there are 
two related reviews on recommendations for initial atropinisation in OP poisoning, 
which have been published roughly 10 years apart (41, 57). The first review pointed out 
great variation in recommendations that existed in the literature, but encouragingly the 
more recent review showed there was an emerging consensus in recommendations 
supported by clinical studies. We hope this article might prompt a similar reevaluation 
of AChE and encourage new evidence.  
 
We used google scholar as the main search engine to find texts that were focused 
upon the management of OP poisoning because it offered a broad search that included 
textbooks, journal articles, and online resources, and to this effect it is argued by some 
authors to provide a sensitive first choice search strategy(86). However, the solo use of 
google scholar is still controversial, and when we used PubMed to perform a 
secondary search, we found two extra review articles.  
 
The key limitation of this study is that our search criteria may have missed texts that 
are from non-English speaking countries and that are widely used. However, we have 
covered a broad range of texts that are accessed by clinicians and most of our 
conclusions are not sensitive to small changes in the number of included texts.    
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The type of publication contained within our source list ranged widely in type and 
length of article, and it is possible word restrictions in some of the smaller publications, 
such as handbooks, and more concise textbook chapters, may have been a factor 
impacting on the wide variation in coverage of all questions and topics assessed. The 
list included clinical handbooks, such as the Oxford clinical handbook of Emergency 
Medicine(77), where the text was only a single page in length, to reports in large 
compendiums of clinical practice, such as Goldfranks toxicology textbook whose 
chapter on OP poisoning was 45 pages in length(63). We also assessed online 
resources(78-83) as we wanted to review all guidelines that were easily accessible to 
clinicians. These online monographs often had a different format and style from 
textbooks and review articles. However, the main finding of variation of 
recommendations was noted both between types of texts and within these subgroups 
(shown in Table 2-1, and highlighted in Figure 2-4c).   
 
It was beyond the scope of the current study to systematically evaluate the quality of 
information that was being cited by the reviewed texts. However, we noted a range of 
sources being referred to including review articles and also original scientific papers. 
Most supporting citations were to other review articles/textbooks; and in some key 
areas such as the interpretation of AChE in oxime therapy, or the use of AChE in 
discharge decisions, there was a complete absence of citations to supporting original 
research. 
 
Conclusion 
This review identified two key gaps in the recommendations for AChE in the 
management of OP poisoning. The first gap surrounds a lack of primary evidence to 
support specific guidance in the use of AChE in relation to oxime use and discharge 
decisions, and whether this approach improves clinical outcomes. Better evidence, 
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may help to reduce variation in guidelines, and improve the management of OP 
poisoning. 
 
The second gap was that existing evidence on pitfalls in measurement and 
interpretation was not widely covered in texts.  Such preventable errors need to be 
highlighted routinely.  
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Chapter 3: A systematic comparison of 
recommendations for advanced life support (ALS) in 
organophosphorus poisoning  
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Abstract 
 
Context: Resuscitation, including advanced life support (ALS) is the main stay of the 
emergency treatment of OP self poisoning. Despite high case fatality from this 
condition, responsible for 200,000 annual global deaths, there are still no international 
guidelines that describe an ALS protocol for OP poisoning, or suggest how this would 
differ from standard ALS.  
 
Objective: The study aim was to find a) whether ALS instructions are described in the 
literature on OP poisoning management, and b) to identify what are the recommended 
components of ALS, including the sequence and priority of specific antidotes, and how 
this differs from standard ALS. 
 
Methods: 
Data sources - Review articles, book chapters and electronic resources were included 
in our source list.  
Study selection - Google scholar and Pubmed search engines were used to identify 
texts that focused on management recommendations for acute OP pesticide poisoning 
published between 2008 and 2013. Articles with an environmental focus on 
environmental poisoning, nerve agents, or chronic exposure were excluded.  The 
source list was supplemented by other relevant toxicological and emergency medicine 
texts that have been used in similar published reviews.  
 
Data extraction: Texts were analysed to see whether they met a predefined criteria for 
having an instructive ALS format. Questions were then asked to identify which 
components of resuscitation were recommended and what their relative priority was. 
The questions used for data extraction covered a range of options including airway, 
breathing, circulation, disability, antidote therapy, exposure and staff safety, 
gastrointestinal decontamination, and post resuscitation care.  
50 
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Results: 27 texts (6 review articles, 15 book chapters, 6 monographs from online 
resources) providing recommendations for the management of acute OP poisoning 
were identified.  Less than half 10/27 recommended were written with an instructive 
ALS framework, and more commonly had a narrative that provided a discussion of a 
range of potential treatments. The majority of texts (9/10) included antidote therapy, 
and atropine was included as a component ALS in 8 of these texts, and a rapid 
atropinisation protocol was specified in 7/8. Oxime therapy was an ALS component in 
5/10 texts. Atropine was given a higher priority in 6/8 texts and an equal priority in 2/8, 
but was mentioned before oximes. Does of atropine specific to cardiac arrest were not 
available in the literature. Airway support was highlighted as a management priority in 
almost all texts, airway opening maneuvers (6/27) and managing the patient in a left 
lateral position (4/27) was only mentioned in a minority of texts.  
 
Conclusions: There is no consistently described protocol for ALS in OP poisoning 
management. We created an ALS guideline based upon a relative consensus in the 
literature that emphasises the importance and priority of early rapid atropinisation such 
as that achieved by using a doubling dose regimen, We did not include oxime therapy 
in the guideline as there was a lack of clear recommendation, and oximes are unlikely 
to provide predictable improvement in the underlying pathophysiology that causes 
acute respiratory failure. Further research needs to be conducted on the specific 
antidote therapy that is likely to improve outcomes in active cardiac arrest. Also 
outcome based research on effectiveness of strategies for airway support at the 
bedside should be undertaken as respiratory arrest is the basis of much of OP 
poisoning mortality and addressing it’s prevention is an important component of ALS 
for this condition.  
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Background  
Organophosphorus pesticide (OP) self-poisoning is a condition that results in up to 
200,000 deaths annually in Asia(1-3, 32, 51). The condition’s case fatality is estimated 
to be 8-15% despite current management, and this is primarily due to respiratory 
arrest, which progresses to cardiorespiratory arrest(32, 87). Resuscitation, including 
advanced cardiac life support (ALS) is the mainstay of emergency treatment in acute 
OP poisoning.  
 
Currently there are no international guidelines that describe an ALS protocol for OP 
poisoning, or suggest how this would differ from standard ALS. However, precedent 
has been set in the resuscitation literature for toxicological resuscitation to be treated 
as a “special condition” in international guidelines on resuscitation(88) and the scientific 
literature(89). Modifications to standard ALS have been described for a number of 
toxicological presentations addressing the underlying pathophysiology of these more 
uncommon presentations. The international liaison’s committee on resuscitation 
(ILCOR) is the largest body of advice for resuscitation and in the 2010 guidelines 
documented special considerations in the delivery of ALS for 10 conditions ranging 
from digoxin overdose to carbon monoxide poisoning(90). However, such modified 
protocols only addressed poisoning presentations that are commonly encountered in 
higher income countries. OP poisoning which is primarily a condition of the developing 
world has not been covered, despite it being the leading cause of poisoning death 
globally and having a higher risk of in-hospital death the the poisonings currently 
covered in ALS guidelines. Development of such a guideline may have been inhibited 
by incomplete consensus on recommendations for the overall management for OP 
poisoning(3, 91-93). 
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Acute ALS in OP poisoning – literature recommendations 
The focus of the current review was to identify whether literature recommendations for 
OP poisoning management can be incorporated into the existing ALS framework, to 
provide a specific focus on acute care delivery within the first 15 minutes to 1 hour of 
acute OP poisoning that requires resuscitation.  
 
Figure 3-1 illustrates 3 commonly encountered case scenarios of OP poisoning that 
demonstrate a spectrum of presentations at this high end of severity, ranging from 
critical illness and peri-arrest, to full blown cardiorespiratory arrest. All of these cases 
require immediate resuscitation according to an ALS framework.  These scenarios 
were based upon real encounters of patients who had consumed variable amounts of 
OP pesticide orally in a rural background, (often with co-ingestion of alcohol) 
presenting to secondary referral centers in Sri Lanka(48, 94). The generalizability of 
these scenarios, is supported by similar presentations in case series reported from 
developed world settings (61), with comparable case fatality (23).  The aim of having a 
backdrop of these scenarios in such settings was to provide a frame of reference to the 
clinical questions we were asking from the literature.   
 
Adequate training in skills, and knowledge of how to act, is likely to be an important 
aspect of reducing mortality in managing the most severely poisoned patients. Such 
management puts the greatest onus on the frontline doctors, who are often not well 
equipped to deal with such situations.  A previous treatment protocol has been 
published targeting this group(5). This protocol dealt with severe poisoning but 
provided minimal advice on the management of the patient in cardiorespiratory arrest. 
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Figure 3-1  Case scenarios depicting a range of severity of acute OP poisoning presentations requiring acute ALS.  
Corresponding research questions for a literature review that would provide a toxicology integrated ALS guideline are also shown. 
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Aim of Tox-ALS management recommendations
1) What proportion of the OP management literature is focussed on the above spectrum of severity and 
is structured in an ALS framework to provide stepwise instructions in the above cases?
2) Does a toxicologically integrated ALS guideline currently exist?
3) Which antidotes would it include, and where with they be inserted in the ALS framework?
4) What would be the focus and order of other ALS components (ABCDEʼs, including decontamination)?
5) How much this guideline based upon recommendation literature be in agreement with current original 
research on the same topic?
Literature 
Review
Research 
Questions
  Arrest Critical illness  Peri- arrest
Spectrum of severity 
Figure 1 - Case scenarios depicting a range of severity of acute OP poisoning presentations requiring acute ALS, and corresponding 
research qu stions for a literatur  review that would provide a toxicol gy intergrated ALS guideline  
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This chapter aims to investigate how well structured the literature on OP poisoning 
management is in the provision of ALS instruction. Specifically we are interested in 
which components ALS components should be included and in what order they should 
be carried out. We also paid particular attention to where specific antidote therapies, 
such as atropine, pralidoxime and diazepam, should be inserted in the sequence, and 
whether they belonged at all in the framework of acute ALS. We were also interested in 
the degree to which the unique aspects of OP poisoning pathophysiology were 
addressed by the components of ALS that were recommended, including muscarininc 
features that compromise both the cardiovascular and respiratory systems and the 
relative position of atropine in comparison with oxime in the ALS framework.   
 
 
Practically speaking the aim of the review was to find out what a junior doctor could 
use within the first 15 minutes of treating an acutely poisoned patient who is either 
critically ill, or who had arrested, and to identify the areas of consensus and variation in 
components and sequence of ALS in OP poisoning, and where antidote therapies fit 
into this sequence.  
 
Methods 
We performed a systematic literature review using google scholar searching for articles 
published between 2008 and 2013 that focused on the management of acute OP 
poisoning using the following search terms;- 
 
(organophosphate OR organophosphorus OR anticholinesterase) AND 
(poisoning OR toxicology) AND (treatment or management) AND (review OR 
book)  
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A secondary search was made using PubMed searching for the same keywords but 
limited to review articles only. 
 
Our area of interest was in management of patients who had been poisoned as a result 
of pesticide ingestion, so we specifically excluded texts that focused on nerve agents 
or chemical warfare, environmental exposures or animals, or that did not have any 
recommendations toward “management”.  
 
We limited the search to the last 5 years (2008 – 2013), and references that had a 
minimum citation index of 2 citations per year for review articles (for articles published 
before 2013), or at least 1 citation per year for book chapters (published before 2011), 
and we set this distinction on the rationale that text book chapters are less likely to be 
cited than articles.  
 
This recent time frame was chosen to allow examination of literature that had the 
opportunity to incorporate the most recent scientific literature. The reason for this is 
that there had been a significant increase in research funding examining 
organophosphate poisoning dating from 2002.  This increase in funding reflected 
concerns of both the global significance of OP poisoning in self-harm and concerns 
about chemical warfare agents. This funded research supported large clinical 
observational studies, randomized controlled trials, and clinical reviews in many areas 
of acute management, such as efficacy of oxime therapy(49, 50, 95), atropine dosing 
regimen(42, 96), bedside monitoring of cholinestase(56) and peripheral nerve 
function(97) in acute poisoning, issues with decontamination(44, 98), reviews on 
alternate antidotes(99), as well as position statements for staff safety in initial 
management(46). Given the recent expansion literature on OP poisoning management 
and the lag time between original research becoming incorporated into guidelines, the 
current is perhaps timely.  
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Major texts of Toxicology and Emergency medicine, handbooks and electronic 
resources were added to the source list. The electronic resources included commonly 
accessed internet based resources such as UpToDate, and eMedicine, as such 
resources have the potential to significantly impact on medical care. 
57 
57 
 
 
Figure 3-2  Search strategy for inclusion of texts in this review 
 
Pubmed 
Search Terms
(organophosphorus or 
organophosphate or 
anticholinesterase) and 
(poisoning or toxicology) 
and (treatment or 
management)
Limitations
Human, English, Review, 
Last 5 years publication 
(2008-2013)
77 results
Title review and/or abstract 
review
5 Review articles identified
(3 already identified from 
google search)
Google Scholar 
Search Terms
(organophosphorus or 
organophosphate or 
anticholinesterase) and 
(poisoning or toxicology) 
and (treatment or 
management)
Limitations
Human, English, Review, 
Last 5 years publication 
(2008 - 2013)
653 hits, 14 relevant
Title review and/or text 
review 
6 articles meet criteria;- 
• 3 book chapter
• 3 review articles
26
Related OP poisoning 
management reviews
33 texts in source list from 
Eddleston et al. (2004) 
List updated and expanded to 
28 current texts by Conner et 
al. (2013)
Source list limited to study 
criteria. Excluded following;- 
> 5 years  -      3
not focus -       7
canʼt access -  3
15 texts remaining from 
Connor et al. source list
1 updated version from 
Eddleston et al. (not included 
in Conner et al.)
Other supplementary texts
Other Book Chapters and 
Online resources that meet 
inclusion criteria
16
327 Texts
• 6 Reviews
• 15 Book chapters
• 6 Online resources  
Inclusion
• Clinical management 
focus 
• Acute poisoning
• Pesticide (not nerve gas)
• Current literature 
(Publication last 5 years)
Exclusion
• Non clinically focussed 
• No management 
instruction
• Environmental focus
• Chronic exposure focus
• Nerve agent texts
• Publication < 2008
• Non English language 
Selection criteria 
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The list of supplementary texts was guided by previously published literature reviews 
on aspects of OP poisoning management (41, 57). A diagram outlining the search 
strategy is shown in Figure 3-2. 
Evaluation*of*recommend*components*and*sequence*of*ALS*in*OP*poisoning*
 
69 specific questions, constructed by a consensus amongst experts in the field, were 
used to evaluate which components of ALS were being recommended in literature on 
management to OP poisoning, and what general sequence these were carried out. 
These questions were grouped according to a standard framework of ALS including 
airway, breathing, circulation, disability, with additional questions focused on post 
resuscitation care, antidote therapy and decontamination which related more to the 
toxicological context of ALS (Table 3-1).    
 
Recommendation*style:*ALS*framework**
We included texts as having an ALS framework based upon characteristics of the 
recommendation style (see Box 3-1). For the style to be considered compatible with an 
ALS framework there had to be a dedicated section of text dealing with the initial 
resuscitation with more than single word descriptions about the steps of management. 
These steps had to include the management of airway, breathing and circulation, at a 
minimum, to be considered to cover the topic of ALS, however, they also could include 
other components such as antidote therapy, disability and decontamination. The 
section also had to be written in an instructive style, rather than a third person 
description to qualify as an ALS framework (Box 3-1).   
 
The rationale for these criteria was to search for a format of recommendation that could 
easily be followed in an emergency without the need for deliberation between 
alternative therapies.  
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ALS framework  (instructive, ordered sequence of steps) 
 
1) Is there a specific section that addresses Airway, Breathing Circulation (ABCs) 
2) Is section instructive ! include ALS framework,  
3) Are components ordered?  ! include ALS framework 
 -  Are components numbered ! note “numbered steps” 
 
 
Box 3-1  Method for determining whether a text was considered 
to provide recommendations within an “ALS framework”;- 
 
Any text that offered a discussion of possible interventions that would require further 
evaluation before taking action was not regarded to have an instructive ALS format.   
 
We also recorded whether a numbered list of steps was provided which was used to 
further differentiate the ALS texts.  
 
Specific Therapies in ALS framework 
 
When an ALS framework was present, it was recorded whether atropine, oxime or 
diazepam administration was reported. When both oxime and atropine were 
recommended we recorded in which order and/or priority atropine therapy was given in 
relation to oxime therapy.    
 
 
Results 
 
Table 3-1 lists 27 texts (3, 58-83) that were analysed to answer the research 
questions.  This includes of 15 book chapters, 6 review articles, and 6 monographs 
from online databases.  
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Table 3-1  Questions answered by different texts across a 
range of topics covering ALS recommendations in acute OP 
poisoning.  
Darker shading indicates when questions were answered by statements that cited 
other literature. The number of citations for each point is also noted.   
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Citations 263 70 1 0 0 0 0 88 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
General 1 Alterations to standard ALS specified -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
2
Respiratory support highlighted as 
Mx priority 0 0 1 0 0 0 2 0 0 0 -1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
3 Left lateral position, neck extended 2 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 -1 -1 -1 -1 -1 -1 -1
4 Oxygen 0 0 0 0 -1 -1 -1 0 -1 0 -1 -1 0 -1 -1 0 -1 0 0 0 0 0 0 0 -1 0 0
5 Open airway 0 -1 -1 0 -1 -1 -1 -1 -1 0 -1 -1 0 0 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1
6 Monitor ventilation volume 0 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 0 1 -1 -1 -1 0
7 Monitor neck flexors 0 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 0 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 0
8 Indication to intubation provided 0 -1 -1 0 0 -1 0 0 -1 0 -1 0 -1 0 -1 -1 -1 -1 0 0 -1 0 -1 0 -1 0 0
9 Aspiration is a complication of OPP 0 -1 -1 0 -1 -1 -1 0 -1 0 -1 -1 0 -1 -1 -1 -1 0 0 -1 -1 -1 0 -1 -1 -1
10 Avoid suxamethonium -1 -1 -1 -1 -1 -1 3 -1 -1 -1 -1 -1 0 -1 -1 1 1 0 -1 -1 0 1 0 -1 0 -1
12 IV access 0 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 0 0 -1 -1 -1 0 0 0 -1 0
13 x2 IV cannulae (one for PAM) 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
14 IV fluids 0 -1 -1 -1 -1 0 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 -1 -1 0 0 -1 0 0 0
15
Rate specfied to target physiol 
endpoint 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
16 Give Atropine 1 0 0 0 0 0 2 0 0 3 0 0 0 0 0 0 0 5 0 0 0 0 3 0 0 0 0
17 Consider PAM 1 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0
18 Arrhythmia management -1 0 0 -1 -1 -1 -1 0 0 0 -1 0 -1 0 -1 -1 -1 0 -1 -1 -1 4 0 0 0 -1 0
19 Inotropic support indication 1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 0 -1 0 -1 0
20 Recommends specific Ionotropes -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1
21 Other circulation guidelines -1 -1
22 Linked to ALS/resuscitation 0 -1 0 0 1 0 2 0 -1 0 0 0 0 0 0 -1 0 -1 0 -1 0 0 0 0 0 0 0
23 Atropine: Doubling dose 2 -1 -1 1 2 -1 2 -1 -1 4 0 -1 0 0 0 4 2 -1 1 -1 -1 0 2 -1 0 0 0
24 Review frequently (every 5 mins) 0 -1 -1 1 -1 -1 2 0 -1 -1 0 -1 0 0 0 4 2 0 0 0 -1 0 2 -1 0 0 1
25
atr endpoints- P, BP, Sweat, Chest 
sounds 0 0 -1 1 1 -1 1 0 -1 -1 0 0 -1 0 0 -1 -1 -1 1 -1 -1 -1 -1 -1 -1 -1 -1
26 Evidence in favour of giving atropine 2 1 -1 1 1 -1 2 0 -1 -1 0 0 0 -1 0 1 -1 -1 -1 -1 -1 0 0 0 0 0
27 No need for oxygen before atropine 4 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
28 Describe Sx of atropine toxicity 1 -1 -1 1 2 -1 1 -1 -1 0 0 -1 0 -1 -1 0 -1 1 -1 -1 1 0 -1 -1 -1 0
29 Describe Mx of atropine toxicity 0 -1 -1 1 -1 -1 2 -1 -1 0 -1 0 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
30 Linked to ALS/resuscitation 0 -1 0 -1 -1 1 0 -1 -1 0 0 0 0 0 0 -1 0 -1 0 -1 0 0 -1 -1 -1 -1 0
31 controversy of efficacy discussed 0 8 -1 1 0 -1 8 2 6 0 7 0 -1 0 -1 1 1 0 -1 -1 5 0 2 0 2 -1
32
Specifies PAM as antidote (mesylate 
or Chloride) 2 1 -1 1 1 0 0 0 0 0 0 3 0 0 0 1 0 0 2 0 0 0 0 0 0 2 0
33
WHO dose PAM (2g Pam, 
pralidoxime 0.5-1g/h in 0.9% 
normal saline) 2 1 -1 1 1 -1 -1 3 -1 -1 0 3 0 0 0 0 0 0 2 0 -1 1 3 -1 1 2 0
34 Alternative dose PAM -1 1 -1 -1 -1 -1 -1 3 1 1 -1 3 -1 0 0 -1 -1 0 -1 -1 0 1 -1 0 0 -1 -1
35 Specifies Obidoxime 2 1 -1 -1 -1 0 0 -1 -1 -1 0 0 -1 -1 -1 4 -1 -1 2 -1 -1 0 0 -1 -1 -1 0
36 WHO dose of Obidoxime 2 1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 1 -1 -1 2 -1 -1 1 3 -1 -1 -1 0
37 Alternative dose Obidoxime -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 2 -1 -1 -1 -1 -1
38 Indication clearly provided -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 0 -1 0 0 0 0 -1 0 0 0 -1 0 -1 -1 0 -1
39 titrate to provided clincal endpoint? -1 0 -1 -1 -1 -1 -1 0 0 0 0 -1 0 0 0 0 0 2 -1 -1 0 0 -1 -1 0 0
40 titrate to RBC-AChE endpoints? -1 -1 -1 -1 -1 -1 3 -1 -1 -1 -1 3 -1 -1 0 0 0 0 2 -1 -1 -1 0 -1 -1 0 -1
41 Other PAM / Atropine comments 1 0 -1 -1 -1 -1 0 -1
42 treatment of siezures with diazepam 0 0 -1 1 1 1 1 8 -1 0 -1 5 0 0 -1 3 1 1 2 -1 0 0 3 0 0 0 0
43 treat agitation with Diazepam 0 0 -1 1 1 1 1 1 -1 -1 -1 5 -1 0 -1 3 1 -1 2 -1 0 0 0 -1 -1 -1 0
44 Do not restrain agitated patients 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
45
Risk of hyperthermia c restrained 
pts 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1
46 Other -1 -1 -1 -1 -1
47
Resuscitation/stabilisation prior to 
decontamination 0 -1 0 -1 0 -1 -1 0 0 0 -1 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0
48
Protection of airway prior to GI 
decontamination 0 0 -1 2 -1 -1 0 0 0 0 -1 0 0 0 -1 -1 -1 0 0 -1 -1 0 -1 -1 0 0 -1
49 Remove contaminated clothes -1 -1 0 0 1 0 0 0 -1 0 0 0 0 -1 0 0 0 0 -1 0 0 0 0 -1 0 0 0
50 Wash skin with soap and water -1 -1 1 0 1 -1 1 0 -1 0 0 0 0 -1 0 -1 -1 0 -1 0 0 0 0 0 0 -1 -1
51
Recommend universal precautions 
for staff 1 -1 -1 0 0 -1 0 -1 -1 2 -1 -1 0 -1 0 0 -1 0 1 -1 0 0 0 0 0 -1 0
52
Only consider Gastric Lavage if less 
than 1 hour post ingestion 1 -1 -1 0 -1 -1 -1 0 -1 0 -1 -1 -1 -1 -1 -1 -1 1 -1 -1 0 -1 -1 -1 -1 0 -1
53
Discuss lack of benefit from charcoal 
Rx 1 2 -1 1 2 -1 1 0 0 0 -1 -1 -1 -1 0 1 1 0 1 -1 -1 -1 0 -1 0 1 -1
54
Discuss potential benefit of charcoal 
given early (within 1-2 hours) -1 1 -1 0 -1 -1 -1 0 -1 -1 -1 -1 0 0 -1 -1 1 -1 -1 -1 -1 1 0 -1 0 0 -1
55
(-)Nosocomial poisoning over 
emphasised -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 1 -1 -1 -1 -1 -1 -1 -1 -1
56 (-)Suggest giving charcoal -1 -1 -1 1 -1 -1 -1 -1 2 -1 0 0 -1 0 -1 -1 -1 0 -1 -1 -1 1 1 -1 0 0 -1
57
(-)Gastric lavage suggested as 
priority -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
58 (-)Forced emesis suggested -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
59 Other 0 -1 1 -1 -1 -1
60
Close monitoriing after cholinergic 
crisis 1 -1 -1 0 0 -1 -1 0 -1 -1 0 0 0 -1 2 -1 0 -1 -1 -1 -1 0 -1 -1 0
61
specifies for delayed respiratory 
paralysis 0 0 -1 -1 -1 -1 0 -1 -1 0 -1 -1 -1 0 0 -1 -1 -1 0 -1 -1 -1 0 -1 -1 -1 0
62
specifies risk of recurrent cholinergic 
crisis ( fat depot of fat soluable OPs) 0 -1 -1 -1 -1 0 1 -1 -1 0 -1 -1 0 0 -1 -1 0 -1 0 -1 -1 1 -1 -1 -1 -1 -1
63
Frequency & duration of monitoring 
specified 0 0 -1 -1 -1 1 -1 -1 -1 0 -1 -1 0 -1 0 -1 3 -1 0 -1 -1 -1 -1 -1 -1 -1 0
64
lower priority of other treatment 
than standard care highlighted 0 0 -1 0 -1 0 -1 0 -1 -1 -1 0 0 -1 -1 0 -1 0 0 -1 -1 0 0 0 -1 -1 0
65 Magenesium sulphate 0 -1 -1 1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 0 -1 -1 2 -1 1 -1 -1 -1
66 Alpha 2 blockers (clonidine) 0 -1 -1 1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 0 -1 -1 1 -1 -1 -1 -1 -1
67 NaHCO3 0 -1 3 1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -1 -1 -1 1 0 -1 -1 -1 1 -1 0 -1 0
68 Haemodialysis 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 6 0 -1 -1 -1 -1 0 -1 -1 -1 4 -1 -1 -1 -1 -1
69 BuChE scavengers 0 -1 1 1 -1 -1 -1 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 0 -1 -1 2 -1 -1 -1 -1 -1
Colour Key - number of citations per recommendation
No recommendation
Recommendation without citation
x Recommendation with "x" number of citations
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Figure 3-3  Resuscitation guidelines in OP management texts showing a) the 
proportion of texts written in an ALS framework, using an instructive format b) 
which antidotes included in ALS framework, and c) the priority and given to 
atropine over oximes in the ALS framework   
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Our search strategy identified a total of 304 hits on Google Scholar, 59 review articles 
from a Pubmed search, and 36 texts from other published clinical reviews on OP 
poisoning from the search terms used, but the list was refined to the final 27 texts 
based on selection criteria outlined in Figure 3-2. The majority of texts were excluded 
because of their focus on basic science or non-clinical aspects of the pharmacology of 
OP poisoning, environmental poisoning or poisoning by nerve agents. 
 
Proportion of texts with ALS framework 
Less than half (10/27) the texts were written within an ALS framework (Figure 3-3a) 
whilst the majority provided recommendations through a narrative that had varying 
degrees of focus on the acute initial management, and often contained a discussion of 
more than one potential treatment.  Over half (6/10) of the former group had 
instructions that were organized in numbered steps providing a clear sequence to the 
components of ALS.  A subset of the texts (2/10) consisted of both a general 
discussion and an ALS framework that supplemented the other in the form of a table 
(82) or a box inset(3). One text clearly outlined in a table alternative sequences to ALS 
components (e.g. intubation, atropine, decontamination) based upon the severity of 
poisoning(68). However, this text was not considered to have an ALS framework due to 
the lack of detail and instruction associated with the components described, thereby 
not meeting the criteria of “detailed stepwise instructions that could be used in an 
emergency” as defined in Box 3-1.   
 
The majority of texts written in an ALS compatible format (9/10) included antidote 
therapy, and atropine administration was included as a component of ALS in 8 of these 
texts (Figure 3-3b). Atropine was recommended for all symptomatic patients, and a 
rapid infusion protocol involving a doubling dose was specified for all but one of these 
texts (7/8). Oxime therapy was included as an ALS component in 5/10 texts and a 
further 2/10 texts where the instruction was either less definite or conditional (e.g. 
“consider giving oximes”(66), or “give oximes if symptoms are present only after 
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atropinisation”(75)).  Atropine was given a higher priority in the sequence of ALS steps 
than oximes in all but two texts (6/8), and in one text oximes were not mentioned in the 
ALS section of recommendations(79) (Figure 3-3c). In the two texts that were marked 
as having no distinction in priority, atropine therapy was mentioned first. However, 
there was insufficient explanation of the significance of this position to favour the 
importance of atropine over oximes in the ALS sequence. Benzodiazepines were 
mentioned as an antidote in 8/10 texts, being recommended for either seizures or for 
agitation.  
 
General recommendations for antidote therapy 
General recommendations for antidote therapy, sourced from the complete set of 
reviewed texts, which include both those texts that had an ALS framework to those 
texts that provided recommendations for more general situations (Figure 3-3).  Atropine 
was linked to resuscitation in the majority of texts (22/27), whereas only 15/27 talked 
about oximes in the context of resuscitation and initial management. More than half the 
texts also highlighted the importance of atropine as core component in management of 
OP poisoning, compared to oxime therapy where 19/27 texts described the controversy 
that surrounds the efficacy of oximes. Evidence was cited in over half of these texts on 
that topic.  
 
The majority of texts recommended a doubling dose of atropine (17/27) and WHO 
equivalent dose of oxime administration (20/27). Obidoxime was less often specified or 
recommended as a potential oxime agent (11/27). 
 
When looking across all texts regardless of whether recommendations were provided 
in an ALS framework, atropine (22/27) was again more widely recommended in the 
context of resuscitation and acute care than oximes (15/27), see Figure 3-4.  
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Figure 3-4  Recommendations for specific therapies in OP poisoning sourced 
from all texts 
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Figure 3-5  Review of literature recommendations regarding airway, breathing 
and circulation components of ALS in OP poisoning resuscitation 
 
  
0 10 20
Recommends specific ionotropes
Inotropic support indication
Arrhythmia management
Rate specfied to target physiologic endpoint
IV fluids
x2 IV cannulae 
IV access
Avoid suxamethonium
Indication to intubation provided
Monitor ventilation volume
Monitor neck flexors
Left lateral position, neck extended
Open airway
Oxygen
Respiratory support is management priority
Number of texts covering topic
Airway, Breathing and Circulation 
ALS recommendations in OP resuscitation
evidence citedNo citation
Airway/ Breathing
Circulation & IV therapy
67 
 
 
 
 
 
 
Figure 3-6  Review of literature recommendations regarding the disability, 
decontamination and staff safety aspects of ALS in OP poisoning resuscitation. 
Post resuscitation monitoring recommendations are also displayed.  
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In over half (19/27) of reviewed texts the controversy surrounding efficacy of oxime’s 
use was mentioned with just under half or these (8/19), providing references to 
evidence to substantiate the uncertainty of this therapy. Whilst all the text mentioned 
the possibility of oxime therapy, only 11/27 texts clearly stated or suggested that it was 
indicated. Conversely the recommendation for atropine was clear across all texts, with 
over half (16/27) identifying it as either a well established or core treatment in OP 
poisoning management.     
 
 A rapid atropinisation regimen was widely recommended, with a doubling dose 
strategy being described in 17/27. Approximately half of the latter group cited the 
research behind this strategy of atropine dosing(41).  
 
Pralidoxime was specified as an oxime in almost all texts, with only 11/27 additionally 
specifying obidoxime as a possibility. The majority of texts (18/27) described the WHO 
recommended dose of oximes, but an alternative dose was described in 12/27 texts.  
 
Other therapies recommended 
 
A range of other treatments including magnesium sulphate, alpha 2 blocking drugs, 
sodium bicarbonate, and haemodialysis or haemoperfusion, and bioscavengers were 
mentioned in a minority of texts (between 5 and 9/27). They were also described under 
sections peripheral to the core management section and given a lower priority than a 
standard antidotal treatment of atropine plus pralidoxime when recommended. One 
exception was in a review article where sodium bicarbonate therapy was given a higher 
priority, with the citation of other supporting evidence(59).  
 
Airway, breathing, circulation, disability and decontamination  
 
Airway support was highlighted as a management priority in almost all the texts (Figure 
3-5) sometimes linked to a description of the pathophysiological basis for this 
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impairment of this system (e.g. both central respiratory depression and bronchorrhoea 
from peripheral secretions).  However, only a minority recommended practices or 
actions that would specifically address airway problems such as airway opening 
maneuvers (6/27), and managing the patient in the left lateral position (4/27) with the 
neck extended to avoid the risk of aspiration. Recommendations to open the airway, 
continued assessment of tidal volume, and neck flexor strength was mentioned in only 
6/27 texts. Indications for intubation was provided in approximately half (14/27) of the 
texts, but these were for the most part an instruction, such as intubate if respiratory 
compromise, rather than measurable criteria such as in one text intubation was 
suggested based upon tidal volume and arterial oxygenation(3).   
 
Less than half the texts highlighted recommendations that specifically prioritized 
aspects of managing the circulatory system (for example, stating that IV access should 
be established, or that 2 IV lines were required). A minority of texts highlighted how the 
pathophysiology of OP poisoning could give rise to hypotension and only 2/27 texts 
emphasized the titration of IV fluid therapy towards a clinical endpoint. Inotropic 
therapy was only discussed in 6/27, and only 2 texts recommending specific inotropes 
however, the recommendations were not accompanied by clear rationale or citations to 
original research. 
 
Disability, decontamination and post-resuscitation monitoring recommendations 
 
Benzodiazepines for seizures and agitation were recommended in 22 and 16 texts 
respectively (Figure 3-6). Agitation due to over atropinisation, and treatment to avoid 
hyperthermia in restrained agitated patients were given as indications in only 3 texts.   
 
There was agreement amongst the texts with the importance of resuscitation and 
stabilization prior to any decontamination attempts (21/27 texts). The lack of evidence 
for gastrointestinal decontamination after 1 hour from ingestion, due to rapid absorption 
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from the stomach, was highlighted in a minority of texts. Protection of the airway prior 
to gastrointestinal decontamination, if indicated, was recommended in half (14/27), but 
only one linked this assertion to evidence such as a published review of 
complications(44) following gastric lavage.  
 
A recommendation of universal precautions for all staff was noted in 13/27 texts, with a 
small subset referring to a position statement(46) that provided further evidence for 
how secondary poisoning of staff was rarely if ever documented. A minority over 
emphasized staff safety, and others suggested elaborate personal protective gear with 
a lack of evidence supporting these recommendations.   
 
Patterns of citations of supporting literature 
The recommendations for airway, breathing and circulation were not supported by 
citations to the literature in general, however some specific points relating to airway 
recommendations such as avoiding suxamethonium (due to the risk of prolonged 
respiratory paralysis) were cited in a high proportion.  
 
A high proportion of the recommendations relating to antidote administration with 
regards to atropine, oximes and other treatments were associated with more frequent 
reference to supporting literature.   
 
Discussion 
  
This review highlighted that there is no consistently described formula for ALS in OP 
poisoning management. Analysis of recommendations from a variety of emergency 
medicine, and toxicology texts across the standard domains of ALS including airway, 
breathing, circulation, disability and decontamination, and specific antidote therapy 
revealed some areas of relative consensus surrounding the importance and priority 
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early rapid atropine administration, and some areas where there was variation such as 
in the recommendation of oxime therapy.  
 
Guideline for ALS in OP poisoning  
 
We created a guideline (Table 2.1 and Table 2.2) focusing specifically on ALS 
guidelines for two levels of severity at high end of the highest end of the critical illness 
spectrum. The three case scenarios gave context to these levels which ranged from 
managing a patient presenting with severe poisoning and critical illness (peri-arrest) to 
patient who has already had a cardiac arrest from OP poisoning (Figure 3-1).  This 
guideline aimed to provide a sequence and priority to the key ALS elements in the 
context of what should a junior doctor do right now, in the first 15 minutes to one hour, 
when faced with any one of these patients.  
 
We review a range of types of text ranging for clinical and toxicology hand books 
(Oxford Clinical Handbook of Medicine(77), Olson’s Poisoning and Drug Overdose(69)) 
to compendiums of Emergency Medicine (Tintinalli(74), Rosen(72)), and Toxicology 
(Goldfrank’s(63)). As such, the scope of recommendation was quite wide. The majority 
of texts were concerned with providing an overview of potential therapies that someone 
studying the topic of OP poisoning management could use, along with reasonable 
detail regarding controversies in treatment, and covered a range of aspects of 
treatment from initial management to ongoing treatment. As hypothesized no text was 
solely focused on the acute initial management and resuscitation of severely poisoned 
or arresting patients. The information concerning ALS components had to be extracted 
to answer our research questions outlined in Table 3-1, and was not always possible 
due to gaps in the provision of ALS instruction.  
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Table 3-2.1  ALS guideline for acute OP poisoning – Severity 
level 1.1 (cardiorespiratory arrest) 
 
 
Sequence § 
 
 
Details 
 
Initial priorities: CPR + Atropine 
 
 
1. Compressions + 
Atropine 
 
 
2. Ventilate/ Intubate 
 
 
 
 
3. Continue IV Atropine 
 
 
 
 
 
 
 
 
 
3. IV Fluids 
 
 
 
 
4. Cardiac monitoring  
 
 
 
5. Ongoing post-
resuscitation monitoring 
 
Monitor atropine 
 
 
 
Monitor for respiratory 
failure 
 
 
6. Decontamination  
 
 
 
 
 
Start CPR according to ALS guidelines  
• Give atropine bolus 5mg 
• Consider longer duration of CPR >30mins   
 
Open airway, oropharyngeal airway, Bag-mask ventilate, 
intubate (without drugs) between cycle when able (consider 
administering via ET tube if no IV access)  
 
 
IV access. Give atropine as soon as possible in 
conjunction with CPR / airway measures. 
 
IV atropine 2mg bolus initial dose, re-assess every 5 mins 
for achievement of endpoints of atropinisation (clearing of 
chest secretions, P>80, sBP>80, drying of peripheral 
secretions/sweating). If endpoints not achieved double the 
dose and continue re-assessment.  
 
 
IV fluids 20ml/kg stat Normal saline, or equivalent 
crystalloid, with continuous infusion -> Aim to keep systolic 
BP above 80mmgHg, and urine output >0.5mL/kg/hr. 
 
 
Apply cardiac leads to check for arrhythmia's if available. If 
Torsades de Points occur - give 2mg MgSO4 as rapid IV 
infusion 
 
After ROSC - will need ICU level monitoring for at least 
24hours 
 
Continue doubling dose of atropine until atropinisation is 
achieved, re-assesing every 5 mins. Follow with an 
atropine infusion of 10-20% the total dose used*.  
 
Check Neck Flexion & Tidal volume (see indications for 
intubation – Table 3.3) 
 
 
Remove excess clothing can occur in conjunction with 
Steps 1-4, but defer skin washing until ROSC (which can 
otherwise impair life saving CPR and ALS). When stable 
wash skin with soap and water.  
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Gastric Lavage (GL) and Activated Charcoal (AC) are not 
indicated unless patient has been stabilised, and treated 
with oxygen and atropine 
 
Thereafter perform GL only if <1-2hours from time of 
ingestion, and airway is protected; with orogastric tube 
ONLY after airway protection with intubation. Finish with a 
dose of AC 
 
 
Table 3-2.2 ALS guideline for acute OP poisoning – Severity 
level 1.2 (critical illness / peri-arrest)  
 
 
Sequence § 
 
 
Details 
 
Initial priorities: Airway management/ Atropine / +/-intubate early 
 
 
1a. Airway management 
 
 
 
 
 
1b. IV Atropine 
 
 
 
 
 
 
+/- Intubation  
 
 
 
 
 
 
 
2. Continue IV atropine 
 
 
 
 
 
 
3. IV Fluids 
 
4. Cardiac monitoring  
 
 
Suck excess secretions 
Open airway (head tilt, chin lift, jaw thrust) 
FiO2 100% via non-rebreather mask 
Manage in left lateral position, head down, avoid aspiration 
 
 
IV access, IV atropine 2mg bolus initial dose, re-assess 
every 5 mins for achievement of endpoints of atropinisation 
(clearing of chest secretions, P>80, sBP>80, drying of 
peripheral secretions/sweating).  
If endpoints not achieved give double the IV dose and 
continue re-assessment.  
 
If respiratory compromise intubate (see “indications for 
intubation” – maintain low threshold) 
 
Intubation pathway  
Induction agent: Diazepam 5mg IV  
Muscle relaxant: Rocuroneum (non depolarising muscle 
relaxant) 
 
re-assess every 5 mins for achievement of endpoints of 
atropinisation. If endpoints not achieved give double the 
IV dose and continue re-assessment.  
 
If atropinisation is achieved, follow on with an atropine 
infusion of 10-20% the total dose used.  
 
20ml/kg, titrate towards sBP>80mmHg, UO >0.5ml/kg/h 
 
Apply cardiac leads to check for arrhythmia's if available. If 
Torsades de Points occur - give 2mg MgSO4 as rapid IV 
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5. Post resuscitation 
monitoring 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Decontamination 
 
 
 
 
infusion 
 
ICU monitoring. If intubated monitor ventilator settings and 
oxygenation 
 
If not intubated, continue to review respiratory function;-  
 
Indications for intubation  
• Tidal volume < 5mL/kg  
• Apnoea 
• PaO2 <60mmHg 
• FiO2 >60% 
 
Check for  
A) re-development of cholinergic signs & symptoms  
B) development of peripheral respiratory failure  
1) Flexor neck strength (ask to life head off bed) 
2) Continue to check Tidal volume every 4 hours  
 
Remove excess clothing can occur in conjunction initial 
resuscitation. When stable wash skin with soap and water. 
(discard contaminated clothing) 
 
Gastric Lavage (GL) and Activated Charcoal (AC) are not 
indicated unless patient has been stabilised, and treated 
with oxygen and atropine 
 
Thereafter perform GL only if <1-2hours from time of 
ingestion, and airway is protected; with orogastric tube 
ONLY after airway protection with intubation. Finish with a 
dose of AC 
 
 
Key to ALS guideline  
 
ROSC - return of spontaneous circulation  
GL - gastric lavage 
AC - activated charcoal  
sBP - systolic blood pressure 
P - Pulse, HR - Heart rate, bpm - beats per minute  
 
§ Staff Safety - Universal precautions (gloves and gown) for all patient contact. Use 
facemask if treating patient in closed environment, and rotate staff to minmise 
exposure to hydrocarbon solvent.  
 
Nosocomial poisoning is not a significant threat(46). Avoid delays to resuscitation of 
patient (NB - sealed whole body suite is not indicated). 
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Table 3-3.1  Guidelines for atropine ALS of OP poisoning 
   
  
Atropine in ALS 
 
Indication  
 
Give to all symptomatic patients to address cholinergic symptoms.  
 
Rapid administration is urgently required in severely symptomatic 
patients, and should be given as a priority, ie together with the 
delivery of other essential ALS components such as airway, 
breathing and circulation   
 
 
Rationale 
 
Aim is to improve cardiac and respiratory function as soon as 
possible through reversal of muscarinic effect of OP poisoning from 
build up of acetycholine. Atropine therapy can improve 
bronchorrhoea, bradycardia and hypotension. It may also have 
anticonvulsant effects(58) 
 
 
Evidence 
 
The rapid atropinisation, doubling dose regimen described below 
has been recommended in order to achieve the high doses of 
atropine necessary(5) and widely incorporated into 
recommendations(57). Clinical trials have demonstrated a lower 
mortality(96) and adverse effects(42) with this approach compared 
to ad hoc administration of atropine. 
 
 
Standard dose 
(severe 
poisoning) 
 
Adult: 2mg IV bolus, (Child: 0.05 mg/kg IV bolus) 
Re-assess every 5 mins for achievement of endpoints of 
atropinisation 
 
Once parameters have begun to improve, cease doubling dose. 
Similar or smaller doses can be used. Once patient is stable start 
atropine infusion of 10-20% of total dose need to stabilise patient 
over 1 hour. (3, 5, 41) 
 
Endpoints Give atropine until 
• Chest is clearing (with clinical judgment as  
• HR > 80 bpm 
• sBP > 80 
(Sweating stops, Pupils dilate) 
 
Keep giving atropine, doubling dose every 5 minutes until endpoints 
achieved 
 
Sweating stops in most cases. Pupils will commonly dilate and not a 
useful sign of endpoint of initial atropine treatment because a delay 
exists before maximal effect. However, very dilated pupils are an 
indicator of atropine toxicity. (3, 5, 41) 
 
Adverse 
effects 
Confusion, urinary retention, hyperthermia, bowel ileus and 
tachycardia (70) 
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Treatment: Stop infusion. Can give diazepam if agitation. Restart 
atropine later.  
 
Do not restrain patient for toxicity as can develop life threatening 
hyperthermia(3) 
 
Guideline to 
dosage 
Cohort of 22 severely poisoned patients required total mean of 
23.4mg of atropine, and maximum of 75(41) 
Hundreds of milligrams of atropine by bolus and continuous infusion 
may be required over the course of several days (82). A maximum 
daily dosage as high as 3.5g has been reported(68). 
 
Arrest dose 
(increased IV 
bolus) 
 
In the context of cardiorespiratory arrest, the most efficacious dose 
has not been established through clinical trials.  
 
In Asia an initial dose of 5-10mg of atropine is commonly used, and 
there is no evidence to suggest that such a dose would be 
detrimental in an arrested patient.  
 
Table 3-3.2  Guidelines for benzodiazpines ALS of OP 
poisoning 
  
  
Benzodiazepines in ALS 
 
Indication  
 
For treatment of seizures and status epilepiticus 
 
For mild sedation in agitation caused by OP toxicity, or adverse 
effects of over atropinisation 
 
WHO recommends this routinely based on animal studies.  
 
Should be given in any ventilated patient for it’s potential 
neuroprotective effect, and limited adverse effects in this setting  
Endpoints Mild sedation  
Maintains safe level of consciousness 
 
Adverse 
effects 
Over-sedation, decreased level of consciousness 
 
 
 
Table 3-3.3  Indications for intubation as part of ALS in OP 
poisoning   
 
  
Intubation in ALS 
 
Acute 
assessment 
 
All patients with respiratory compromise should be adequately 
atropinised (See atropine dose) as this may improve bronchorroea 
and bronchospasm 
 
Suck secretions, open airway, administer oxygen 
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Ongoing 
assessment 
 
Assess neck flexor strength regularly in conscious patients  
(Ask patient to lift head off the bed and hold it in that position 
whilst pressure is applied to the forehead) 
 
Tidal volume should be measured every 4 hours in these patients 
 
Indications for 
intubation (3) 
Intubate and ventilate patients if either;-  
• tidal volume is below 5mL/kg  
• vital capacity is below 15mL/kg,  
• apnoeic spells are present  
• PaO2 < 8kPa (60mmHg) on FiO2 >60% 
 
 
Considerations 
in OP poisoning  
 
Avoid suxamethonium as prolonged respiratory muscle paralysis 
may occur due to inhibition of pseudocholinesterase 
 
Instead a competitive neuromuscular blocker such as rocuroneum 
can be used  
 
Diazepam should be given to all patients after intubation as animal 
studies have shown a neuroprotective effect, and paradoxical 
improvement in respiratory function 
 
 
Table 3-3.4  Guidelines for oximes in OP poisoning  
 
  
Oximes in OP poisoning  
(not indicated in acute ALS) 
 
Indication  
 
In symptomatic patients who are not responding to atropine therapy.  
 
PAM is most likely to be effective early, however, do not delay 
active resuscitation (ie Airway, Breathing, Circulation and Atropine) 
to administer PAM. There is a lack of evidence to suggest it’s 
befit in the ALS framework for OP poisoning.  
 
Considered if there are nicotinic symptoms for certain OP within 
certain time limits;   
dimethyl - 4 hours   
diethyl - 24 hours 
 
 
Endpoints 
 
Clinical 
• no clear established endpoints (effects may be delayed).  
• may see improvement in muscle power or decrease in 
fasiculation  
• NMJ function using RNS or “train of 4” 
 
Biochemical  
• Increase in RBC-AChE in response to bolus may indicate 
effectiveness of oxime therapy 
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• Decline of RBC-AChE within 6 hours post stopping oximes may 
indicate OP still active in system and benefit of re-starting oximes  
 
Adverse 
effects 
Rapid administration can lead to hypertension, vomiting and a 
transient reversible neuromuscular blockade(72) 
 
 
The question of what sequence antidotes should be inserted or integrated into an ALS 
framework could only be accurately answered from the 11 texts reported in a format 
that allowed interpretation of a sequence of components. Comparing recommendations 
across both this subset of ALS framework texts and the entire collection, the message 
of atropine being an integral component of OP poisoning treatment and oximes being 
secondary was clear.  Many of the texts acknowledged the controversy of oxime 
efficacy; many without explicitly stating whether they were advocating its use or 
not(63). Oximes are unlikely to provide a predictable improvement in the underlying 
pathophysiology that causes acute respiratory failure. In addition given the overall lack 
of evidence for efficacy, in any phase of OP toxicity, we have left oximes out of the ALS 
algorithm. This is in keeping with the majority of texts that were reviewed.  
Use of guidelines to manage case scenarios 
Scenario A in the depicted in Figure 3-1 is relevant to OP ALS algorithm, severity level 
1.1 which outlines a cardiac arrest algorithim where there is muscarinic hyperactivity.  
Scenarios B and C pertain to the severity level 1.2.  In both these ALS guidelines the 
key feature that is emphasized, and only covered in a minority of the reviewed texts, is 
the integration of ongoing rapid atropine infusion during the delivery of other 
components of ALS. In both cases establishing an initial intravenous bolus of atropine, 
followed on by doubling doses and frequent reassessment is present in conjunction 
with cardiopulmonary resuscitation in the level 1.1 algorithm, and in conjunction with 
airway opening and intubation in the level 1.2. There is a sound rationale for the use of 
an antimuscarinic in OP poisoning, and particularly in resuscitation as the majority of 
cardiac arrests are as result of an initial respiratory arrest, that progresses to 
cardiorespiratory arrest. As many as 25% of acute OP presentations require ventilation 
and intubation, and this is likely to occur within the first 24 hours(32). Early respiratory 
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failure develops because of central respiratory failure due to the CNS effects of OP of 
poisoning, and peripheral respiratory failure due cholinergic activity leading to 
increased lung secretions and bronchospasm; atropine in adequate doses reverses 
these processes.  The highly cited paper that has promoted this treatment protocol (5), 
has led to extensive adoption of this approach by other texts(57). However, the position 
of atropine early in the sequence of ALS was only promoted or emphasized in a few 
texts and this gap in ALS recommendations is a key finding in the current review that 
has been addressed within the proposed ALS guideline.  The lack of emphasis for 
early atropine is compounded by the fact that the position of antidotes in a sequence of 
management steps is less clear or not possible in texts that don’t provide instructions in 
an ALS framework or some other kind of ordered format.  
 
A further difference in the proposed guideline to the reviewed texts is the removal of 
oximes from the ALS guideline. Only one text that had recommendations in a ALS 
format omitted oximes as we are suggesting(79). However, all 8 texts that 
recommended antidotes as part of their ALS framework suggested a lower priority of 
oxime therapy compared with atropine in the sequence or ALS components.  The 
evidence base for controversy surrounding oxime therapy is wide and some of these 
articles were cited in over half (11/19) the texts that mentioned the controversy. 
However, two studies that are important in the debate were only cited by a minority of 
texts that describe the controversy, these being Cochrane review published in 2011, 
which showed a lack of evidence to determine whether oximes were harmful or 
beneficial(95), and an RCT that examined the WHO dosing regimen of pralidoxime 
published in 2008, that showing no evidence of benefit in clinical outcomes(50).  These 
add further support for not including oximes in ALS framework. Having said that, we 
are not making any comment with regards to the use of oximes in the non ALS / 
resuscitation setting, and it may be reasonable to administer oximes under the 
discretion of the treating clinicians after initial stabilisation has occurred, particularly if 
there is a poor response to atropine, as mentioned in one text(75). 
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Diazepam is an adjunctive therapy that was widely recommended for agitation and 
seizures, and has been suggested through animal studies to have neuroprotective 
effect(100), and cause a paradoxical improvement in respiratory function(101, 102), 
and therefore could be given to all patients. However, this role was not reflected in the 
reviewed texts.   
OP management’s influence on aspects of standard ALS  
 
Airway support as a management priority was highlighted in nearly all the texts.  
However, less than half the texts provided any specific instructions in this regard, such 
as open airway, or manage in a left lateral position to decrease the chance of 
aspiration. Also the link between early and rapid atropinisation and improvement of 
respiratory function was not always described.  Monitoring of tidal volume, and neck 
flexion strength was stated to be useful by some texts, and one included this as a basis 
for indications for intubation, which we have adopted in the ALS guideline we have 
proposed. However, it was also noted that the description of these measures were not 
supported by citations to clinical research and the effectiveness of such an approach 
remains to be demonstrated.    
 
Circulation  
Only a minority of texts mentioned insertion of two IV cannulae, and with good rationale 
(e.g. one for giving antidotes, another for fluids, particularly if intubation is 
contemplated). This could be better highlighted as in our experience it is a common 
error in Sri Lanka for severely poisoned patients to have only a small single cannula at 
the time of arrest.  
 
There was some variation regarding cardiovascular elements of ALS, where less than 
half the texts mentioned arrhythmia management. This ranged from stating that cardiac 
monitoring should be carried out to suggesting specific treatment strategies, such as 
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the use of magnesium in the management of Torsades de Pointes. Also only a minority 
(6/27) described or recommended the use of inotropes, and only 2 mentioned specific 
inotropes which suggest there may be a gap in the literature with regard to evidence for 
an approach to hypotension in OP poisoning. 
 
Decontamination  
The priority of ‘ABC’ over decontamination is agreed by most texts and has been 
reiterated in the ALS guideline. Similarly, that GI decontamination should occur only 
after airway protection was stated in over half the texts, however, a corresponding 
paper on the hazards of gastric lavage(44) was rarely cited.  
 
Staff Safety and Personal protection  
Universal precautions is all that is suggested by a nosocomial poisoning position 
statement(46), and most recommendations reflected this, although there was some 
variation as to whether this meant gloves and gown, or glove gown and mask.   
 
There was further variation in recommendations, with a number of texts pointing out 
that nitrile gloves are more impervious to chemical such as OP than latex and rubber 
gloves. However, access to these gloves is limited in Asia and there are no reports of 
nosocomial poisoning in such settings despite high patient loads and the use of 
standard universal precautions.  Specialized full body suits with charcoal masks (as 
suggested by one text) are not necessary for the hospital setting described in our 
scenarios, however the text in question was more focused on providing information in 
the pre hospital context. 
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Future clinical studies   
This process of carrying out this review uncovered a number of unanswered questions 
to do with guidance in cardiac arrest management in the specific context of OP 
poisoning. Whilst there has been a reasonable amount of research on the clinical 
effectiveness of atropine regimens, such as the doubling dose regimen, in severely 
poisoned patients, we found no research investigating the ideal doses of atropine in a 
cardiac or cardiorespiratory arrest. On the ground observations of practice in Sri Lanka 
peripheral hospitals was that 5mg or 10mg doses of atropine were frequently 
administered via infusion or bolus (sometimes before transferring the patient to a 
secondary referral center) and there did not appear to be any serious problems from 
this practice. A ceiling on the total dose of atropine, or targets of a minimum achievable 
therapy in arrests has not been established. Thus, it may be reasonable to give even 
up to 20mg as bolus in a cardiac arrest situation, considering that an average dose of 
atropine of 23.4mg was given in one case series, and administration of this dose over 8 
to 30 minutes, and has been the basis for of the doubling dose protocol that has been 
widely adopted in recommendations for non arrested patients(41, 57).  
  
The measurement of details regarding characteristics of arrests due to OP poisoning 
would provide valuable information that could aid protocols for CPR and resuscitation. 
Collection of data on type of arrest (e.g. pulseless electrical activity versus ventricular 
fibrillation) and average duration of CPR performed where there are good neurological 
outcomes, would help inform which algorithm is optimal (e.g. pathways that either 
involve or don’t involve defibrillation), and what should be the maximum duration of 
CPR before making a decision to withdraw CPR. In general a convention of 30 minutes 
is used for fear of poor prognosis with prolonged CPR, but in the general toxicology 
literature good neurological outcome has been reported in cases arrest where CPR 
has been carried out for long periods of time (e.g. 3 to 5 hours), which led to guidelines 
that suggested that more prolonged CPR and resuscitation may be warranted in 
patients with overdose(103).  
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Standardised cardiac arrest registries that are already in use in many parts of the 
world, allow for collection and analysis of cardiac arrest outcomes providing valuable 
information on the abovementioned matters.  These may provide valuable information 
if conducted in settings where there are frequent cardiac arrests due to OP 
poisoning(104). A recent retrospective study that collected detailed data on 33 OP 
poisoned patients in a western hospital showed that CPR was conducted on 6 
occasions where 5 were asystolic arrests and 1 was a VF arrest. There was one 
survivor but it is not clear how long CPR was conducted before return of spontaneous 
circulation occurred.  Similar observational studies with greater numbers could help 
better guide cardiac arrest protocols such as the one being suggested in Table 3-2.  
This is a feasible future research idea that may more easily be carried out in 
developing countries where there are high volumes of poisoned patients and high case 
fatality. 
 
Translation of ALS guidelines in Developed and Underdeveloped EM systems – 
impressions from the field 
Having experience of working in Emergency Medicine systems that can be classified 
as mature, such as in Australasian Emergency Departments(105), and Sri Lankan 
secondary referral centers which have a more developing Emergency Medicine 
systems (106), it is likely that a guideline such as proposed will translate differently in 
these two settings, according to background practice. Doctors in western countries with 
highly developed critical care systems have a clinical practice more focused on 
advanced life support. In contrast, rural developing country doctors are highly reliant on 
and rehearsed in providing acute medical therapies.  We anticipate they will persist 
with escalating atropinisation protocols, whereas Western doctors may move more 
rapidly to intubation and ventilation.  A further practical issue for OP resuscitation in 
Western countries is the absence of a stockpile of atropine that is required in 
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abnormally high quantities in acute OP poisoning. Even a single severely ill patient 
may exhaust the hospital supply of atropine.  Thus implementation of these draft 
guidelines may require logistical and knowledge deficits to be addressed. 
Limitations  
One limitation of this study is that our search criteria may have missed texts that are 
from non-English speaking countries and that are widely used. However, we have 
covered a broad range of texts that are accessed by clinicians and most of our 
conclusions are not sensitive to small changes in the number of included texts.    
 
Whilst the guideline for ALS in OP poisoning was informed by a systematic review of 
existing recommendations, it could be strengthened further by additional systematic 
reviews of original evidence. Each component of ALS as listed in the summary Table 
3-1, deserves its own systematic review in order appraise the evidence for each 
recommendation, but this was beyond the scope of the current study. The guideline 
described in the present study aimed more to be a working model in which to capture 
key recommendations, that were congruent with strategies to address the unique 
characteristics of OP poisoning management, and this can be developed and modified 
further in the future after clinical testing, rather than providing a definitive guide.   
 
Further development of the ALS guideline   
Demonstrating its impact in clinical practice would strengthen the support for an ALS 
guideline. Such research should also examine any translational blocks and the face 
validity of the recommendations. Research could also assess the understanding of 
proposed protocol by the target audience, as well as what strategies can be used to 
promote its integration into practice.  
 
There is evidence to suggest that adoption of different guidelines is quite variable, even 
guidelines based on widespread consensus such as the guideline recommendation of 
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the ILCOR guidelines on resuscitation. The guideline we have proposed is based on an 
instructive format that outlines clearly the sequence of resuscitation steps. This format 
has been devised in accordance with clinical experience of treating many cases of 
severe OP poisonings, where it has been recognised that both the provision of detail 
surrounding the steps of resuscitation and the sequence in which they are carried out 
are likely to be important factors in addressing the unique pathophysiology of this 
poisoning. However, as with all guidelines, there should be some evaluation process to 
assess the uptake of policy as well as whether it makes a difference in clinical 
outcomes. Tools are available to aid with guideline development(107, 108), however, 
there is some debate about even some commonly used tools in this arena(109).   
 
Finally, original basic science research and clinical studies are indicated to explore the 
numerous components of resuscitation that have been uncovered with variable 
recommendations in this review (e.g. what is the clinical impact of more careful 
monitoring of respiratory function in preventing respiratory failure, or delayed 
intubation).   
 
Conclusions 
 
Despite high proportions of patients requiring CPR for cardiac arrest, and a there being 
a reversible component to the pathophysiology of OP poisoning existing, no ALS 
guideline exists in international recommendations to guide the management of this 
frequent global presentation. There is a gap in the literature in the provision of 
management guidelines at this acute end of the spectrum. Furthermore, the majority of 
OP poisoning management texts have not been written with an ALS framework in 
mind.   
 
We have created an instructive ALS guideline tailored for the severely poisoned, 
ranging from the arrested patient to the critically ill and severely poisoned patient, 
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based largely upon what is already being recommended, but taking into account 
advances in the scientific literature during the past 5 years.  
 
There is consensus over the beneficial role of atropine in the ALS of OP poisoning, and 
early rapid aggressive atropinisaton in all critically ill, or arrested patients, and this is a 
key feature of the ALS guideline.  
 
Oxime therapy is controversial even in standard management and has no role in the 
acute initial care focus of the ALS guideline, but may be consider after resuscitation 
and stabilization of the patient.  
 
The sequence of CPR components would place atropine as top priority that can be 
considered as running in parallel to the more conventional therapies for ‘ABC’; as it is 
expected to improve both the cardiovascular and respiratory physiology.  Respiratory 
failure and a low threshold for early intubation is also a feature of the guideline, and we 
recommend some of the guidelines involving tidal volume highlighted in a minority of 
the reviewed texts.  
 
Future research is needed to validate the use of an ALS guideline such as the one 
provided, and it is likely that a process of further development and modification may 
necessary. Research is also recommended to further address gaps in evidence that 
evaluate the efficacy of aspects of clinical practice in advanced cardiac life support 
such as antidotal efficacy during cardiac arrests, indications for intubation, and 
assessment of benefits of monitory respiratory function.  
 
 
 
87 
 
Chapter 4: Evaluation of the Test-mate ChE 
(cholinesterase) field kit in acute organophosphorus 
poisoning  
 
 
Published: This chapter has been published as a journal article. 
 
Citation: Rajapakse BN, Thiermann H, Eyer P, Worek F, Bowe SJ, Dawson AH, et al. 
Evaluation of the Test-mate ChE (cholinesterase) field kit in acute organophosphorus 
poisoning. Ann Emerg Med. 2011 Dec;58(6):559-64 e6. 
88 
 
Abstract 
 
Study Objective: Measurement of acetylcholinesterase (AChE) is recommended in 
the management of organophosphorus (OP) poisoning, which results in 200,000 
deaths annually. The Test-mate ChE 400 is a portable field kit designed for detecting 
occupational OP exposure that measures red blood cell acetylcholinesterase (RBC-
AChE) and plasma-cholinesterase (PChE) within 4 minutes. This study evaluates the 
Test-mate ChE field kit against a reference laboratory test in the context of acute OP 
self-poisoning. 
  
Methods: A prospective comparison study of 14 patients with acute OP poisoning was 
carried out between November 2007 and June 2008. RBC-AChE and PChE was 
measured in 96 and 91 samples using the Test-mate ChE field kit and compared with a 
reference laboratory. The limits of agreement method (Bland and Altman), kappa 
statistics, and correlation coefficients (Pearson) were used to evaluate the agreement 
between the two test methods.  
 
Results: There was good agreement between the Test-mate ChE and the reference 
laboratory for RBC-AChE. The mean difference (Test-mate - reference) was -0.62 
U/gm Hb, 95% limits of agreement -10.84 to 9.59 U/gm Hb. Good agreement was also 
observed between the different clinical categories; (weighted kappa 0.85). 
Measurement of PChE also showed good agreement with a mean difference (Test-
mate – reference) of +0.06 U/ml blood, 95% limits of agreement -0.41 to 0.53 U/ml 
blood. Pearson’s correlation coefficients were 0.88 (95% CI 0.83 to 0.92) for RBC-
AChE and 0.87 (95% CI 0.81 to 0.91) for PChE. 
 
Conclusion: The Test-mate ChE field kit reliably provides rapid measurement of RBC-
AChE in acute OP poisoning. 
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Introduction  
Background*
OP pesticide self-poisoning is a serious public health problem resulting in 
approximately 200,000 annual deaths worldwide (3, 48). The case fatality is as high as 
15-30% depending on the type and amount of OP agent consumed and the delay in 
the initiation of treatment (47). Respiratory failure is common leading to intubation rates 
as high as 25% of all cases of acute OP poisoning(32). Poisoning is due to the 
inhibition of acetylcholinesterase (AChE; EC 3.1.1.7) in nerve tissue leading to the 
accumulation of synaptic acetylcholine. However, because neuronal AChE cannot be 
directly measured in patients, AChE in red blood cells (RBC-AChE) and plasma 
cholinesterase (PChE; EC 3.1.1.8) are used as biomarkers of exposure to OP 
compounds(110, 111). The measurement of these biomarkers is recommended in the 
management of OP poisoning(3), as they can be used to confirm the diagnosis, grade 
the severity of poisoning, guide antidote therapy, and they may also help in facilitating 
early discharge in cases of mild poisoning. However, the test is not available in most 
parts of the developing world, where the highest number of cases are seen.  
 
One of the greatest challenges in carrying out RBC-AChE assays in OP poisoned 
patients is the need for special measures during blood collection, such as immediate 
dilution and cooling of samples, in order to prevent ex-vivo reactions occurring in cases 
of acute poisoning2. These measures are particularly important in patients who are 
receiving oxime antidote therapy, as results may be inaccurate when omitted(3, 85, 
112). However these precautions are not taken in many settings where cholinesterase 
monitoring is required clinically, including in the developed world. Therefore a rapid and 
accurate system of AChE testing is not available for acute OP poisoning in most parts 
of the world. Improved methods to rapidly monitor severe OP poisoning, would also be 
relevant to the treatment of anticholinesterase nerve agents used in chemical 
warfare(113). 
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Importance*
The Test-mate ChETM is a portable field kit, which measures RBC-AChE and PChE 
within 4 minutes per test, and was designed for determining exposure to 
anticholinesterase pesticides in agricultural workers. There have been 4 studies 
published on the evaluation of this field kit, but only two of these involved direct 
measurements from patients(114-117). We have concerns about the generalisability of 
results from these studies to the setting of acute OP self-poisoning because the field kit 
was designed for occupational use and to be more accurate when measuring higher 
levels of AChE (personal communication with the manufacturer), and may be less 
accurate in acute poisoning where the poison load is much higher.  
Goals*of*this*investigation*
The aim of our study was to evaluate the performance of the Test-mate ChE field kit in 
acute OP poisoning by measuring the agreement between results from the field kit and 
results from a reference laboratory test5 in cases of OP self-poisoning.  
 
Materials and Methods 
Study*Design*&*Setting*
A prospective comparison study was carried out at a secondary referral hospital in rural 
Sri Lanka.  
 
Selection*of*participants*
Consecutive patients admitted with a history of OP self-poisoning between November 
2007 and June 2008 were eligible for inclusion.  This study was investigating the 
impact of bedside cholinesterase testing on decisions made by physicians. Local 
internal medicine physicians were responsible for the management of patients. 
Symptomatic OP poisoned patients were initially resuscitated with intravenous atropine 
using bolus doses and infusions titrated to clinical response. Pralidoxime was 
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sometimes prescribed depending on the preference of the treating physician (usual 
dose of 1g pralidoxime chloride IV every 6 hours for 48 hours).  
 
At the time of patient selection we already had 12 months experience in using the Test-
mate ChE field kit for the measurement of cholinesterase levels in pesticide poisoned 
patients. Fourteen patients were selected in whom we expected the ‘reference test’ to 
be most accurate because of a lower likelihood of ex-vivo reactions.  
 
These patient’s samples were all collected within the 6 months before the shipment to 
the reference laboratory and had a documented cold chain. Carbamate poisoning was 
excluded from the comparative sample because of the authors’ experience of rapid ex-
vivo reactivation in such cases, which could render the reference test results unreliable 
(unpublished data).  
 
Interventions*
The protocol was approved by the ethics review committee of Peradeniya University 
(Sri Lanka). All OP poisoned patients were tested for RBC-AChE and PChE using the 
Test-mate ChE field kit. Duplicate samples were prepared at the same time to be 
tested at a later date in a reference laboratory. The frequency of blood tests depended 
upon the severity of poisoning, and whether oximes were being used (see Figure 4-1). 
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Figure 4-1  Study protocol showing frequency of blood testing for 
acetylcholinesterase.  
Symptomatic patients were tested more frequently than asymptomatic patients. 
Patients who were receiving oxime therapy were tested pre and post pralidoxime dose.  
 
 
Methods*of*Measurement*
Cholinesterase,measurements,using,the,Test1mate,ChE,field,kit,
This study used a Test-mate ChE field kit [model 400, EQM research] designed for use 
over an extended temperature range (10-50 degrees centigrade)(118). The field kit 
consisted of a battery operated portable cholinesterase testing system that used the 
modified Ellman method. The amount of yellow colour produced as a result of the 
Ellman reaction is measured using a photo spectrometer indicating the quantity of 
cholinesterase present (see online appendix for further details). RBC-AChE and PChE 
were measured within 4 minutes per test using venous blood.  
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The precision of the Test-mate ChE field kit had previously been established by the 
manufacturer with analysis of 100 replicate samples of blood to which OP agents had 
been added(119).  
 
10 microlitres of venous blood was transferred from the EDTA anticoagulated tube and 
mixed with the buffer solution. The acetylthiocholine or butyrylthiocholine within the 
buffer solution hydrolyses the RBC-AChE or PChE respectively, producing carboxylic 
acid and thiocholine, which reacts with the Ellman reagent (dithionitrobenzoic acid) to 
form a yellow colour. The rate of production of the yellow colour was measured on the 
photometer at 450nm, and this value indicated the activity of cholinesterase(114). 
RBC-AChE activity was determined in the presence of a specific inhibitor of PChE and 
the value is corrected for the amount of haemoglobin by dividing the measured AChE 
by the haemoglobin concentration (also measured photometrically). The machine was 
operated in an air-conditioned research room (temperatures between 19C to 22C) 
within the hospital premises. 
 
The measurement of PChE was similar, also utilising 10 microlitres of whole blood. It 
simply requires a “mode change” button to be pushed on the Test-mate ChE device, 
prior to testing.  
 
In cases of very low cholinesterase levels the Test-mate ChE field kit displayed the 
warning “No Reaction” followed by the level of enzyme activity. In some instances a 
negative integer (close to zero) was obtained. We converted these values to zero for 
the purpose of data analysis, as negative enzyme activity is not possible. 
 
 
Standard deviations of 0.82 (U/g Hb) and 0.15 (U/ml blood) were observed for 
repeated RBC-AChE and PChE measurements respectively, and from this we 
calculated the limits of quantification (LOQ) to be 4.1 U/g Hb for RBC-AChE and 0.75 
U/ml blood for PChE. Testing above these limits, we verified the precision of the Test-
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mate ChE in our setting by testing replicate cholinesterase measurements in 10 
patients with OP self-poisoning. The mean coefficient of variance (CV) was 4.5% for 
RBC-AChE (range 1.3% to 8.4%) and 6.0% for PChE (range 2.0% to 11.6%). Using 
regression to extrapolate values where we would expect the CV to be greater than 
20%, we re-estimated the LOQ for Test-mate ChE in our setting to be 1.3 U/g Hb 
(4.1% of normal) for RBC-AChE and 0.26 U/ml blood for PChE.  
 
 
Cholinesterase,measurements,using,the,reference,test,
Duplicate samples were tested for RBC-AChE and PChE at the Bundeswehr Institute 
of Pharmacology and Toxicology, in Munich, Germany, and the modified Ellman 
method was used as previously described(85). The reference laboratory sample was 
prepared at the same time as testing with the Test-mate field kit. Sample preparation 
for RBC-AChE measurement consisted of transferring 200 microlitres of whole blood to 
another collection tube. This sample was immediately diluted and mixed with ice-cold 
distilled water in a 1:20 dilution, and frozen soon afterwards in order to minimise ex-
vivo reactions. 
 
The mean coefficient of variance (CV) measured at the reference laboratory was 
2.75% for RBC-AChE (range 0.50% to 4.26%) and 4.00% for PChE (range 2.23% to 
5.54%). The limits of quantification were 0.2 U/g Hb and 0.026 U/ml for RBC-AChE and 
PChE respectively(85).  
 
Samples for PChE measurement were prepared by centrifuging the anticoagulated 
blood and transferring 1ml of plasma into a separate tube. 
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All samples were stored in a minus 20 degree centigrade freezer before being 
transported to the reference laboratory in Germany. The cold chain was strictly 
maintained during transport.  
Data*Collection*and*Processing*
All blood samples were collected by research assistants who were junior doctors 
trained in venipuncture. They were also trained in the operation of the Test-mate ChE 
field kit according to the users manual (supplied by EQM research), and with additional 
power point presentations and a training video specifically created for education of the 
research protocol. As a quality control measure the principle investigator supervised 
the performance of each research assistant during the collection, processing and 
storage of samples in 5 test cases.  
 
Results for RBC-AChE and PChE measurements obtained from the Test-mate ChE 
field kit were recorded on a datasheet and transferred to a computer spreadsheet 
program (Microsoft Excel). The results from the reference laboratory were also entered 
into an Excel spreadsheet. The reference laboratory staff did not have access to the 
Test-mate results.  
Outcome*measure*
Primary outcome measures were the RBC-AChE and PChE levels measured at the 
bedside using Test-mate ChE field kit, and in the reference laboratory. 
Primary*data*analysis**
The ‘limits of agreement’ method (described by Bland and Altman(120, 121)) was used 
to assess agreement. The differences between the two methods were plotted against 
their mean for each individual blood sample. This plot is bounded by the 95% limits of 
agreement (which is equivalent to +/- 1.96 SDs above and below the mean difference) 
[calculated using GraphPad Prism v5]. The agreement for the different clinical 
categories of RBC-AChE inhibition was analysed using the weighted Cohen’s kappa 
statistic [using STATA 10].    
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Regarding the clinical categories of RBC-AChE inhibition, we based the cut-off points 
upon literature findings for the degree of symptoms associated with different levels 
RBC-AChE activity, which were as follows:- ‘normal’ >75% ( >23.6 U/g Hb), ‘mild 
inhibition’ 30-74% (9.4-23.5 U/g Hb), ‘moderate inhibition’ 10-29% (3.1-9.4 U/g Hb) and 
‘severe inhibition’ <10% (<3.1 U/g Hb) (Table 4-1)(27, 28, 39, 122, 123).  
 
Table 4-1  Clinical categories of RBC-AChE activity.  
The cut-off points were based on animal and clinical research that correlated expected 
symptoms with levels of RBC-AChE activity. 
 
Clinical 
category of 
AChE inhibition 
% Normal AChE 
(Normal taken at 
31.4 U/g Hb) 
AChE level 
(U/g Hb) 
Expected symptoms 
based on Evidence 
Normal ≥ 75% ≥ 23.6 Asymptomatic(28). 
Occupational 
guidelines suggest 
>77% signifies ‘no 
exposure’ (122, 123) 
Mild inhibition 30-74% 9.4-23.5 Clinical symptoms 
with normal muscle 
function (Based upon 
animal studies(39) and 
neuromuscular 
transmission data 
from clinical cases(27, 
113) )  
Moderate 
inhibition 
10-29% 3.1-9.4 Diaphragmatic Muscle 
paralysis expected(28, 
39) 
Severe inhibition <10% <3.1 Strongly impaired 
neuromuscular 
transmission and 
diaphragmatic 
paralysis expected (27, 
39) 
 
 
For the purpose of comparing test methods the reference test PChE results were 
multiplied by (1- packed cell volume) to adjust units from ‘U/ml plasma’ to ‘U/ml blood’. 
The fractional packed cell volume was estimated by multiplying the haemoglobin 
concentration (g Hb/100 mL) by 3 and dividing by 100(124).  
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Results 
Characteristics*of*Study*Subjects*
A total of 14 OP poisoned patients were studied and 96 pairs of test results for RBC-
AChE and 91 pairs for PChE were compared. The patient characteristics and types of 
OP agents responsible for poisoning are shown in Table 4-2. The median age was 35 
years, and there were a greater proportion of male patients (79%, 11/14). The most 
commonly ingested OP agent was chlorpyrifos (50%, 7/14). All but 3 patients received 
pralidoxime therapy. The average number of tests per patient was 6.6, collected over a 
mean of 4 days in hospital. The delay to reference test analysis after blood sampling 
ranged from 2-8 months. Two patients (14%) were intubated during the course of 
admission and no patient deaths were observed in the study group.  
Table 4-2  Patient characteristics of study group, number of 
cholinesterase tests, and specific OP agents ingested. 
 
Sample characteristics No. (%)* 
Median age, y    35 (range 19-52) 
Male sex    11 (79) 
Median length of stay, days      3 (range 1-11) 
Patients intubated       2 (14) 
Patients receiving pralidoxime     11 (79) 
Deaths               0 
Median no of RBC-AChE tests/ patient   6.5 (range 2-13) 
Median no of PChE tests/ patient      7 (range 0-13) 
Type of organophosphorus ingested 
Chlorpyrifos      7 (50) 
Diazinon      1 (7) 
Quinalphos      1 (7) 
Phenthoate      1 (7) 
Dimethoate      1 (7) 
Unknown organophosphorus     3 (21) 
*Data are provided as No. (%) unless otherwise indicated 
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Main*Results*
Agreement,of,RBC1AChE,measurements,
There was good agreement between the Test-mate ChE and the reference test for 
RBC-AChE and the Pearson correlation coefficient was 0.88, (95% CI 0.83 to 0.92).  
Figure 4-2 displays the levels of RBC-AChE recorded by each test method and shows 
that the majority of points lie within the same clinical category, indicated by dotted 
lines. The agreement between the clinical categories of normal, mild, moderate and 
severe inhibition is shown numerically in Table 4-3 (weighted Cohen’s kappa 0.85).  
 
 
Figure 4-2  Scatter diagram showing RBC-AChE activity determined by the Test-
mate ChE field kit plotted against activity determined by the reference test.  
The different clinical categories for levels of RBC-AChE inhibition; - normal, mild, 
moderate and severe inhibition is indicated by dotted lines.  
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Table 4-3  Distribution of RBC-AChE results according to 
clinical category.  
Shaded cells show where the same category was observed by both test methods. 
Overall there was a good agreement observed between the two tests (weighted 
Kappa=0.85). 
 
  
Reference Test results (U/g Hb) by clinical category 
 
Normal 
(≥ 23.6)) 
Mild 
inhibition 
(9.4-23.5) 
 
Moderate 
inhibition 
(3.1-9.4) 
 
Severe 
inhibition 
(<3.14) 
 
Totals 
 
Te
st
-m
at
e 
C
hE
 re
su
lts
 (U
/g
 H
b)
 b
y 
cl
in
ic
al
 c
at
eg
or
y 
Normal  
(≥ 23.6) 
 
30 
(31.2%) 
2 
(2.1%) 
1 
(1.0%) 
0 33 
(34.4%) 
Mild 
inhibition 
(9.4-23.5) 
5 
(5.2%) 
7 
(7.3%) 
2 
(2.1%) 
0 14 
(14.6%) 
Moderate 
inhibition 
(3.1-9.4) 
1 
(1.0%) 
4 
(4.2%) 
26 
(27.1%) 
5 
(5.2%) 
36 
(37.5%) 
Severe 
inhibition 
(<3.14) 
1 
(1.0%) 
0 
 
1 
(1.0%) 
11 
(11.5%) 
13 
(13.5%) 
 
Totals 
37 
(38.5%) 
13 
(13.5%) 
30 
(31.3%) 
16 
(16.7%) 
96 
(100%) 
 
The Bland Altman plot (Test-mate – reference) shows the mean bias was -0.62 U/g Hb 
and the 95% limits of agreement were from -10.84 to 9.59 U/g Hb (Figure 4-3a).  
Agreement,of,PChE,measurements,
Good agreement was also demonstrated for PChE (Figure 4-4), but there was less 
evidence for this as 64% (58/91) of the measured values were below the limits of 
quantification (LOQ) for the Test-mate ChE. However, when results were categorised 
into being either above or below the LOQ there was good agreement (kappa = 0.69).  
The Bland Altman plot (Test-mate-Reference) shows a positive bias of 0.06 U/ml for 
Test-mate ChE. The 95% limits of agreement were from -0.41 to 0.53 U/ml (Figure 4-
3b). The Pearson correlation coefficient was 0.87 (95% CI 0.81 to 0.91).  
100 
 
 
Figure 4-3  Bland Altman plots showing the difference measurement between the 
Test-mate ChE and reference test results plotted against the mean of both 
methods for a) RBC-AChE and b) PChE  (*after adjustment to U/ml of whole 
blood).  
Horizontal lines represent the mean bias and 95% limits of agreement, and associated 
95% CI’s. The limit of quantification for PChE measurement by Test-mate ChE (0.26 
U/ml) is marked by a vertical dotted line.  
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Figure 4-4  Scatter diagram showing the Test-mate PChE activity are plotted 
against the reference test PChE activity (*after adjustment to U/ml of whole 
blood).  
The line of equality is represented by a dotted line. The limit of quantification (LOQ) for 
the Test-mate ChE (0.26 U/ml) is marked on the Y axis.  
 
 
Discussion  
Our study found good agreement between the Test-mate ChE field kit and a reference 
test in the measurement of RBC-AChE.  The good agreement (weighted kappa 0.85) 
between the different clinical categories of RBC-AChE inhibition suggests this test is 
sufficiently accurate to guide clinical decisions in the management of OP poisoning.  
 
Our findings were different to that of a previous study, which found a large upward bias 
in Test-mate RBC-AChE results (+8.2 to 9.9 U/g Hb), contrasting the small negative 
bias (-0.62 U/g Hb) that we found(115). Variation in the temperature at time of testing 
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in the field was subsequently raised as a possible source of error to explain this 
bias(117). This was not a significant consideration in our study as we used the latest 
model (Model 400) of the Test-mate ChE field kit, which contains a temperature 
compensation algorithm allowing its use over an extended temperature range.   
 
A second more recent study also contrasted our findings by noting a systematic 
positive bias of 42-48% in RBC-AChE measurement when compared with a reference 
test, and this was thought to be related to differences in haemoglobin estimation by the 
different test methods(114). The use of dilution or cooling to avoid ex-vivo reactions by 
their reference laboratory method was not documented, and it is possible that the 
discrepancy in RBC-AChE results related to problems with their reference test(3).  
 
Previous studies of PChE measurement by the Test-mate ChE in an occupational 
setting have had conflicting results(114, 115).  One study contrasted our results for 
PChE by finding poor agreement with a large negative bias and wider 95% limits of 
agreement(115), and the second more recent study supported our findings of good 
agreement(114). However, it is worth noting that the units of PChE in reference tests 
(U/ml plasma) have to be adjusted to match the Test-mate ChE (U/ml blood), and only 
one of these studies clearly documented this. Conversion adds another potential 
inaccuracy caused by the use of another measured variable, Hb concentration. Our 
findings suggest PChE measurement can be used to detect inhibition in a qualitative 
sense, as might be the case with confirmation of diagnosis in cases of suspected OP 
or carbamate poisoning. However, in practice the interpretation of PChE is difficult, due 
to its large variation in the normal population, and comparison against a baseline level 
is recommended(122). This may be possible in an occupational setting but it is 
impractical in acute poisoning. RBC-AChE is a more clinically useful biomarker due to 
its closer resemblance to neuronal AChE and its capacity for reactivation from an 
inhibited state after oxime therapy(3).  
103 
 
Limitations 
Junior doctors carried out the outcome measure of Test-mate ChE cholinesterase 
results instead of trained lab personnel contrary to the manufacturer’s 
recommendations. Thus it is possible that operator error could have been a factor 
accounting for some of the observed discrepancies when comparing the two test 
methods, and this was not controlled for. Previous studies evaluating the use of Test-
mate ChE in both a laboratory and “field setting” by non-laboratory staff have 
concluded reduced accuracy and precision in the field setting(114, 115). In contrast to 
these finding, our data showed that there was acceptable agreement between the 
Test-mate ChE field kit and the reference test despite this limitation of the field kit being 
operated by non-laboratory personnel.  
Future research directions 
We also observed that in some cases the patterns of AChE activity over time matched 
the patient’s clinical features more closely for measurements made by the Test-mate 
ChE compared with those by the reference test (data not shown). This raised the 
possibility that the Test-mate could have been more accurate than the reference test in 
the current study setting. The reference test in this case could not be considered as a 
‘gold standard’ because of possible inaccuracy related to the speed of freezing, quality 
of cold chain during storage and shipment, as well as time delay between sampling 
and testing, despite the stringent measures that were taken to minimise these factors 
during the study. These factors could have been avoided if the reference test consisted 
of simultaneous measurement in a local laboratory that has experience in 
cholinesterase testing (a facility that was not available at the time of the current study). 
Future research could aim to achieve this and further investigate the discrepancy 
observed in some test results in more detail. 
 
The measurement of AChE in carbamate poisoning (the other major group of 
anticholinesterase agents responsible for high numbers of poisonings) should also be 
carefully planned in future studies. This type of poisoning was excluded from our 
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sample because of the high potential for ex-vivo reactions in carbamate poisoning that 
would result in unreliable reference laboratory values.  
 
Conclusions 
Based on the findings of our study we can recommend the measurement of RBC-
AChE when using the Test-mate ChE in acute poisoning because of its good 
agreement with reference test from a laboratory experienced in cholinesterase 
determination. A key strength of our study is that a much wider range of RBC-AChE 
inhibition (from 0 – 100%) was studied, whereas previous clinical studies had not 
studied inhibition exceeding 50%  (e.g.(114)). Also, our results were novel in that they 
demonstrated that this agreement was present amongst OP poisonings by 5 different 
agents and in patients receiving pralidoxime.  
 
The Test-mate ChE field kit appears a reliable method to rapidly measure RBC-AChE 
in OP poisoned patients, and can be used to confirm the diagnosis and indicate the 
severity of poisoning. Further research is required to see if serial AChE measurements 
aid the management of OP poisoning, and whether the test is also reliable in patients 
with carbamate poisoning.  
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Chapter 5: Effect of acetylcholinesterase (AChE) point-
of-care testing in OP poisoning on knowledge, attitudes 
and practices of treating physicians in Sri Lanka 
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Abstract 
 
 
Background: Toxicology and Emergency medicine textbooks recommend 
measurement of acetylcholinesterase (AChE) in all symptomatic cases of 
organophosphorus (OP) poisoning but laboratory facilities are limited in rural Asia. The 
accuracy of point-of-care (POC) acetylcholinesterase testing has been demonstrated in 
acute OP poisoning but no study has investigated how it would be valued in a practical 
setting. This study aims to assess the effect of seeing AChE POC test results on the 
knowledge, attitudes and practices of doctors who frequently manage OP poisoning.  
 
Methods: We surveyed 23 clinicians, who had different levels of exposure to seeing 
AChE levels in OP poisoned patients, on a) knowledge about the management of OP 
poisoning and biomarker interpretation, b) attitudes towards the value of AChE in 
guiding poison management, oxime therapy and discharge decisions, and c) practices 
of ordering AChE in scenarios of mild and severe self-poisoning.   
 
Results: An overall high proportion of doctors valued the test (68-89%). However, we 
paradoxically found that doctors who were more experienced in seeing AChE results 
valued the test less. Lower proportions valued the test in the guidance of acute 
poisoning management (50%, p=0.015) and the guidance of oxime therapy (25%, 
p=0.008), and it was apparent the test would not generally be used to facilitate early 
discharge. The time at which AChE was measured influenced the perceived value of 
the test (p<0.001), and the highest proportion of respondents valued it on admission. A 
lack of correlation of test results with the clinical picture, and a perception that the test 
was a waste of money when compared to clinical observation alone were comments 
raised by some of the respondents who did not value the test.   
 
Greater experience with seeing AChE test results was associated with increased 
knowledge (p=0.034). However, a disproportionate lack of knowledge on interpretation 
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of biomarkers and the pharmacology of oxime therapy (12-50%) was noted, when 
compared with general knowledge on the mechanism of OP poisoning and 
management (78-90%).  
 
Conclusions: Our findings suggest an AChE POC test may not be valued by rural 
doctors. The practical use of AChE in OP poisoning management is complex, and a 
poor understanding of how to interpret test results may have affected its perceived 
utility. Future research should evaluate the impact of providing both AChE and training 
in interpretation on clinicians’ attitudes and practice. 
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Background  
 
Organophosphorus (OP) insecticide poisoning is responsible for significant mortality 
and morbidity. The case-fatality of OP self poisoning is high and there are over 
200,000 annual deaths worldwide(3).     
 
Toxicology and Emergency medicine textbooks recommend that acetylcholinesterase 
(AChE) measurement should be performed in all symptomatic cases of OP poisoning 
where the test is available, as this biomarker may help confirm diagnosis and severity, 
guide the starting and stopping of oximes by titrating the dose to changing enzyme 
levels, and may help in guiding patient disposition(37, 52-55).  Some text books 
recommend checking AChE every 12-24 hours in symptomatic patients(54).  However, 
accurate laboratory tests require complex collection methods and a lack of availability 
of reliable point-of-care (POC) laboratory services makes these recommendations 
difficult to follow(55). Recent research has validated the use of a POC 
acetylcholinesterase testing device (Test-mate ChE) for acute OP self-poisoning in 
rural Sri Lanka, but to date there are no studies to indicate how clinicians would value, 
and use, such a test should it become available(56). We were not able to find studies 
that evaluated the benefit of POC devices in Asian countries, and a deficiency in 
research surrounding the role of POC testing in a rural hospital setting has also been 
identified by other researchers(125). 
 
We designed a study, which surveyed the knowledge, attitudes and practices of 
clinicians in a secondary referral centre who are frequently treating OP poisoning. We 
looked at what effect exposure to seeing AChE test results had on these parameters. 
We specifically asked whether clinicians would order such a test if it were available, 
and how useful it would be in their management of OP poisoning (if at all). Our study 
intervention was to make AChE results available to clinicians in acute OP poisoning 
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through POC testing, without specific training or education on how to interpret the test 
results.  
  
Our hypothesis, based upon textbook recommendations, was that AChE tests would 
be widely ordered and regarded as useful if they were made available. We also 
hypothesised that doctors with greater experience of the test would report a higher 
perceived benefit from the test in terms of showing improved knowledge about OP 
poisoning, guidance of oxime therapy, and the facilitation of early discharge of patients 
with mild symptoms. 
  
This study aimed to assess the knowledge, attitudes, and practices amongst a range of 
treating clinicians who manage high volumes of OP poisoned patient, and who did not 
generally have access to AChE results.  We also aimed to report changes that 
occurred in relation to the introduction of a point-of-care AChE device(56). 
 
Methods 
 
The University of Peradeniya Ethical Review committee approved the study, and 
consent was implied by participation in a paper survey.  
Selection of Doctors 
The study targeted the practicing doctors who worked in the General Medical ward and 
intensive care ward of a secondary referral centre (with approximately 800 hospital 
beds) in a rural Sri Lankan setting. All levels of the medical hierarchy including 
Consultants, Senior House officers (SHO’s), Medical officers (MO’s), and house 
officers (HO’s) were included in the study.      
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Intervention  
The intervention consisted of the provision of AChE results from OP poisoned patients, 
over a 13 month period, to treating clinicians. Clinicians were surveyed at beginning 
and end in order to capture respondents with a range of experience of the seeing 
AChE test results (see Figure 5-1).   
Measurement*of*AChE*results***
 
Blood samples were taken from all consenting OP poisoned patients admitted to the 
medical wards and intensive care unit by trained research assistants according to a 
study protocol and the results were added to the patient record so that clinicians could 
use this information if they desired. 
 
The RBC-AChE and PChE levels were measured, using the Test-mate ChE point-of-
care device, before and after doses of oxime in patients who were on this therapy. 
These results were graphed to highlight any relationship to doses given (Figure 5-2), in 
a similar fashion to what has been recommended in the literature(52).   
AChE*testing*protocol*
 
A specific protocol guided the frequency and timing of blood tests in relation to oxime 
doses (Appendix B1). Symptomatic patients who were treated with oximes had blood 
tests taken pre and post doses of oxime during the first 48 hours, and a pre and post 
dose test were taken on a daily basis thereafter.  Symptomatic OP poisoned patients 
who weren’t treated with oximes were tested at the same time points, omitting the post 
oxime measurement.  
 
Asymptomatic patients had an initial blood test followed by a daily blood test thereafter. 
Patients with unknown poisoning were treated as described depending on whether 
they were symptomatic or not, and whether they were being treated with oximes or not. 
After 5 days of admission the frequency of blood testing was reduced to alternate day 
testing.  
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Figure 5-1  Flowchart showing distribution of surveys and response rate. 
Surveys handed out 
(n=20)
26 surveys completed
3 doctors 
completed 
survey twice
(Phase 1 & 2)
Survey distribution - 
Phase 1 (pre)
Surveys handed out   
(n=20)
Survey distribution - 
Phase 2 (post)
Intervention: Observational Study
Evaluation of the Test-mate ChE bedside 
acetylcholinestase field kit in acute OP poisoning
(13 months)
“experience with AChE testing” 
1 doctor didnʼt answer 
“No of AChE tests seen” 
No previous 
AChE tests
5-20 tests 
seen
1- 5 tests 
seen
Phase 2 survey 
excluded from analysis 
14 doctors didnʼt return the survey 7 doctors 7 doctors
22 surveys for main analysis 
112 
 
 
Figure 5-2  Shows the method of making AChE levels from OP poisoned patients 
available to treating clinicians (study intervention).  
Red blood cell acetylcholinesterase (AChE) and plasma cholinesterase (PChE) results 
were presented to clinicians via results sheet consisting of a table and graph, which 
was added to patient record.  
 
Normal Values of red blood 
cell acetylcholinesterase 
(RBC-AChE) and plasma 
cholinesterase (PChE) 
were provided
RBC-AChE values were plotted in 
relation to selected doses of oxime, 
as per study protocol
Numeric values of AChE, 
exact times of blood tests, 
and oxime (pralidoxime) 
doses were recorded here
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Management*of*OP*poisoned*patients*on*whom*tests*were*performed*
 
Internal medicine physicians were responsible for the management of all pesticide 
poisoned patients who were treated according to local practice. Symptomatic OP 
poisoned patients were generally resuscitated with atropine via an intravenous bolus 
followed by infusion, with the dose titrated to clinical response. Oximes were 
sometimes prescribed depending on the preference of the treating physician.  
 
Study endpoints: 
Survey*of*treating*doctors*
 
A self reported survey (Appendix C2) was distributed to all the doctors including an 
information sheet explaining the confidentiality of the data that would be obtained. 
 
The survey had 3 components:- 
1) 25 True/false statements (worth 1 mark each) organized into 5 questions on 
knowledge of OP poisoning, use of oximes and AChE testing  
2) Short answer questions assessing attitudes towards AChE testing and 
choice of oxime therapy      
3) Scenario based questions assessing clinical practice regarding ordering 
AChE tests, oxime therapy, and patient discharge.   
 
The principal investigator delivered the questionnaire personally to each doctor in the 
sampling frame of 40 doctors responsible for treating poisoned patients. They were 
instructed to complete and return the questionnaire as soon as possible. 
True/False,knowledge,questions,
 
The knowledge component comprised 5 areas each covered with 5 true/false 
statements. Each correct answer was given one mark and each incorrect answer a 
negative mark resulting in a maximum score of 5 and a minimum score of -5 for each 
of the 5 areas, which was then converted into a percentage. The questions tested 
114 
 
knowledge on the mechanism of OP pesticides toxicity, the inhibition of AChE, types of 
biomarker in OP poisoning, the clinical correlation of biomarker levels in poisoned 
patients and the response of AChE to oximes (Appendix B2.1). The level of difficulty 
was aimed at ‘expert’ level (ie. a level that a toxicologist could be expected to know). 
Short,answer,questions,on,experience,and,attitudes,,
 
A short answer question format was used to assess the doctors’ prior experience with 
treating OP poisoned patients, number of AChE test results seen, and perceived 
usefulness of the AChE test (Appendix B2.2). The doctor’s usual practice regarding the 
dose and duration of oximes therapy in mild, moderate and severe OP poisoning was 
recorded in this section.   
Scenario,evaluation,of,attitudes,and,practice,in,cases,of,OP,poisoning,
 
The last part of the survey consisted of four commonly encountered patient scenarios: 
two scenarios with severe poisoning, and florid cholinergic signs, and two scenarios 
with mild poisoning, either receiving or not receiving oximes (Appendix B2.3). These 
scenarios were based upon commonly encountered patients. The scenarios assessed 
whether oximes would be prescribed, and whether an AChE test would be ordered 
(and thus considered beneficial OP poisoning management) at different time points in 
course of the patient admission. Survey questions also explored the willingness to 
discharge a mildly poisoned patient earlier than the standard 4 days of inpatient 
observation.  
Clarifying,statements,as,an,adjunct,to,survey,data,
 
We provided respondents with the opportunity to clarify their choices with free text. 
Headings such as “Comments…”, or prompts like “Why/Why not?” would follow 
questions that required either a binary or categorical answer such as “Do you think an 
acetylcholinesterase level (AChE) will be useful in helping guide treatment with 
oximes?”. 
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Survey*analysis*
 
The study was initially designed to compare survey responses before and after 
exposure to the intervention (which was participation in an observational                                                                                                                                                                                                               
study providing doctors with bedside AChE results). Because some doctors reported 
prior experience with AChE tests, and some respondents reported having no 
experience of seeing AChE levels after the intervention we decided to analyse the 
survey respondents as a cross sectional sample categorizing respondents according to 
level of experience with seeing AChE test results, and comparing the groups. 
Respondents were divided into three groups (no tests, 1-5 tests, or 5-20 tests) based 
on the number of AChE test they reported they had seen, which was asked in the first 
section of the survey. Three doctors completed the survey twice during the study 
period and we only used the first survey response in this group so that the data we 
analysed was uniform with regards to not having previously completed a survey (see 
Figure 5-1).        
 
Statistical*tests*
 
The mean scores from the knowledge questions were compared using the oneway 
ANOVA test. The categorical answers to the survey questions were analysed using the 
Kruskal Wallis test where the data was ordinal, and the Fisher’s exact test where the 
data was nominal.  The answers for some questions were coded as ordinal data where 
some authors could have viewed it as nominal data. For example, when respondents 
were asked if AChE could guide oxime therapy; the possible answers were “no”, “not 
sure” or “yes”, because in this context “not sure” represented a point mid way between 
“yes” and “no”. Also in the answers where respondents would select the dose of oxime 
that would be prescribed, the categorical choices were an increasing dose so we 
coded their responses as an ordinal variable.  The scenario data, which comprised 
multiple responses from doctors, were analysed using generalized estimating 
equations (GEE). Associations between patient risk factors and the decision to order 
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AChE test were expressed using odds ratios.  All statistical calculations were 
performed on STATA version 12, and graphs drawn on Prism version 6.   
Results   
 
The 22 doctors who were included in the analysis consisted of both senior and junior 
medical staff from departments of medicine (68%) and intensive care (32%), and they 
reported treating on average 51-100 cases of OP poisoning per year (see Table 5-1). 
Their experience of seeing the point-of-care AChE test results ranged from never 
having seen a test previously (i.e. ‘0 tests’) in 11 participants, to having seen ‘1-5 tests’ 
in 7 participants, and ‘5-20 tests’ in 4 participants. 
 
Table 5-1  Survey respondent characteristics. 
  
 
 
 
Number of 
respondents (%) 
Seniority   
Consultant     3       (14%) 
House officer     11     (50%) 
Medical officer     5       (23%) 
Senior House officer     3       (14%) 
  
Specialty  
Medicine     16      (72%) 
Intensive Care     6        (27%) 
  
No of OP poisoned patients seen  
less than 5     2        (9%) 
5 to 20     5        (23%) 
21 to 50     5        (23%) 
51 to 100     5        (23%) 
greater than 100     5        (23%) 
  
Exposure to AChE tests  
zero     11      (50%) 
1 to 5     7        (32%) 
5 to 20     4        (18%) 
21 to 50     0        (0%) 
51 to 100     0        (0%) 
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Knowledge 
Those with most experience of AChE test results (e.g. 5-20 tests) had the highest 
knowledge with a significant increase noted in the total score (p=0.034, see Figure 5-
3). This was most marked in the questions to do with “biomarkers of exposure”, 
“interpreting AChE in OP”, and “oximes in OP poisoning”, but the increase only 
reached statistical significance for question 5 on “oximes in OP poisoning” (p=0.046).  
 
 
Figure 5-3  Knowledge scores for questions (based on answers to true/false 
statements).  
This column graph shows the differences in scores by level of experience with the 
AChE test. 
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Attitudes: AChE in OP poisoning management 
The perception that AChE test was useful in managing OP poisoning was 100% 
amongst respondents with no AChE test experience (0 tests) and minimal experience 
(1-5 tests), but was significantly less (50%) in respondents with the most experience of 
seeing test results (5-20 tests) (p=0.035, Figure 5-4a, Table 5-2).  
 
However, the two respondents who stated the test was “not useful” qualified their 
answers with the following statements suggesting a mixed impression about the utility 
of the test;-  
 
“Not necessary to manage OP poisoning but useful to identify (diagnosis)” 
 
“AChE level is not related to the amount of poison or the clinical symptoms but 
is useful in unknown poison management” 
 
The AChE test was noted to be helpful in guiding oxime therapy in 73% and 86% of 
respondents with no experience, or minimal experience, but this proportion was 
significantly less (25%) amongst respondents with the most experience of seeing 
AChE test results (p=0.05, see Figure 5-4b, Table 5-2).    
 
Respondents who reported that the test was helpful in guiding oximes clarified their 
choice with comments that valued the role of AChE in assessing severity of poisoning, 
and the titration of AChE levels with oxime administration;- 
“I think acetylcholinesterase is a fairly reliable method of assessing the level of 
poisoning”  
“need to check whether the AChE level is up or down with oxime” 
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Figure 5-4  Attitudes towards AChE testing in organophosphorus management.  
The perceived value of an AChE level (a) in the treatment of organophosphorus 
poisoning, and (b) in the guidance of oxime therapy is shown according to level of 
experience with the test. 
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Table 5-2  Attitudes towards oxime therapy and AChE testing. 
 
  
Question 
  
  
Response 
  
Level of AChE Experience † 
p 
value 
 
 
"0 tests" 
n (%) 
"1-5 
tests" 
n (%) 
"5-20 
tests" 
n (%) 
What dose of intravenous 
pralidoxime would you 
prescribe to a severely 
symptomatic patient? 
 
 
None 0    (0%) 1   (14%) 0   (0%) 
  
  
0.008 
1g 6 hourly 10  (91%) 6   (86%) 1   (25%) 
2g bolus + 500mg 
continuous IV 
infusion 
 1   (9%) 0   (0%) 3   (75%) 
For what duration would 
you give the above dose? 
  
 
None 0   (0%) 1   (14%) 0   (0%)   
  
  
0.089 
24 hours 1   (11%) 0   (0%) 0   (0%) 
48 hours 6   (67%) 5   (71%) 0   (0%) 
Other time period 2   (22%) 1   (14%) 3   (100%) 
What dose of intravenous 
pralidoxime would you 
prescribe to a mildly 
symptomatic patient? 
 
None 1   (9%) 4   (57) 1   (25%) 
  
  
0.105 
1g 6 hourly 10 (91%) 3   (43) 2   (50%) 
2g bolus + 500mg 
continuous IV 
infusion 0   (0%) 0   (0%) 1   (25%) 
For what duration would 
you give the above dose? 
  
  
None 1   (11%) 4   (57%) 1   (33%) 
  
  
  
 0.116 
24 hours 0   (0%) 0   (0%) 1   (33%) 
48 hours 7   (78%) 3   (43%) 1   (33%) 
Other time period 1   (1%) 0   (0%) 0   (0%) 
What dose of intravenous 
pralidoxime would you 
prescribe to an 
asymptomatic patient 
who is not getting 
atropine? 
None 6   (64%) 7   (100%) 4   (100%) 
  
  
 0.097 
1g 6 hourly 4   (36%) 0   (0%) 0   (0%) 
2g bolus + 500mg 
continuous 
infusion 
 
0   (0%) 
 
0    (0%) 
 
0   (0%) 
 
For what duration would 
you give the above dose? 
  
  
  
None 5  (56%) 4    (100%) 4   (100%) 
  
  
  
0.435 
24 hours 2  (22%) 0    (0%) 0   (0%) 
48 hours 2  (22%) 0    (0%) 0   (0%) 
Other time period 
0  (0%) 
 
0    (0%) 
 
0   (0%) 
 
Do you think an 
acetylcholinesterase level 
(AChE) will be helpful in 
guiding treatment with 
oximes? 
Yes 8   (73%) 6    (86%) 1  (25%) 
  
  
0.051 
Not sure 3   (27%) 1    (14%) 1  (25%) 
No 0   (0%) 0    (0%) 2  (50%) 
Is this test was available 
and affordable. Would it be 
useful in treating OP 
poisoning? 
Yes 9   (100%) 6    (100%) 2  (50%) 
  
0.035 No 0   (0%) 0     (0%) 2   (50%) 
 
† The total number of answers for each question do not always add up to 22 as some 
respondents omitted answering questions. 
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Others raised concerns regarding the interpretation of test result despite stating that 
they thought it was helpful;- 
“Yes. But I am not sure of a cut off point to decide on giving oxime - Evidence is 
needed on this” 
“I think it is useful in guiding the effectiveness of oximes. I don’t think there is a 
symptomatic correlation” 
 
Conversely, respondents who did not believe that the test was helpful in guiding 
oximes, expressed concern about the clinical correlation of AChE in OP poisoning;    
“(AChE) level does not correlate with clinical symptoms of the patient” 
 
as well as valuing clinical assessment over biomarker evaluation;    
“the most important thing is whether the patient is symptomatic or not” 
 
The oxime dose and duration in relation to severity of poisoning, and the range of 
oxime prescription patterns amongst survey respondents is shown in Table 5-2.  
 
The majority (75%) of the group with most experience chose a dosing regime of “2g 
intravenous bolus followed by 500mg/hour intravenous infusion”, compared with 9% 
and 0% of respondents from the subgroups with no experience and minimal 
experience (p=0.008, see Figure 5-5a).  These latter two subgroups chose to use a 1g 
boluses every 6 hours, 91% and 86% of the time, instead.   
 
The subgroup with most experience also chose a “flexible” duration of therapy 
contrasting those with no experience or minimal experience, who chose 48 hours of 
therapy in 67% and 71% of responses respectively (p=0.089, see Figure 5-5b).   
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Figure 5-5  Attitudes towards oxime dose (a) and duration (b) in a case of severe 
OP poisoning, show by level of AChE test experience. 
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The comments for this section clarified that the popular “flexible” duration of therapy in 
the group of respondents with most experience was related to clinical recovery, (see 
examples below);- 
“Until the patient is asymptomatic or off atropine” 
“Until the patient gets rid of the OP effects clinically” 
 
No respondents made specific reference to the concept of an AChE level guiding either 
the “dose” or “duration” of oxime therapy in the clarifying comments for this section.  
 
Scenario Analysis: Ordering AChE at different time points in admission   
 
“Time” (since admission) was a factor affecting whether respondents would order an 
AChE test, with a lower propensity for ordering an AChE test each subsequent day in 
the hospital admission (OR 0.85 [0.79-0.91], p<0.001, see Figure 5-6). AChE was 
ordered most frequently on admission (ranging from 86% to 65%, depending on 
severity and concurrent oxime therapy), and a progressive decline was noted during 
the following 3 days of hospital admission. Conversely there was an increased 
propensity for ordering an AChE test with greater severity of poisoning (OR 1.22 [1.10- 
1.37], p<0.001). There was a trend for increased propensity of ordering an AChE test in 
scenarios where oxime therapy was concurrent, however the influence of “oxime 
therapy” was not statistically significant (OR  1.09 [0.96-1.25], p=0.182). We noted a 
lower propensity for ordering AChE in those with the most experience compared those 
with no test experience, a difference which approached statistical significance (OR 
0.78 [0.61-1.00], p=0.052), when level of experience with seeing AChE test was 
considered. 
 
 
 
 
 
 
 
 
 
124 
 
 
 
 
 
 
 
Figure 5-6  Proportions of respondents ordering AChE over time according to the 
clinical scenario.  
(a)The effect of time, clinical severity, and concurrent oxime therapy on willingness to 
order an AChE test is demonstrated.   
 
Proportion of respondents ordering AChE over time according to clinical scenarios, 
plotted by number of AChE tests seen (b) 0 tests (c) 1-5 tests (d) 5-20 tests (next 
page). 
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Scenario analysis: Ordering AChE and guidance of oxime therapy 
 
A minority of clarifying comments in this section of the survey stated that ordering of 
AChE would help with making a decision about oxime therapy;- 
 
“to decide whether to prescribe pralidoxime or not”  [Severe poisoning, oximes, 
Day 2]   
 
 “can obtain a relative idea of the proportion of aging”  (no specific reference to 
oximes; but reference to ‘aging’ may be implied to relate to the effectiveness of 
oxime therapy)  [Severe poisoning, no oximes, Day 3] 
 
however, such comments were not offered by the majority or respondents, nor were 
they offered over the range of time points in the scenario. 
 
We noted a trend for higher proportions ordering an AChE test after oximes were 
stopped, in the scenario of severe poisoning, when comparing respondents with 
minimal and most experience (100% and 75% respectively), with those with no 
experience (37%, see Figure 5-6 b-c). This observation suggests the use of AChE in 
guiding a decision to re-starting oximes, however, the difference in proportions was 
non significant (p=0.450). Furthermore, the clarifying comments did not clearly identify 
this as a reason for AChE being ordered at this time point in any of the respondents, 
regardless of their level of experience.  
 
One comment indicated that AChE may be used in this way by saying the reason for 
ordering the test post stopping oximes was;   
“to compare with initial enzymes”   
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but there was a lack of detail about what action would be taken if the AChE enzyme 
levels had decreased, and it is uncertain whether the respondent would use the 
comparison to restart oxime therapy.  
 
Scenario Analysis: Early discharge and ordering AChE  
 
If AChE was perceived as helpful in facilitating early discharge one would expect a high 
proportion of respondents ordering an AChE test on day 2 or day 3 in the scenarios of 
a mildly poisoned OP patient, and comments that showed a link between the use of an 
AChE level to aid the decision to discharge a patient. 
 
This was not the case as respondents suggested they would order an AChE test on 
only 38% of occasions (6/16) where they said they would discharge a patient home, 
and there was no association between the decision to order an AChE test and the 
decision to discharge (see Figure 5-7). We also noted that in general a low proportion 
(50%) of respondents would opt to discharge a mildly symptomatic patient home on 
either day 2 or day 3 post admission.  
 
However, two respondents made the following clarifying comments as reasons for 
ordering an AChE test; 
“can discharge the patient early”  
“it would decide in keeping or discharging the patient” 
 which suggests that the role of AChE levels in guiding disposition decisions was 
considered by at least a minority of respondents.   
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Figure 5-7  Association of ordering an AChE test with the early discharge of a 
mildly poisoned patient who has a) initially received oximes, or b) initially not 
received oximes.  
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Figure 5-8  Proportion of survey respondents providing clarifying comments in 
scenarios of a) severe poisoning, with oxime therapy, b) mild poisoning, without 
oxime therapy. 
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Other reasons for ordering AChE based on comments     
 
Respondents qualified their answers with clarifying comments for just under half (48%) 
of the scenario questions in favor of the decision to order an AChE test, with 48% 
(Figure 5-8), providing some insight into the thinking behind ordering and not ordering 
an AChE test.    
 
Many answers supported perceived value of AChE testing having a role in diagnosis of 
OP poisoning, and gauging severity; 
 
“(useful) in cases of unknown pesticide poisoning for guiding treatment on 
certain occasions” 
 “I think acetylcholinesterase is a reliable method of assessing level of 
poisoning” 
“it will be an indicator showing the degree of poisoning” 
 
and in guiding oxime therapy;   
“Titrate the pralidoxime dose frequency with the enzyme level in the plasma” 
“when to start oximes, When to stop oximes” 
“(with measurement of AChE) unnecessary treatment can be avoided” 
 
However, the details of specifically how oxime doses would be titrated were absent as 
highlighted in the previous section.  
 
Many statements that were against the use of AChE in management of OP poisoning 
highlighted the sentiment that “clinical assessment” should take precedence over 
biochemical guidance;  
   
“Level does not correlate with clinical symptoms of the patient” 
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“Most important thing is if the patient is symptomatic or not” 
 
and other comments raised concerns about the potential wastefulness of such an 
investigation;    
“this will not change patient management, it will waste money” 
 
 
Discussion  
 
The literature states that the AChE levels can help guide OP poisoning management, 
oxime therapy and disposition decisions, and our study found that “overall” a high 
proportion of surveyed doctors valued ordering AChE test in accordance with these 
recommendations. However, paradoxically we noted that doctors with more experience 
of seeing test results through the study intervention were less likely to value the AChE 
test in guiding OP poisoning management and oxime therapy, and there was no 
suggestion it would be used to facilitate early discharge. Respondents raised a number 
of general concerns about a lack of correlation between test results and the clinical 
picture, and a perception that ordering a test would be a waste of money when 
compared to the standard practice of clinical observation.   
 
The experience of seeing test results was associated with improved knowledge scores 
across all domains. These scores were highest for knowledge in clinical management 
of OP poisoning (78% improving to 90% post intervention), contrasting the lower 
scores for questions related to biomarkers and the use of oximes (12-20% improving to 
40-50% post intervention). A relative lack of knowledge about the interpretation of 
biomarkers in guiding general management and oxime therapy may have been one 
factor explaining our unexpected findings.  
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Difficulty in interpretation of results: Pitfalls in AChE monitoring 
AChE is being increasingly recognized as a complex test with regard to the 
interpretation of levels in the context of acute OP poisoning. Difficulty with 
interpretation of AChE levels arises for several reasons including a variation in 
cholinesterase inhibition from different types of OP agents(47), the wide normal range 
for both kinds of AChE (plasma cholinesterase and red cell cholinesterase), irreversible 
inhibition (“ageing”) by a proportion of the enzyme, and the fact that inhibition can be 
non specific due to other factors that can reduce AChE levels such as concurrent 
chloroquine therapy, or conditions like pernicious anaemia (3, 54). Re-inhibition of 
AChE may occur when an oxime is discontinued and there is a residual poison load. 
Thus, in such situations it may be dangerous to discharge based on early recovery of 
AChE. Our study found that doctors generally would not use AChE to support 
discharge decisions, however, the explanations provided suggested that such nuanced 
considerations were not relevant. Further, comments suggested clinicians found it 
challenging to negotiate the pitfalls in AChE measurement highlighted in textbooks. 
 
Lack of specific decision rules for AChE guidance  
The lack of knowledge regarding AChE interpretation may in part be explained by a 
lack of precise values of AChE informing decisions rules in OP poisoning management 
(37, 52-55).  This gap in the literature was apparent on further examination of 
recommendations regarding the use of AChE in guiding oxime therapy and disposition 
decisions in particular. In relation to re-starting oximes, for example, one text quoted 
“further deterioration of cholinesterase activity should be treated by reinstituting a 
pralidoxime infusion, even though the patient may still be asymptomatic”(54), without 
providing numeric qualification on the ‘degree of inhibition’ that should lead to action. 
The challenge of interpretation of such advice, and a similar style of advice in other 
textbooks was well described in the comments of one respondent in particular from the 
scenario section of the survey who wrote;   
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“I am not sure of a cut off point to decide on giving oxime - Evidence is needed 
on this”.  
 
There is a complete lack of evidence regarding the practical use of AChE in guiding 
oxime therapy.  While some texts have suggested graphical representations of the 
titration of oximes with AChE levels(56), these only provide guidance on principles of 
antidote titration rather than specific levels that can be referenced in an algorithmic 
fashion. More sophisticated laboratory test methods exist to support decision making 
and oxime therapy; for example the in vitro measurement of response to oximes and 
estimation of the reactivatable RBC-AChE enzyme (28, 112). However, the practical 
employment of these methods in POC tests has not yet been described or validated.  
 
There is also little data to guide interpretation of AChE for its role in of supporting 
disposition decisions. Here many texts recommend discharge in association with other 
features like cessation of a need for further antidote therapy, clinical improvement and 
“stable” or “minimally depressed” cholinesterase activity (54, 55).  
 
Clinical correlation of AChE, and outcome  
On the other hand, the evidence on how RBC-AChE can provide guidance about 
diagnosis and severity of poisoning has been more clearly described, with extent of 
inhibition correlated with clinical findings (27, 28, 39, 56, 113, 122, 123). However, 
even the when specific ranges of AChE are known, the application of this information in 
a clinical setting may be complex, as it requires clinicians to incorporate an 
understanding of the potential pitfalls that can be encountered. Variations in AChE 
inhibition from different agents may lead to “some patients presenting highly 
symptomatic after minimal reduction in cholinesterase, whilst others can be 
asymptomatic after losing 50% of activity”(54).    
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Thus AChE appears to be a test where background factors, such as understanding its 
role in pathophysiology of poisoning, are important in making decisions about 
treatment, but there is no specific guidance available for doctors.   
 
This point can be illustrated by contrasting the use of AChE in OP poisoning 
management with the use of peak expiratory flow rate (PEFR) in management of acute 
asthma. PEFR can also be used for guiding diagnosis, severity and disposition 
decisions in emergency departments. The difference is that published decision rules for 
the use of PEFR in asthma management, exists (126, 127), whilst similar decision rule 
research and evidence based guidelines for the use of AChE in OP poisoning 
management is lacking.   
Study intervention provided without education or training  
No attempt was made to train doctors on how to use the test, the results were 
presented in a format that would allow the AChE test to show benefit, such as by 
graphing pre and post oxime doses (see Figure 5-2) to facilitate guidance of oxime 
therapy. Given national recommendations(37) were available for AChE interpretation 
we expected the test to be used widely in clinical treatment. Our results highlight the 
effects of introducing a complex test without specific training in how to interpret test 
results.  
 
It is interesting that knowledge increased without didactic teaching. One possible 
explanation is that by seeing the tests results doctors had an increased awareness 
about the mechanisms of OP poisoning (inhibition of the AChE enzyme), and the use 
of oximes to regenerate inhibited AChE.   
 
A qualitative study assessing the introduction of a different POC test reported that 
some clinicians were more likely to use certain tests if they had recent formal education 
in the domains surrounding the test(125). The difficulties surrounding the interpretation 
of AChE in the context of OP poisoning, that have been observed in the current study, 
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emphasise the importance of training doctors who may use the test on the assay’s 
capabilities and limitations. Such training should include appreciation of the pitfalls of 
collection, measurement, interpretation of AChE results in the context of guiding oxime 
therapy and facilitating discharge. 
 
Educational interventions are likely to affect attitudes and practices, and future studies 
should therefore incorporate concurrent education into the assessment of new POC 
tests. 
 
Limitations 
Our initial planned design was pre-post analysis but because of the high turnover of 
doctors in the study intervention wards, we ended up with data suited to a cross 
sectional survey, comparing subgroups by “level of experience with seeing AChE test 
results”.  Small numbers in these sub groups, despite a fairly good response (26 out of 
40) was a limitation.  However, the effect of the study intervention was large enough to 
result in significant differences between subgroups in some domains. 
Less “AChE test experience” than expected  
Whilst we recorded a range of AChE experience amongst survey respondents we 
expected the range to be broader, with some doctors potentially seeing up to 100 test 
results (20 tests was the highest reported experience in our study). A total of 81 
patients had AChE levels measured during the study intervention and many of these 
patients had multiple tests. Some respondents may have interpreted “tests seen” as 
the number of patients with tests seen. More objective data on exposure to tests, or 
more detail on reported exposure (e.g. asking both how many patients with results and 
how many tests) may have provided a more accurate classification of level of 
experience. However, the lower than expected test exposure may just be due to the 
high staff turnover.    
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Mixed methods approach for future research on use of POC tests 
We used a quantitative study design to assess knowledge, attitudes and practices, 
however, the collection of comments that respondents sometimes used to qualify their 
survey choices provided a deeper understanding of the main study results. The 
quantitative answers considered in isolation may have given a different impression. For 
example, whilst we found that increased experience with AChE tests led to decreased 
value being attributed to the test, often the same respondents who said they would not 
order a test also provided nuanced comments about its potential benefits. This 
highlights the degree of ambiguity amongst experienced respondents in their attitudes 
towards the test. 
 
However, only 53% of questions had an associated comment, and thus it is possible 
that certain comments may preferentially highlight the views of a few individuals. We 
also observed that respondents who answered in favour of the test more frequently 
qualified their answer with a comment (67%) than when they chose not to order the 
test (43%), see Figure 5-8.    
 
Blattner et al. assessed the acceptability and effectiveness of POC testing in rural New 
Zealand, and carried out both a quantitative study, and a qualitative thematic 
analysis(125, 128). Their quantitative study demonstrated the cost effectiveness of 
introducing the test through ability to avoid unnecessary transfers, as well as facilitate 
discharge. However, the qualitative component of their research uncovered some of 
the challenges of introducing POC testing, such as increased workload, and the 
challenge of continued professional education given that “up-skilling” of doctors may be 
required for the interpretation of some of the available test results.  These authors also 
commented that their depth of understanding about the impact of introducing the test 
would have been missed if they had relied on the quantitative results alone.   
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We suggest that future research on POC tests use a mixed methods approach with the 
development of a robust study design for its qualitative component.    
 
Conclusions 
  
An AChE POC test was valued by a majority of rural doctors but it was valued less by 
those with greater experience of seeing test results. These unexpected findings could 
be related to the complex nature of the test, no decision rules and poor knowledge of 
the interpretation. The absence of specific education on how to interpret test results 
may have been a contributing factor. 
 
We recommend that health services that want to introduce a POC AChE test provide 
doctors with concurrent training on how to use and interpret AChE results, and 
research the impact through a mixed methods approach. Such research should ideally 
be conducted with larger numbers, and include medical staff with a wide range of 
experience and include multiple primary care settings. 
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Abstract 
 
Background: Sri Lankan rural doctors based in isolated peripheral hospitals routinely 
resuscitate critically ill patients but have difficulty accessing training. We tested a train-
the-trainer model that could be utilised in isolated rural hospitals. 
 
Methods: Eight selected rural hospital non-specialist doctors attended a 2-day 
instructor course. These “trained trainers” educated their colleagues in advanced 
cardiac life support at peripheral hospital workshops and we tested their students in 
resuscitation knowledge and skills pre and post training, and at 6- and 12-weeks.  
 
Knowledge was assessed through 30 multiple choice questions (MCQ), and 
resuscitation skills were assessed by performance in a video recorded simulated 
scenario of a cardiac arrest using a Resuci Anne Skill Trainer mannequin. 
  
Results/Discussion/Conclusion: Fifty seven doctors were trained. Pre and post 
training assessment was possible in 51 participants, and 6-week and 12-week follow 
up was possible for 43, and 38 participants respectively. Mean MCQ scores 
significantly improved over time (p<0.001), and a significant improvement was noted in 
“average ventilation volume”, “compression count”, and “compressions with no error”, 
“adequate depth”, “average depth”, and “compression rate” (p<0.01). The proportion of 
participants with compression depth ≥40mm increased post intervention (p<0.05) and 
at 12-week follow up (p<0.05), and proportion of ventilation volumes between 400-
1000mls increased post intervention (p<0.001). A significant increase in the proportion 
of participants who “checked for responsiveness”, “opened the airway”, “performed a 
breathing check”, who used the “correct compression ratio”, and who used an 
“appropriate facemask technique” was also noted (p<0.001). 
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A train-the-trainer model of resuscitation education was effective in improving 
resuscitation knowledge and skills in Sri Lankan rural peripheral hospital doctors. 
Improvement was sustained to 12 weeks for most components of resuscitation 
knowledge and skills. Further research is needed to identify which components of 
training are most effective in leading to sustained improvement in resuscitation.   
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Introduction 
 
Resuscitation education is an emerging field in Sri Lanka, run largely by consultant 
anaesthetists working at tertiary referral centers and the larger secondary hospitals. 
The heavy workload of these specialists limits the opportunity to provide training to 
rural peripheral hospital doctors. Previous research has identified that rural peripheral 
hospital doctors feel professional isolation due to a lack of training opportunities (15). 
There is a need for good resuscitation knowledge and skills in these doctors as they 
are the first point of contact for patients who frequently require resuscitation such as 
those presenting with pesticide poisoning and snake bite injury(87, 129, 130). A 
common emergency presentation and cause of death in rural Sri Lanka is 
organophosphorus pesticide (OP) self-poisoning, which is a condition that results in up 
to 200,000 deaths annually in Asia(1-3, 32, 51). OP poisoning has a case fatality of 8-
15% primarily due to respiratory arrest, which progresses to cardiorespiratory 
arrest(32, 87). Snakebite envenomations also require frequent resuscitation and high 
proportions (48%) of patients with neurotoxic symptoms who require mechanical 
ventilation have been reported(131, 132).  
 
At the time of this study advanced cardiac life support training (either according to the 
American Heart Association, UK or Australian resuscitation councils) was not nationally 
available for doctors. There are considerable logistic barriers in the delivery of training 
to doctors in these rural peripheral hospitals. Many peripheral hospitals are run by only 
one to two doctors, so they cannot be released from clinical duties to travel for up to 2 
hours to the central hospitals where resuscitation education occurs. 
 
The train-the-trainer (TTT) model of resuscitation education has been used 
successfully in higher resourced settings for various levels of resuscitation skills. For 
example, it has been successfully used to train university students to teach basic life 
support (BLS) but not advanced life support (ALS)(133, 134). The use of ‘non 
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specialist’ trainers to teach resuscitation to doctors in teaching hospitals has also been 
previously described(135), however, the effectiveness of using peripheral hospital 
doctors as trainers in their own low resource rural hospital setting has not been 
examined.  
 
Those experienced in the global development of emergency medicine have advocated 
the TTT model of education to help leverage limited resources(136). However, there 
have been no studies in the adult resuscitation education literature to date that have 
evaluated the effectiveness of this model by analysing validated knowledge and skills 
endpoints (137). Two studies from Africa investigated the use of a TTT model but this 
was specifically for neonatal resuscitation(138, 139), and another study commented on 
the success of the TTT approach in training nurses in cardio pulmonary resuscitation 
(CPR) in the Middle East, but did not objectively assess resuscitation skills in their 
course participants(140). The only identifiable study that referred to a TTT model in 
either Sri Lanka or India was in the context of trauma care rather than cardiopulmonary 
resuscitation (141). 
 
We sought a potentially sustainable solution to overcome the barriers to education and 
training for rural Sri Lankan peripheral hospitals by assessing the effectiveness of a 
TTT model that used non-specialist peripheral hospital doctors as trainers, who taught 
basic and advanced life support (ALS) training to their colleagues. Effectiveness was 
defined as a statistically significant improvement in components of resuscitation 
knowledge and skills towards an internationally recognised standard (based upon the 
International Liaisons Committee on Resuscitation – 2005 resuscitation guidelines). 
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Materials and Methods 
 
 
This study was approved by the Ethical Review Committee at the Faculty of Medicine, 
University of Peradeniya, Sri Lanka.  As the study was carried out in conjunction with 
the regional government health training authority within the framework of usual practice 
the ethics committee did not require written consent. However as per protocol, trained 
research assistants described details of the study to participants and verbal consent 
was obtained prior to the commencement of the peripheral hospital workshop. 
Participant data was subsequently de-identified. 
 
The study was conducted in the North Central Province of Sri Lanka between 
November 2008 and July 2009. The province has 45 peripheral hospitals with inpatient 
facilities supported by 2 central secondary referral hospitals. The TTT resuscitation 
training program was developed and conducted collaboratively with the North Central 
Provincial Department of Health. Our study population consisted of non-specialist 
doctors working at peripheral hospitals who were participants in the resuscitation 
training workshops and attended both the pre and post training assessments, including 
follow up at 6 and 12 weeks.   
 
Training the trainers  
 
The first phase of the study involved training of the trainers who consisted of 8 non-
specialist doctors from five peripheral hospitals in the North Central Province of Sri 
Lanka. These 8 were selected from 20 candidates at an initial resuscitation workshop 
organized in conjunction with the provincial department of health, and were chosen 
because of their interest in becoming trainers and their observed competence. The 
prospective trainers each underwent two further sessions of residential training based 
at the tertiary teaching hospital for the province, which was centrally located (see 
Appendix C1 for an overview of the workshops).  
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In the first one day session the candidates’ knowledge of the resuscitation syllabus was 
reinforced. In the second session, which was a two day ‘instructor workshop’, they 
were taught “how to teach” and how to run a peripheral hospital workshop (see 
Appendix C2 for schedule). The instructors who taught the prospective trainers were 
certified resuscitation instructors from schools of teaching affiliated with the 
International Liaisons Committee on Resuscitation (ILCOR). All instructors were 
experienced in teacher training according to either the ACLS (Advanced cardiac life 
support - American Heart Association standard) or ALS (Advanced life support - UK 
/European/Australasian resuscitation council standard) courses overseas. The manual 
for the course that the trainers were trained to teach was largely based upon the 
content of the UK resuscitation council’s “Intermediate ALS” course, which is also 
endorsed by the Australian and New Zealand resuscitation councils.  
 
The teacher training included adult education theory, how to run interactive lectures 
with digital video disc (DVD) support for content, and how to teach using a mannequin 
in skill stations and scenario stations. This session concluded with a practice workshop 
using volunteer participants who were junior doctors from the central hospital. The 
‘trained trainers’ were directly observed and assessed on their ability to deliver 
lectures, run skills stations and conduct simulated scenarios according to a 
standardized checklist at this practice workshop (see Appendix C3 for checklists).  
 
A comprehensive instructor manual describing the workshop schedule and teaching 
goals was provided to the instructors and the trainers (see Appendix C3 for instructor 
manual). This also outlined the skills stations and scenarios being taught, and relevant 
adult education theory that would aid the delivery of course content. This manual also 
contained teacher assessment checklists that were used by the instructors to facilitate 
the feedback and assessment of the trainers, and allowed standardisation of the 
teacher training process. Our clearly defined teacher training methodology meant that 
145 
 
outcomes measured later in the study could be linked to the effectiveness of teaching 
by the trainers, and thus the TTT model of resuscitation education being tested. The 
adult education theory and teacher training module in the manual was taken from the 
“Pocket guide to Teaching for medical instructors” by the BMJ group(142).   
 
Prospective trainers from remote locations were accommodated in the same residential 
facility provided for by the course. This allowed time for orientation to the course goals, 
and for group reflection and consolidation of learning at evening meals, a situation that 
was likely to be different to their previous educational experience (see Appendix C2 
includes schedule of workshop). This strategy was used in recognition of the time 
intensive nature of the instructor workshop, and in hope of supporting a team approach 
to learning that could increase esteem and self confidence during the process of 
‘learning how’ to teaching.  
 
Peripheral Hospital Resuscitation Workshops (Training Intervention) 
 
The second phase involved sending the “trained trainers” to selected larger peripheral 
hospitals where they delivered eight resuscitation training workshops, teaching BLS 
and ALS, over a two month period (see Appendix C4 for course outline and contents). 
In this phase the resuscitation ‘Trainers’ worked in pairs to deliver education to 6-12 
participants per session maintaining a minimum ratio of 1 instructor to 6 participants at 
all sessions. The participants were peripheral hospital doctors who were either from the 
same hospital where the trainers worked or who had travelled from a nearby smaller 
hospital.  The aim of this workshop was to teach resuscitation to doctors who were 
assumed to have had no prior post-graduate resuscitation knowledge. The focus of the 
workshop was on the practical skills of BLS and ALS that would be required by these 
doctors in their daily practice, including an approach to the unresponsive patient, 
performance of chest compressions, and performance of ventilations using a bag valve 
mask apparatus, intubation and ventilation of an intubated patient.  
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Participants of the peripheral hospital workshops were supplied with a resuscitation 
training manual, (which was a modification of the ALS manual for ‘intermediate life 
support’), and a wallet card with the cardiac arrest algorithm printed on it.  Trainers 
carried out resuscitation education with the aid of training mannequins and other 
supporting equipment including a DVD containing video lectures, and wall charts of the 
resuscitation algorithm  (see Appendix C5 for a list of supporting material for trainers 
and participants). Baseline data on the characteristics of the participants and their 
feedback on the training workshop were collected. Real resuscitation experiences that 
the participants encountered during the 12 week study period were also collected 
through a log sheet that was supplied to them at the beginning of the workshop.    
 
Each workshop was held from 0800hrs to 1645hrs, which included one and a half 
hours for multiple choice question (MCQ) testing and scenario testing, immediately 
before and after the resuscitation training intervention. The training intervention started 
with a series of lectures about BLS and airway management, which were pre-recorded 
and played from a DVD lasting approximately an hour. During this time the trainer 
would periodically pause the DVD and interact with participants about the content of 
the DVD lecture. A practical session teaching bag mask ventilation and intubation 
followed where each trainer worked with 6 participants in skills stations that were 
equipped with either a mannequin or an airway-training device. The practical skills 
were taught using Peyton’s 4-stage teaching approach as described in the European 
Resuscitation Council resuscitation course strategy(143).  
 
The afternoon DVD lectures covered treatment algorithms for shockable and non-
shockable cardiac arrest, and these skills were practiced in the same groups under the 
supervision of the trainer who made use of resuscitation mannequins to run two set 
scenarios. The trainers were required to give positive feedback and constructive 
criticism to participants during all the practical session including the scenarios. Posters 
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of the cardiac arrest treatment algorithms were also supplied to each hospital that 
participants came from as part of the service component of the educational 
intervention. 
 
The knowledge and skills of participants was assessed before and after they received 
resuscitation education from the trainers. This assessment was carried out by 3 
research assistants, however, the workshop participants were taught exclusively by the 
“trainers”. The research assistants were all junior doctors and were trained and 
overseen by the principal investigator (PI).  At 6 and 12 weeks participants were 
followed up with an identical assessment. Feedback on performance in the scenario 
was not given for the pre-training assessment, but provided for the post-training 
assessment, 6-week and 12-week follow ups.  
Outcomes 
 
The primary outcome was to assess the effectiveness of this model of teacher training 
in improving resuscitation knowledge and skill endpoints among the peripheral hospital 
doctors taught by the ‘trained trainers’. Knowledge and skills were judged by scores in 
an MCQ test and performance in a simulated cardiac arrest scenario with concurrent 
video analysis. Assessment was carried out immediately pre and post training, and 
again at 6 and 12 weeks, following the advice of international guidelines that 
recommended repeat assessments to ensure adequate retention of knowledge and 
skills following resuscitation training(144). The secondary endpoint of this study was to 
investigate how long any improvements in knowledge and skills would be sustained. 
 
Knowledge assessment: MCQ test  
 
The MCQ was a modified version of the American Heart Association (AHA) advanced 
cardiac life support (ACLS) course, which tested aspects of BLS and ALS including 
ECG arrhythmia recognition (see Appendix C6). One mark was awarded for every 
correctly answered question for each of the 30 questions, and no penalty was given for 
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missed or incorrect answers. Five questions were modified to fit the Sri Lankan medical 
context of health care. For example, terms like “ER”, an acronym for ‘emergency room’ 
didn’t exist in the Sri Lankan health care terminology, so this was replaced with more 
appropriate terms such as “OPD” (outpatient department), or “ETU” (emergency 
treatment unit) for the written scenario statements that formed the basis of some 
questions.  The same MCQ test was used at all assessments, but participants were not 
told their test scores nor were they given feedback on their answers to previous tests.   
 
Skills assessment: performance in a cardiac arrest scenario  
 
Participant’s knowledge and skills in the initial response to an unconscious patient, and 
performance of CPR was tested through a video recorded simulated scenario of 
cardiac arrest involving an instrumented mannequin(145).  
 
A temporary ‘simulation suite’ was established in the room where the peripheral 
hospital training session was being conducted (see Appendix C7). The simulated 
patient was a male mannequin lying in a hospital bed wearing local attire, cordoned off 
from the rest of the room by hospital screens. The participant was read the scenario 
script from outside the simulation suite and was told that a 50 year old man had 
collapsed and the participant was asked to “do what you would do in real life” (see 
Appendix C7 for script).  The participant then entered the suite and was expected to 
check the responsiveness of the patient, call for help, open the airway, perform a 
breathing check and after this assessment initiate single rescuer CPR. If CPR had not 
commenced by 60 seconds they were given the following prompt:- 
 
“I want you to start cardiopulmonary resuscitation on this patient please” 
 
The scenario was continued to capture 60 seconds of chest compressions once CPR 
had commenced and the participant was then told that help had arrived.  
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Assessment of compression and ventilations  
 
The instrumented mannequin, Resusci Anne Skill Trainer™ (by Laerdal), was 
connected to a laptop, which recorded the following measurements of resuscitation 
skill;- ventilation count, adequate ventilation volume, average ventilation volume 
(milliliters), compression count, compression with no error, average depth (millimeters), 
adequate depth, compression rate, and adequate rate. We analysed the data by 
describing any changes in the raw scores of these variables in relation to the training 
intervention. We also described the changes in proportions of participants achieving 
clinically relevant benchmarks described in the literature reflecting the quantity and 
quality of compressions and ventilations. The benchmarks we reported were;- mean 
compression depth between 40-50mm, mean compression depth ≥ 40mm, mean 
compression rate 80-120/min, and mean ventilation volume 400-1000mls(146).   
 
Assessment of initial approach and steps of CPR 
 
Video assessment of simulated scenarios is an established methodology in measuring 
effectiveness of resuscitation training (145-149). A video recorded scenario was to 
measure objective endpoints on quality of compression and ventilations, and steps of 
cardiopulmonary resuscitation (CPR) employing validated metrics(145, 146).     
 
The video recorded scenarios were marked by 3 trained research assistants who 
coordinate the assessments at the peripheral hospital workshops. A marking schedule 
was adapted from a validated assessment tool for CPR performance called the ‘Cardiff 
Test version 3.1’(145), and these variables were modified to be consistent with the 
2005 ILCOR guidelines for CPR where necessary. The marking criteria assessed 
whether participants correctly carried out the following steps of initial approach and 
performance of CPR;- calls for help, checks for responsiveness (shouting), checks 
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responsiveness (shaking victim firmly), opens airway (using either head tilt, chin lift or 
jaw thrust), checks for airway obstruction, performs a breathing check, uses correct 
compression ratio, and uses appropriate facemask technique (see Appendix C8 for 
marking checklist). The participants’ practice of checking for a pulse centrally, or 
utilising a precordial thump was also observed.  
 
The video assessors were trained on how to mark the video scenarios according to the 
marking schedule by the principal investigator (PI) in an initial 30 minute teaching 
session, Thereafter they independently marked 5 video recordings of scenario 
assessments, and a kappa score for inter-observer reliability of 0.69 was calculated for 
the variables that the study was reporting. This score was within the range of kappas 
reported by the original article for the Cardiff Test(145). They subsequently received a 
second group training session where any discrepancies in marking were discussed and 
consensus was achieved.  
 
The remaining participant videos were then divided and allocated to each video 
assessor to mark independently. Participant’s sequential assessments were staggered 
between the three assessors, and they were blinded to their previous results when 
marking. The score from each assessment was recorded on a checklist, followed by 
subsequent data entry into an excel spreadsheet. The skills variables were analysed 
as binary outcomes where the task was either performed correctly or not.  
  
Statistical analysis 
 
A power calculation estimated a total of 50 participants were needed to provide more 
than 90% power to detect a statistically significant difference between the before and 
after composite scores using a two-sided paired t-test at significance level 0.05. This 
calculation was performed under the assumption that the performance scores would 
increase by an average of 15 points (from 50% to 65%) with a standard deviation of 30 
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points, based on observations from a previously conducted pilot study. The sample 
size calculation was performed using Stata v12. We aimed to recruit 75 doctors, to 
allow for attrition. 
 
The mean MCQ scores were compared using a Wilcoxon signed rank test for paired 
non parametric data.  Continuous variables were compared between assessment 
sessions using the repeated measures ANOVA test looking for a change in 
performance over time, and we have presented unadjusted p-values. Differences in 
proportions were tested using the McNemar exact test. Statistical tests were carried 
out using STATA v12, and graphs were created using GraphPad Prism (v6). 
  
 
Results  
 
57 participants attended the peripheral hospital workshops but two participants were 
excluded because they did not have a pre-intervention assessment leaving 55 
participants for analysis. One participant did not complete the baseline data survey so 
demographic data was represented for only 54 participants (Table 6-1). Some 
participants were unable to sit the post-training and follow up assessments due to work 
commitments. 52, 44 and 47 participants received the post-training, 6 week and 12 
week follow up MCQ assessments respectively (Figure 6-1).  51, 43 and 38 
participants received the post training, 6 week and 12 week follow up scenario 
assessments respectively (Figure 6-2). In addition, data was lost for 7 participants in 
the 12 week follow up assessment due to a technical error involving the computer 
backup of data. A complete set of assessment data was available for 32 participants 
due to a combination of non-attendance for follow up assessments and missing data.  
The median age of participants was 34 years and there was a male predominance 
(39/55, 71%). The participants ranged from 2 to 28 years post graduation from their 
medical degree, and there was a median of 6 years postgraduate experience in the 
study group. 14/54 (26%) had experienced some form of previous resuscitation 
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education, but only 3/54 (6%) experienced this education within the last year. Just one 
participant reported scenario training or interpretation of cardiac rhythms as a 
component of previous education. 3/14 (21%) from the subgroup reporting prior 
educational experience felt their resuscitation training was adequate, and overall 20/54 
(37%) felt their resuscitation training experience was adequate prior to taking part in 
the study (Table 6-1).     
 
Figure 6-1  Flowchart showing the number of participants recruited to the study, 
receiving the training intervention and receiving follow up MCQ assessments. 
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Figure 6-2  Flowchart showing the number of participants recruited to the study, 
receiving the training intervention and receiving follow up scenario 
assessments.  
The number of participants that did not attend follow up assessment and where there 
were technical errors leading to missing data is also shown.   
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Table 6-1  Demographics and baseline characteristics of the 
study population. 
 
,, n=54,(%),
Age$and$Seniority$
Median,age,(range), 34,(28153),
Median,years,post,graduation,(range), 6,(2128),
Other$characteristics$
Male, 39,(71%),
Any,previous,resuscitation,education,experience, 14,(26%),
1,Education,included,Scenarios, 1,(2%),
1,Education,included,Cardiac,Rhythms, 1,(2%),
Course,attended,within,last,12,months, 3,(6%),
Level,of,resuscitation,training,felt,to,be,adequate, 20,(37%),
 
 
MCQ Assessment 
 
The mean MCQ score increased from 54.1% pre intervention to 66.6% post 
intervention, and 69.8% and 72.9 % at 6 week and 12 week follow ups, and this 
change over time was significant (p<0.001, Wilcoxon signed rank test) (Table 6-2). The 
repeated measures ANOVA also showed a difference in scores over time (p<0.001).  
 
 
Table 6-2  Mean scores and 95% confidence intervals for MCQ 
assessment.  
Data was analysed with the non-parametric Wilcoxon signed rank test, and a 
significant difference between pre-training score and subsequent post-training 
assessments. The p value is also shown for the repeated measures ANOVA test  
which compared differences in mean scores over time.   
 
 
 
*p<0.001 Wilcoxon signed rank test 
** Repeated measures ANOVA  
 
MCQ 
Assessment 
Pre-
training, 
n=55 
Post-
training, 
n=52 
6 weeks 
post, n=44 
12 weeks 
post, n=47 
p 
value** 
Mean score  54.1 66.6* 69.8* 72.9* 
<0.001 
95% CI 49.1-59.1 62.1 - 71.1 65.1-74.5 67.7-78.0  
Median (p50) 52 68 72 76  
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Table 6-3  The effect of training on variables of resuscitation 
skills as recorded by the Laerdal mannequin.  
Category Time Variable Mean p value 
Ventilation count (number of  Pre-training  4.6  
ventilations) Post-training 5.2   
  6 weeks post 3.4   
  12 weeks post 3.3  0.213 
Adequate ventilation volume  Pre-training  1  
(number of ventilations)  Post-training  2.1   
  6 weeks post 1.9   
  12 weeks post 1.7 0.134  
Average ventilation volume  Pre-training   307.2  
 (milliliters) Post-training  458.8   
  6 weeks post 398.3   
  12 weeks post 342.5 0.004*  
Compression count  Pre-training   40.4  
(number of compressions) Post-training  75.6   
  6 weeks post 73.1   
  12 weeks post 70.4  0.001* 
Compressions with no error  Pre-training   2.5  
(number of compressions) Post-training  19.2   
  6 weeks post 14.3   
  12 weeks post 19.6  0.001* 
Adequate depth  Pre-training   4.9  
(number of compressions) Post-training  25.4   
  6 weeks post 21.9   
  12 weeks post 27.3  0.001* 
Average Depth  Pre-training   28.8  
(millimetres) Post-training  36.9   
  6 weeks post 37.1   
  12 weeks post 39.1  0.001* 
Compression rate  Pre-training   106.1  
(compressions/minute) Post-training  116.3   
  6 weeks post 107.1   
  12 weeks post 105.2  0.016* 
Adequate rate  Pre-training   46.9  
(no of compressions) Post-training  59.4   
  6 weeks post 75   
  12 weeks post 75  0.054 
The p value was calculated using the repeated measures ANOVA test checking for a 
difference in mean performance over time.    
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Scenario Assessment  
 
The mannequin data showed a significant difference over time for 6 out of 9 variables 
related to performance of compressions and ventilations after analysis by the repeated 
measures ANOVA test.  A significant change was noted for average ventilation volume, 
compression count, compression with no error, adequate compression depth, average 
compression depth, and compression rate (Table 6-3).  The mean number of 
compressions almost doubled from 40 to 75.6, and compression with no error numbers 
improved from 2.5 to 19.2 when comparing pre with post (p<0.001), the latter variable 
reflecting the correct hand position, and depth considered together.   
 
 
Table 6-4  Percentage of participants appropriately performing 
aspects of chest compression and bag valve mask ventilation 
pre-training, immediately post-training and at 6 week and 12 
week follow up.   
 
 
*p<0.05 
** p<0.001 
p-values based upon a comparison of pre-training and post training intervention 
percentages using McNemar’s test (immediately post training, at 6 week follow up, and 
12 week follow up) 
✝  95% exact CI were used  
 
 
 Percentage performing (95% CI✝), n=32 
 
 
Pre-training Post-training 
6 weeks 
post 
12 weeks 
post 
Mean compression 
depth 40-50mm  6 (1-21) 25 (11-43) 22 (9-40) 28 (14-47) 
Mean compression 
depth ≥40mm 13 (4-29) 38 (21-56)* 34 (19-53) 47(29-65)* 
Compression rate 80-
120 per minute 50 (32-68) 56 (38-74) 72 (53-86) 72 (53-86) 
Ventilation volume 
400-1000mls 34 (19-53) 78(60-91)** 56 (38-74) 50 (32-68) 
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Figure 6-3  Graphs plotting percentage of participants achieving clinically 
relevant benchmarks (those achieving benchmark/total number in studied);  
a) mean compression depth of 40-50mm, b) mean compression depth ≥40mm, c) 
mean compression rate 80-120, and d) mean ventilation volume of between 400-
1000mls. (The mean percentage has been plotted with error bar representing the 95% 
confidence of the mean)  
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Clinically relevant benchmarks of compression and ventilation after the training 
intervention also improved. The proportion of participants with a mean compression 
depth ≥40mm (p<0.05) and proportion of participants with ventilation volumes between 
400-1000mls (p<0.001) increased from the pre-training (baseline) to the post-training 
assessment (Figure 6-3, Table 6-4). There was a trend for sustained improvement at 6 
and 12 weeks, for the “compression depth ≥40mm” variable, however, the 
improvement in proportions reached statistical significance only at the 12 week follow 
up. Conversely, the improvement in “ventilation volume between 400-1000mls” was not 
sustained beyond the post-training assessment. However, the proportion of 
participants achieving this benchmark at the 6 and 12 week follow up assessments 
was still greater than the baseline proportion (56% and 50%, versus 34%). Similarly a 
trend for increasing proportion for participants who achieved a “mean compression 
depth of 40-50mm”, and “compression rate of 80-120” was observed after the training 
intervention, but statistical significance was not achieved for these increases.   
 
Results for the video assessment showed significant improvements in checking for 
responsiveness (shouts), airway opening, breathing check, performance of the correct 
compression ratio, use of an appropriate facemask technique, p<0.001 for all 
mentioned variables, (Figure 6-4a,b, Table 6-5). There was also a reductions 
proportions performing precordial thump (p<0.05), and checking the pulse at a 
peripheral location (p<0.001), which was not recommended.  
 
The greatest proportional increases were observed for initial approach, where the 
proportion checking responsiveness by shouting “are you okay” increased from 16% 
pre intervention to 77% post intervention, and in CPR for “airway opening”, and  
“correct compression ratio”, increasing from 18% to 84%, and from 5% to 84% 
respectively. The improvement with the pre training scores remained significant at the 
6 week and 12 week follow ups in the majority of variables as depicted in Table 6-5. 
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Table 6-5  Performance in video assessment variables before 
and after the training intervention.  
 
Video 
assessment 
variable 
Mean percentage achieving variable in relation to training 
intervention, (95% CI) 
Pre-training Post-training 6 weeks post 12 weeks post 
 
Calls for help 55 (38, 71) 50 (28, 72) 73 (53, 94) 73 (49, 98) 
Checks 
responsiveness - 
Shouts 16 (6, 31) 77 (55, 98)** 69 (50, 87)** 58 (38, 78)** 
Checks 
responsiveness - 
Shakes 3 (0, 14) 5 (0, 13) 6 (0, 25) 14 (1, 26) 
Pulse Check (all) 95 (82, 99) 79 (63, 96) 66 (46, 86)* 66 (47, 85)** 
- Checks pulse 
(central location) 50 (33, 67) 71 (50, 92) 53 (30, 75) 55 (31, 80) 
- Checks pulse 
(only 
peripherally) 45 (29, 62) 8 (0, 28)** 13 (0, 31)** 11 (0, 30)** 
Airway Opening 18 (8, 34) 84 (66, 100)** 50(29, 70)** 65 (42, 88)** 
- Head tilt 18 (8, 34) 76 (58, 94)** 36 (18, 55) 63 (40, 86)** 
- Chin lift 8 (2, 21) 66 (48,84)** 42 (24, 60)** 37 (17, 57)* 
- Jaw thrust 5 (1, 18) 39 (18,60)** 26 (7, 45)* 26 (7, 45)* 
Airway 
obstruction 
check 47 (31, 64) 63 (38, 88) 44 (19, 69) 31 (5, 58) 
Breathing check 45 (29, 62) 82 (61, 100)** 61 (40, 82) 82 (61, 100)** 
Correct 
compression 
ratio 5 (1, 18) 84 (66, 100)** 79 (62, 95)** 89 (75, 100)** 
Appropriate 
facemask 
technique 3 (0, 14) 40 (22, 58)** 29 (13, 46)** 56 (36, 76)** 
Precordial thump 18 (8, 34) 0 (0, 15)* 2 (0, 16)* 0 (0, 15)* 
 
*p<0.05 
** p<0.001 
 
p-values based upon a comparison of pre-training and post training intervention 
percentages using McNemar’s test (immediately post training, at 6 week follow up, and 
12 week follow up).  
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Figure 6-4a  Shows proportion of participants carrying out the following 
responses from the video assessment component of the scenario (those 
performing task/total number studied);  
i) appropriately checking responsiveness by shouting, ii) using the correct compression 
ratio when performing cardiopulmonary resuscitation iii) appropriately calling for help, 
and iv) checking for the pulse only in a peripheral location (incorrect).  
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Figure 6-4b  Shows proportion of participants who correctly performed i) 
opening of the airway (either head tilt, chin lift or jaw thrust), ii) an obstruction 
check, iii) a breathing check, and iv) used an appropriate facemask technique  
(Nb - for Figures 6-4a and 6-4b the mean proportion has been plotted as a horizontal 
line with error bars showing the 95% confidence interval of the mean). 
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Resuscitation Logbook 
 
During the 12 week follow up period 31 participants (56%) reported between 1 to 4 real 
life resuscitation encounters in their hospital jobs (Table 6-6). They also reported that 
they found the training they received during the study intervention helpful in 91% of 
these encounters.  
 
 
Table 6-6  The number of real life resuscitation encounters 
reported in logbooks of study participants.  
 
 
Experience of real life resuscitation  
  
Number of 
Participants, n=55 
(%) 
  
No reported resuscitation experience 24 (44) 
  
Reported 1 or more resuscitation events  31 (56) 
Number of resuscitation encounters  
   
   0 26 (47) 
   1 17 (31) 
   2 5 (9) 
   3 7 (13) 
   4 2 (4) 
Events where training was helpful  
  
Number of events, 
n=57 (%) 
 Yes 52 (91) 
 No 5 (9) 
 
Discussion  
 
The current study tested a novel approach to resuscitation education that has not been 
previously reported in the literature. Whilst there are other studies that measure the 
benefit of different educational interventions in improving ALS and BLS outcomes in 
highly resourced urban settings, the key difference with our study was its focus on the 
assessment of a train-the-trainer (TTT) model of education using non-specialist doctors 
in a resource limited peripheral hospital setting. We also reported objective and 
validated endpoints in resuscitation knowledge and skills, directly after and up to 12 
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weeks following the training intervention. Our study has direct relevance to rural Asia 
where there is a high incidence of respiratory failure from pesticide poisoning and 
snake bite envenomation(1, 130-132), in addition to the standard range of primary 
cardiorespiratory pathology seen throughout the world. 
 
The main objective of our training intervention and evaluation was to improve 
outcomes in accordance with the recommendations set out by ILCOR. These 
guidelines emphasised high quality chest compressions with minimal interruptions, and 
recommended a cardiac compression to ventilation ratio of 30:2 and a target chest 
compression rate of 100 per minute(150).  
 
We observed improvement in all the domains of data we collected including knowledge 
from the MCQ scores, quality of compressions and ventilations from the mannequin 
data, and knowledge and skills in carrying out the “steps of CPR” through the video 
assessment.  The improvement seen in these metrics was similar to reports of 
comparable endpoints from training interventions delivered in high resourced clinical 
environments(146, 151, 152).   
Improvement in Compressions and Ventilations 
 
The improvements we noted in compression and ventilation skills, as recorded by the 
instrumented mannequin, were significant, but in general not as large as that observed 
for the “steps of CPR” as measured by the video analysis. The most prominent 
improvements were compression counts (number of compressions), and compression 
depth (including adequate depth), which both significantly improved after the training 
intervention. The increases in endpoints from the instrumented mannequin data also 
translated into significant improvement in clinically relevant benchmarks, specifically in 
the proportion of participants achieving compression depths of ≥40mm, and ventilation 
volumes of 400-1000mls (Table 6-4). However, the absolute proportions of post 
intervention compressions depth was suboptimal, reflected by low absolute proportions 
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(38 - 47%) of participants achieving ≥40mm depth, despite improving significantly from 
the baseline proportion (13%).  
 
Suboptimal chest compression depth is a recognised challenge in ALS training and 
other studies have reported similar, or lower, chest compression depths than reported 
in the current study despite being conducted in high resourced settings(151-153). 
Perkins et al. studied the quality of CPR achieved by health care professions attending 
ALS training courses in the UK, and reported mean chest compression depths of 
between 24.1 – 28.2mm(151), whereas the mean compression depth in our study 
increased from a baseline 28.8mm to between 36.9 - 39.1mm post training. Two 
studies identified that poor chest compressions depths in mannequins placed on 
hospital beds may be due to pressure dissipation through the mattress rather than due 
to lack of chest compression skill (152, 153). Another study reported higher proportions 
(70-79%) of participants achieving an adequate compression depth (≥40mm)(146), 
however, it is likely that the mannequin they used was placed on the floor which may 
have aided their compression depth recordings(153).  
 
While there was no increase in the “ventilation counts” there was a significant increase 
in the “volume of ventilation”, and the proportion of participants who delivered a 
clinically acceptable ventilation volume, i.e. 400-1000mls when comparing baseline 
with post intervention assessments (Tables 6-3 and 6-4). The proportion of participants 
who delivered an acceptable ventilation volume following training increased from 34% 
to 78%, this was higher than that reported by Mpotos et al. who reported between 52-
59% of participants achieving the same following training intervention(146).  
 
The skills that improved the most were use of the correct compression: ventilation ratio, 
correct airway opening, and delivery of adequate ventilation volume. The improvement 
in correct compression ratio is notable because it was in alignment with the CPR 
guidelines taught at the peripheral hospital workshops. The observed improvements in 
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ventilation and airway opening skills were of particular importance in the study setting 
of rural Sri Lanka because airway compromise is commonly encountered due to the 
high incidence of organophosphorus poisoning and snakebite injury in the region(3, 32, 
52, 87, 130, 132). 
 
The skills that improved the least were calling for help, checking responsiveness 
through shaking the victim, and checking for an airway obstruction. The latter two 
variables were difficult to measure through video analysis and are known to have a 
lower inter-observer reliability than for other measured variables measured(145).    
 
  
Retention of knowledge and skills over time  
 
The retention of knowledge and skills at 6 weeks and 12 weeks, was a secondary 
endpoint in our study, and we noted that the mean post-training MCQ scores stayed 
elevated compared to the baseline assessment scores, and the improvements in most 
categories of the video assessment evaluating correct steps of CPR were also 
sustained until 12 weeks.  However, when looking at the skills of chest compression 
and delivery of ventilations, only improvement in chest compressions (mean 
compression depth ≥40mm) was sustained until 12 weeks. The percentage achieving 
ventilation volumes of 400-1000mls dropped down from 78% at the post intervention 
assessment to 56% and 50% at the 6 and 12 week follow up assessments 
respectively. This suggests that the improvement in ventilation skill was not 
significantly sustained beyond the post intervention assessment.   
 
We also observed non statistically significant trends for increasing outcomes at the 6 
week and 12 week follow up assessments for MCQ score, at the 12 week follow up for  
“initial airway opening” and “initial breathing check”, and at the 6 week follow up for 
“mean compression rate of 80-120” (Figure 6-3, and Figure 6-4b). One would expect a 
decrease in skill outcomes the greater the time from training intervention, so these 
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trends were unexpected. In search of a plausible explanation we considered the 
possibility of continued learning following the initial training intervention, and the 
possibility of the follow up assessments having an educational benefit. Kromann et al. 
showed testing as a final activity in a resuscitation skills course increases learning 
outcomes (a so called “testing effect”), however, the effect of multiple testing without 
preceding formal training was not studied(154, 155). Our study was not designed to 
evaluate the role of repeat testing, but it would be worthwhile asking this question in 
future research investigating what factors lead to a sustained improvement of 
knowledge and skills in the peripheral hospital setting.    
 
This study confirms previous reports of a deficit in resuscitation training in the rural Sri 
Lankan setting(15). Whilst 14 participants (26% of study group) had received previous 
resuscitation education (and only 6% had attended one within the previous year), none 
had received education equivalent to the standard of an ALS course. We know this 
because ALS training was not available for rural hospital doctors at the time of the 
study intervention. However, it was also confirmed through the participant data where 
only one participant reported prior exposure to scenario based education and 
education about cardiac rhythms as part of their previous resuscitation training 
experience (Table 6-1), which is an essential characteristic of ALS training. The lack of 
equivalency between the previous resuscitation education that was reported by 
participants and the education provided in the current study meant that prior training 
was unlikely to be a confounding variable in our analysis. In addition, the fact that 57% 
of the entire group, and 79% of the 14 participants had received previous resuscitation 
education, felt their level of resuscitation training was inadequate prior to the study 
intervention, perhaps provides further evidence of the magnitude of the resuscitation 
training deficit that exists in the peripheral hospital setting.  
 
In contrast to other studies reporting resuscitation training interventions, which are 
often set in urban teaching hospitals, our study delivered training to quite a diverse 
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range of doctors who had between 2 and 28 years of post graduate experience. The 
heterogeneity of clinical experience within the study group, suggests a range of 
different learning aptitudes, and it is possible that this diversity could have been a 
challenge for the training model, and may have impaired the effect of the training 
intervention. It would be useful for further research to investigate the impact diversity of 
age and clinical experience on learning and teaching future studies in similar settings, 
as this appears to be a feature of rural doctor populations.   
 
The logbook data showed that 54% of participants were involved in real resuscitations 
over the 12 week follow up period and that they considered the training intervention 
helpful in a large majority (91%) of these events (Table 6-6). A subgroup analysis of 
those participants who reported real life resuscitation exposure is limited by the low 
numbers of resuscitation events per participant, even though a relatively high 
proportion of the group experienced real-life resuscitation. Furthermore, a meaningful 
correlation of real life exposure with the study endpoints would be flawed given that 
many of the resuscitation events occurred at different times in relation to the follow up 
assessments. In addition there was no unified experience with exposure as participants 
reported a number of different cardiac arrest scenarios ranging from myocardial 
infarction, snakebite, electrocution, trauma to intentional overdose (data not presented 
in results). Whilst a detailed analysis of the logbook data was beyond the scope of the 
current study, further research investigating the impact of real life resuscitation 
exposure on the learning and retention of resuscitation skills would be valuable in 
further developing course content. This is of particular relevance to the rural developing 
world setting, where the most common causes of cardiac arrest are likely to differ from 
the countries from which most of the clinical evidence behind the ALS courses 
originates.  
 
Study limitations 
As our study did not have a control arm there was the potential for participants to self 
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learn between the intervention and assessment. However, improvement in the 
assessment immediately post intervention, when compared with the baseline 
assessment, strongly supports the finding that the study intervention was effective in 
this setting. It is conceivable that learning independent to the training intervention, 
could have affected the 6 and 12 week follow up assessments, but this was unlikely 
given the lack of institutional resuscitation training routinely available to participants in 
the study setting. Another study that did not have a control arm, reported a study 
design that involved testing immediately after the training intervention similar to that of 
our study(156). By contrast, other studies where there was either no baseline(146, 157, 
158) or a long interval between the baseline and post training assessment(154, 155, 
159), a control arm was necessary because candidates could conceivably practice or 
learn independent to the training intervention. Nevertheless, we would recommend a 
randomized controlled trial in particular for research whose primary focus is on 
retention of resuscitation skills.  
 
The use of the same MCQ test in each assessment was a potential limitation as it is 
possible that repeated testing may have contributed in part to the increased scores that 
we attributed to increased theoretical knowledge. However, we attempted to minimise 
the learning of specific answers by not providing feedback to participants after they sat 
their MCQ tests. The alternative of using different MCQ tests for repeated assessment 
has reported limitations related to a lack of equivalency between tests (160). A study 
by Ringstead et al. attempted to validate the reliability of different tests, and found a 
small, but significant, difference (4%) between MCQ tests scores that were designed 
by an expert panel from the European Resuscitation Council, and thus suggested 
caution should be used in interpretation of learning outcomes from different tests(161). 
 
Missing data resulting from non-attendance by some participants for the follow-up 
assessments also limited our study. The most common reason for non-attendance was 
participants working as peripheral hospital doctors in situations of relative professional 
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isolation with limited back up for clinical duties, precluding them from attending training 
sessions, a problem that has been identified in previous research(15). Three 
participants were lost to follow up due to personal health factors; two participants 
became pregnant, and one participant developed chronic illness. Financial pressures 
were also a factor as many rural hospital doctors would often work a second clinical job 
that started in the late afternoon and evening, sometimes close to the time when follow 
up assessments were being conducted.  This same issue affected the trainers 
themselves who devoted the most personal time toward this training intervention out of 
all the peripheral hospital doctors involved in the study. It is also possible that follow up 
assessments themselves were initially viewed as less educationally valuable than the 
resuscitation training workshop, which could have accounted for the initial drop in 
numbers between the post training assessment and the 6 week follow up assessment. 
However, the positive feedback that participants provided and the lack of increasing 
numbers of non-attendees in the 12 week follow up (Figure 6-2) suggests that 
participants may have seen benefit in the follow up assessment despite their work 
challenges, after attending one and understanding what it entailed.  
 
Data from the instrumented mannequin was missing in 8 participants and this also 
contributed to the study limitations. Stored data was lost from the computer in 7 
participants due to a problem with backing up of laptop data, and data was lost from 
the mannequin itself in 1 participant due to a power failure at the peripheral hospital 
where testing was being conducted (lasting 30 mins). These technical errors were not 
easily avoidable given the context of “remote testing” in a rural part of a developing 
world country, and given our experience we recommend that any research using 
mobile simulation devices in a similar setting should employ a robust strategy for 
maintaining mannequin power supply and ensuring adequate computer storage of 
mannequin data.   
 
Despite these challenges the missing follow up data did not affect the comparison 
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between the pre and post intervention which lead to the main conclusions of the study, 
and it also did not preclude us from making statistically significant findings regarding 
the sustained improvement of resuscitation knowledge, and some aspects of 
resuscitation skills, up to 12 weeks following the training intervention. Nevertheless, the 
problems of non-attendance and technical difficulties illustrate the challenges of 
conducting a study in a resource limited rural setting. In the same vein, other studies 
looking at resuscitation education in similar contexts have argued the value of research 
being based in a “typical” setting despite the challenges associated with it(162). Other 
researchers reporting methodology guidelines for studies introducing complex 
interventions have also suggested that researchers need to carefully consider the trade 
off between the “importance of the intervention” and the value of the evidence that can 
be gathered given the constraints(11). In accordance with this message we considered 
that the limitations of conducting research in our study setting (such as needing to use 
a mobile simulation suite rather than testing participants in a simulation centre that was 
absent in the region) may have been outweighed by the gaining a real life practical 
analysis of the intervention in question.  
 
The scenario we used was validated for initial approach and cardiopulmonary 
resuscitation(145, 146). However, it was not sensitive enough to capture the 
assessment of all the components of ALS such a specialised resuscitation treatment 
algorithms (such as ventricular fibrillation), some other areas of decision making, and 
team leadership. Some other studies coming from teaching hospital settings have used 
more complex metrics, involving more then one scenario where participants also 
worked in teams, but these metrics relied upon experienced ALS instructors to be 
assessors (156, 159, 161, 163). Such an approach would not have been possible in 
the rural setting that our study was conducted, as access to experienced ALS 
instructors was not possible for the duration of the study follow up. We chose to use a 
single video recorded scenario on an instrumented mannequin rather than multiple 
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scenarios that were assessed real time because this approach had been 
validated(145), and was more practically suited to our study setting.  
 
Future research directions 
 
There have been no studies that compare and contrast the delivery of a standard ALS 
course though the TTT model of training, with other methods of resuscitation training. 
Self-learning using multimedia and other educational technology are becoming 
increasingly employed as strategies in resuscitation training, with the advantage of 
learner flexibility, and the (unproven) suggestion of cost effectiveness(146, 156, 158, 
164). However, there have been mixed results from this approach in the context of ALS 
training and it has been suggested that face to face learning is unlikely to be replaced 
by education technology (158, 164). One study of ALS training yielded positive 
resuscitation outcomes from a multimedia learning strategy compared with reading 
alone(156), and another RCT evaluating e-learning failed to show improvement in 
objective outcomes despite positive evaluations by students of the course. These 
studies were all conducted in urban teaching hospital settings, in contrast to our 
resource limited study setting, where training hardware (including computers and 
resuscitation mannequins) were lacking. The effectiveness of these newer educational 
interventions needs to be assessed against current benchmarks for training in various 
clinical and resourced settings.  
 
Train the trainer resuscitation education: complex intervention  
 
The implementation of a train-the-trainer system of education in a rural resource limited 
setting represents a complex intervention because the infrastructure necessary to 
conduct a standard resuscitation education course does not exist in the same way that 
is present in an urban teaching hospital environment. We recommend that our results 
should also be interpreted in the context of the complex intervention that occurred 
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which were probably essential for the results we observed. The in-depth teacher 
training component described in the methods and appendices, and collaboration with a 
local training authority (the Provincial Department of Health), which allowed the 
appropriate leave and provision of residential training for the trainers, as well as 
provision of a course manual, and wallet card and poster visual aids were either 
directly or indirectly part of our study intervention and therefore likely to be linked to the 
results we observed. However, the relative importance of these non-core training 
activities in achieving these results remains a topic for further process-based research 
to differentiate. For instance, the same course taught without the same level of 
emphasis on teacher training, or same support and collaboration offered by the local 
training authority may not have achieved the same results. Thus whilst we can be 
confident of our findings in the setting in which they were studied, we suggest that 
policy makers and researchers pay attention to the detail contained within the 
methodology of the “teacher training” and “assessment” components. We also suggest 
that the systems and processes employed in the use of this model of train-the-trainer 
resuscitation education be taken into account when planning and developing future 
related research and educational policy.   
 
Conclusions 
We found that the train-the-trainer model of resuscitation education reported in this 
study, which used non-specialist trainers, was effective in improving resuscitation 
knowledge and skills amongst peripheral hospital doctors in Sri Lanka. Furthermore 
many variables of assessment showed improvement that was sustained for up to 12 
weeks post training intervention. Further research investigating the components of a 
training course that lead to improved knowledge and skills retention would be of benefit 
in developing effective resuscitation education programs for rural developing world 
emergency care systems.  
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Supporting Information  
 
Appendix C1 - Resuscitation training intervention – overview of workshops 
Appendix C2 - Instructor workshop (‘training the trainers’) – course outline 
Appendix C3 - Resuscitation Training “Instructor Manual” 
Appendix C4 - Peripheral hospital resuscitation workshop – course content and outline 
Appendix C5 - Supporting material for trainers & checklists of performance 
Appendix C6 - MCQ test used at assessments  
Appendix C7 - Script for resuscitation scenario & picture of assessment room 
Appendix C8 - Marking schedule for video assessment 
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Chapter 7: Conclusions 
 
The first section of this concluding chapter outlines the main contributions of the 
research presented in this thesis in two areas aimed at improving OP poisoning 
management: acetylcholinesterase measurement and resuscitation training.  
 
The second section discusses some limitations of this research in improving the 
medical management of OP poisoning. It also provides reflection upon the conceptual 
frameworks used to structure the thesis, and insights from carrying out health services 
research and training having used a ‘participatory action research’ methodological 
approach.   
 
The third section outlines future directions that research to improve the acute 
management of OP poisoning could take based upon the findings of research 
contained within the thesis, and concluding comments.  
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Summary of contributions 
 
This thesis contributed to the literature on OP poisoning management by addressing 
two deficiencies in acute clinical care that contribute to mortality and morbidity. The 
studies were conducted in a resource limited rural setting in Sri Lanka.  However, the 
findings also have some relevance to high income settings where acute OP poisoning 
also has high mortality(23).   
 
AChE POC testing in resource limited secondary referral hospitals 
 
One stream of research addressed the provision of a point-of- care 
acetylcholinesterase (AChE) activity test. This biomarker is widely recommended in the 
management of OP poisoning (3, 165, 166). It has been suggested that AChE may 
have a role in guiding patient discharge decisions and oxime antidote therapy, both of 
which would aid overall management(3, 63, 72). It was hypothesized that an AChE 
point-of-care (POC) test originally designed for occupational settings may also be of 
benefit in acute OP poisoning in rural Sri Lanka. To investigate this hypothesis a series 
of studies were carried out starting with the validation of a POC test (the Test-mate 
ChE field kit) against a reference laboratory (Chapter 4).  
 
A concurrent study was set up to observe changes that occurred in the knowledge, 
attitudes and practice of treating clinicians through the provision of the AChE test at the 
point-of-care, when managing OP poisoned patients. This study found that a high 
proportion of doctors valued the test in general, but also surprisingly found that doctors 
who were more experienced in seeing AChE results valued the test less (Chapter 5). 
Low proportions valued the test in guidance of acute poisoning management (e.g. to 
direct oxime therapy and early discharge).  
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These findings prompted a systematic review to examine in more detail the specific 
parameters provided in texts to guide the use of AChE in acute poisoning, and to what 
extent a consensus on the use of AChE had been achieved in the literature (Chapter 
2). This review highlighted a lack of primary evidence supporting guidelines for the use 
of AChE in relation to oxime use and discharge decisions. This finding suggested that 
the lack of decision support in the interpretation of test results may have been 
accountable, at least in part, for the observed changes in knowledge, attitudes and 
practices from exposure to the test results.  
 
The systematic review also showed that whilst AChE was recommended in most OP 
management texts, evidence was lacking on the use of AChE in oxime therapy and to 
facilitate early discharge. These are both complex areas of management. In contrast, 
there was abundant evidence for the use of the test in diagnosis and severity, despite 
the clinical diagnosis being generally straightforward. The lack of evidence for specific 
cut-off points for AChE, limited the capacity of even the more detailed texts to provide 
decision support for clinicians. There was a widespread failure of translation of existing 
evidence on pitfalls in measurement and interpretation of AChE into texts guiding the 
management of OP poisoning.  
 
The conclusion from this stream of research was there is a need for more primary 
evidence to support specific guidance in the use of AChE in relation to oxime use and 
discharge decisions, and whether this approach improves clinical outcomes. Also 
training in test interpretation and pitfalls of measurement should be delivered 
concurrently with the provision of AChE POC devices.   
 
Resuscitation training in rural peripheral hospitals  
 
The other stream of research addressed the deficit in resuscitation training for primary 
care doctors in the peripheral hospitals where OP poisoned patients usually make first 
177 
 
contact with the health system. Here early effective resuscitation using skills such as 
“airway management”(32) could avoid preventable complications like pulmonary 
aspiration(44). Despite the recognition of the importance for resuscitation in OP 
poisoning management (Chapter 1) a lack of specialist trainers and the professional 
isolation of the peripheral hospital doctors were barriers to the delivery of training.  
 
To overcome this isolation, a train-the-trainer (TTT) model of resuscitation education 
was evaluated in the rural Sri Lankan setting (Chapter 6). Despite advocacy for this 
approach(136), its effectiveness through objective learning outcomes had not 
previously been reported for advanced life support in adults. The conclusion of this 
study was that the described TTT model of resuscitation education was effective in 
improving resuscitation knowledge and skills in rural peripheral hospital doctors, and 
improvements in most components was sustained for 12 weeks (Chapter 6).  
 
This paper made a number of contributions to the resuscitation literature, and in 
particular the literature coming from lower-to-middle income countries where 
educational studies reporting objective endpoints are limited(137). It was the first study 
reporting the effectiveness of using non-specialist doctors to conduct peer-led ALS 
training in a low resource peripheral hospital setting, using objective knowledge and 
skills endpoints according to standardized metrics. The study also focused on the 
analysis of the TTT model of training rather than the specific course.  
 
Previous reports of deficiencies in rural doctor professional education were confirmed. 
No participants had previous resuscitation education to an ALS standard prior to the 
study intervention, and only 6% of participants reported having attended any form or 
resuscitation education (e.g. lecture) within the past year. This was despite over half of 
participants being involved in real resuscitations (many from OP poisoning) over a 12-
week period. The majority (91%) reported their education through TTT resuscitation 
training intervention was helpful in managing these clinical events. These findings 
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highlight a gap between the availability of international resuscitation guidelines and its 
practice in a rural doctor population. The results of the current study suggest that a 
TTT model of resuscitation education could be a strategy that could help close this 
evidence-practice gap.  
 
Given the effectiveness of the TTT model in rural resuscitation education the next step 
in using ALS training as a means to improving OP poisoning management was to find 
out what literature based course modifications, if any, should be applied to standard 
ALS guidelines. This was the goal of the systematic review (Chapter 3); the specific 
aims were to determine the sequence ALS steps, including where specific antidotes fit 
in that sequence, and describe this in an instructive format that a junior and isolated 
peripheral hospital doctor could follow. The review found no text that was solely 
focused on the acute initial management and resuscitation in OP poisoning, and very 
few texts were written in an instructive ALS format, which made assessment of 
recommended sequence of ALS steps difficult. From the components and sequence of 
ALS an ‘OP specific’ ALS guideline incorporating the key review findings was 
proposed. This instructive guideline highlighted the priority of rapid atropine 
administration and specified that its delivery should be at the same time as immediate 
airway, breathing and circulation management. By contrast, the uncertain role of 
oximes in general meant these had even less of a role in early ALS, and they should 
not be in the ALS guideline. The guideline identified gaps in literature 
recommendations for specific treatment of a patient in an OP induced primary cardiac 
arrest. The was a lack of consensus on issues such as maximum initial bolus dose of 
atropine that would be beneficial, and the duration of CPR that should be delivered 
before ending a resuscitation in OP poisoning. Systematic collection of data on cardiac 
arrest in the rural developing world setting would be useful to collect data on the 
treatment and subsequent outcomes to address these questions. Such an approach 
needs further research and validation, which could be carried out through incorporation 
in ALS training programs. 
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The future of resuscitation education in addressing OP poisoning management 
involves further modification and validation of OP specific ALS guidelines.  Thereafter 
future ALS training studies should be performed with this modified content 
incorporated.  
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Conceptual frameworks & research strategy  
 
OP poisoning is a complex problem that is multifactorial in origin and conceptual 
frameworks such as the Haddon matrix have been used to argue that a comprehensive 
public health approach may be of benefit to identify strategies to decrease the high 
mortality and morbidity in OP poisoning(4).  Within this framework I chose to look at 
improvement of treatment through health services research and training, but it is 
important to consider my research in the context of the range of other strategies. For 
example, preventative strategies banning the most lethal poisons have been shown to 
be highly effective strategies in reducing mortality(48, 167). Improved medical 
management has also been shown to improve outcomes. Within this domain of 
‘improved management’ I focused on early primary and secondary hospital 
management, but other strategies could be employed to try and reduce mortality and 
morbidity, such as development of pre-hospital care, or first aid delivery by community 
members, for example.  
 
My research on health professional training was limited to a focus on early initial 
management and the treatment of primary cardiac arrest. Longitudinal data suggests 
that only one third of deaths are from primary cardiac arrest, and approximately two 
thirds of deaths occur between 6 and 100 hours from admission(32, 47, 50, 168). This 
suggests that medical training might also usefully focus on strategies to improve 
ongoing monitoring and supportive care, perhaps paying particular attention to 
assessment of the respiratory system as highlighted in ALS guidelines presented in 
Chapter 3. 
Health services research and training as knowledge translation 
The health services research and training presented in this thesis also could be 
conscribed within the framework of translational research or “knowledge translation” 
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(KT) because these studies were aimed at closing the evidence-practice gap (Figure 
1).  
 
The studies within both streams of research encompass more than one of the 3 
domains for KT, described in the heading of the diagram: knowledge synthesis, 
exchange, and application(6). The systematic reviews carried out in Chapters 2 and 3 
are forms of knowledge synthesis; the assessment of stakeholders knowledge, 
attitudes and practice in Chapter 5 are forms of knowledge exchange; and the train-
the-trainer study are forms of implementation.    
 
Considering the research within this framework further raises the key question “when is 
evidence ready for translation into practice?”. The two health systems addressed 
(provision of a POC AChE test, and resuscitation education) illustrated the challenge of 
knowledge translation when knowledge may not be optimised for translation. With the 
TTT study the focus was on effective implementation of relatively established evidence, 
with the availability of published international guidelines for resuscitation(169). In 
hindsight, the AChE translational studies were possibly conducted prematurely when 
there was no clear consensus about guidelines and major gaps in the clinical science.  
 
There are no black or white answers to the question of when evidence is ready to be 
translated and many consensus teams struggle with this conundrum (170). 
 
Some have promoted the use of quantitative assessment to address this problem. 
They suggest that once research evidence has been established there should be prior 
integration with the values and perspectives of all the relevant stakeholders(170). To 
some extent this approach was used through the use of a systematic review, and 
engagement with stakeholders through the assessment of knowledge, attitudes and 
practices of the rural hospital doctors. However, the implementation of an accurate and 
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reliable AChE POC was still unsuccessful, perhaps because there was not a robust 
research base providing evidence for its utility in improving outcomes.    
 
‘Participatory action research’ framework for methods 
 
The methods used in the research presented in this thesis had many features of 
participatory action research (PAR). The focus the research was on addressing locally 
recognized problems geared towards action and implementation. Both streams of 
research also involved collaboration with local authorities and an understanding of the 
local context and stakeholder needs, which in this case was represented by research 
evaluating the knowledge, attitude and practices of clinicians in terms of the AChE 
study, and also assessment of effectiveness in terms of the resuscitation study.  
 
The AChE studies were carried out in collaboration with local partners through the 
research collaboration I was working with (SACTRC). This led to support from the local 
clinical leaders within the hospital, and access to patients and doctors upon who I 
carried out survey based research. Later on when carrying out the TTT study, 
collaboration proved to be essential for the running of workshops that formed the 
backbone of the study methodology. The major issues of 65 doctors getting leave 3 
times over a 3 month period to attend training were minimized as there was strong 
support from the health department.   
 
The interventions studied interacted with multiple levels of the health system and were 
thereby inherently “complex interventions”. Medical research council (MRC) guidelines 
suggest that complex intervention research works best if tailored to local contexts(11). 
Both the AChE and resuscitation interventions studied in this thesis had to be 
extensively revised to fit in with local hospital requirements, requests and restrictions. 
The MRC guidelines also emphasize the need to carefully trade off between the 
importance of intervention, and the limitations imposed by evaluation taking place  
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Figure 7-1  Photos showing participation between the research team and the 
hospital staff whilst conducting health services research on the use of POC 
AChE tests in a rural secondary referral hospital.  
A research team, principal investigator and research assistants (top, left), who were 
responsible for measurement of AChE in consenting OP poisoned patients. A research 
assistant transcribes a patient’s AChE result (top, right) obtained from the POC device 
to worksheets clinicians will have access to at the bedside. Interaction of research 
team with clinical collaborators (i.e. health service workers) who were responsible for 
delivery of care for patients recruited in the observational studies (bottom). The 
presence and contributions of research assistants in the senior medical staff’s ward 
rounds was essential to the support given to the research and clinical studies (bottom).    
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Figure 7-2  Photos showing the collaboration and participation between the 
researchers and local health service and policymakers (i.e. the North Central 
Province Provincial Department Health Service, NCP-PDHS) in train-the-trainer 
rural hospital resuscitation study.   
Peripheral hospital resuscitation workshop education delivered by a trained trainer (top, 
left). Data collection setup necessary for the research component (top, right). Award 
ceremony run by NCP-PDHS in collaboration with researchers (middle and bottom). 
Empowerment of the research participants was assisted through presentation of 
certificates, and feedback and discussion was facilitated between participants, 
researchers and officials. The main research findings were summarized and 
disseminated to participants and local policymakers to allow incorporation into future 
programs.   
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alongside implementation(11, 18). In the TTT project the local health authorities viewed 
the education being implemented as part of their annual training program, whilst my 
focus was on evaluation and demonstrating clinically relevant improvements. This 
collaborative approach encouraged human resource and financial support that was 
helpful, but at the same time required extra non-research activities such as certificate 
presentations for the doctors who attended the course/study evaluation and 
demonstrating clinically relevant improvements. This was also critical to assess 
feasibility in both the AChE and resuscitation training streams of research. 
 
Figure 7-1 and Figure 7-2 show scenes from the research fieldwork depicting the 
participation between the research team and health service community in the 
respective secondary referral hospital and rural peripheral hospital settings. PAR is 
becoming increasingly recognized as a useful paradigm in health service research in 
indigenous populations in Australia(171, 172) and North America(173, 174), and the 
current research contributes to the literature reporting this approach being used to 
address problems in the health systems of the Indian sub-continent(10).    
 
Benefits for local participants and systems  
During the course of conducting research for the AChE study, cholinesterase testing 
was provided for 13 months to clinicians looking after OP poisoned patients in two 
secondary referral centres. Also, 65 doctors were trained in resuscitation, 8 of whom 
were ALS trainers. A key feature of participatory action research used in health 
services research and training is the empowerment of the research communities 
resulting in direct benefit(9). Research findings should also be disseminated and fed 
back to the researched community(16). For example, the participants of the TTT study 
received group feedback at an awards ceremony organized by the provincial director of 
health for the region at the end of the 3 month training intervention and follow up 
period. Here preliminary results were shared with the group so that participants were 
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aware of some aspects of the data that was collected from them. This, in turn, 
contributes to trust, empowerment and engagement for the behavior being 
promoted(9). Other features of PAR or CBPR are the dissemination of research into 
policy and practice, which is dependent on high levels of community and stakeholder 
engagement. Interestingly the study protocol for the TTT study was also used for a 
national resuscitation curriculum module in an ongoing World Bank project called the 
“health sector development project”(175).  
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Future Directions  
 
There are many possible directions for future research to build on this work and 
experience. Those with the potential to fill a translational gap, engage key participants, 
and potentially improve patient outcomes are the following;-    
 
AChE in guiding management  
 
• Development of decision support rules that provide specific values of AChE that 
can guide clinicians in oxime therapy (e.g. when to start, modify dose and stop 
therapy), and in patient discharge (e.g. identification of cases of non-significant 
poisoning). 
 
• Translation of existing evidence on pitfalls in collection and measurement of 
AChE into recommendations in the literature; particularly the possibility of ex-
vivo reactivation of samples that are not immediately cooled and diluted after 
collection.  
 
• Research demonstrating improvement of clinical endpoints (e.g. decreased 
mortality, frequency of complications, and length of stay) or economic benefits 
(e.g. a positive cost benefit analysis in the use of the test). 
 
• Reliability of the Test-mate ChE and other point-of-care devices in use for acute 
carbamate poisoning  (as this is a differential diagnosis in the management of 
OP poisoning, and the test may behave differently). 
 
• Assessment of knowledge, practices and attitudes of treating clinicians 
introduced to AChE POC test results with concurrent training on pitfalls in 
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collection and measurement, and instruction on how to interpret the test in 
aiding clinical decisions. 
 
Resuscitation training in OP poisoning  
 
Further development of a TTT model, by targeting ALS components that improved 
least in study (Chapter 6);-  
• Targeting elements where least improvement was seen immediately such as 
“calling for help”, “checking responsiveness (shaking)”, and “checking airway for 
obstruction”  
• Targeting elements where there was adequate improvement immediately post 
intervention but not at 6 or 12 week follow-up  
• Investigation of strategies to increase sustainability of the TTT model of 
resuscitation education  
• More detailed investigation of the impact of real life resuscitation exposure on 
the learning and retention of resuscitation skills   
Training*course*strategy*!
 
Comparison of ALS training workshops presented in this work with other approaches or 
training modalities, with the aim to increase objective knowledge and skill endpoints;-  
- Self directed learning using multi-media 
- Exploration of effectiveness of “assessment only” educational interventions (e.g. 
MCQ and simulation assessment, with feedback). Hypothesis based upon the 
observation of delayed increases in MCQ scores and certain components of 
ALS (initial airway opening, initial breathing check, and mean compression 
rate), which appeared to be related to a “testing effect”.   
 
Training*course*content**
 
Comparison of standard course content with alternative approaches: 
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• Evaluation of BLS course content instead of ALS course content. It is possible 
that a lower level of resuscitation education may better suit resource limited 
settings, as many hospitals did not have basic resuscitation equipment 
precluding components of ALS (such as defibrillation) 
 
The introduction of an ALS guideline specific for resuscitation of acute OP poisoning, 
such as the one proposed in Chapter 3. The translation of these guidelines into 
practice would be aided by further research in the following areas: 
• Evaluation of the efficacy of an OP specific ALS guideline through analysis of 
clinical endpoints  
• Evaluation of the effectiveness of implementation within the health system  
 
Closing*evidence*gaps*in*resuscitation*and*critical*care**
 
As highlighted in chapter 3 there is a need for more primary evidence in the following 
areas; 
• Efficacy of treatments in cardiac arrest in OP poisoning. Evidence for the 
recommended initial bolus of atropine, and ceilings of therapy. Questions such 
as how long should one carry out CPR for in an OP arrest would be helpful for 
treating clinicians as well as for those who write guidelines.  
• Useful data could be collect by setting up of cardiac arrest registries, particularly 
in rural Sri Lankan settings where cardiac arrest is frequent occurrence.  
• Studies evaluating effectiveness increased monitoring of respiratory status in 
OP poisoned patients to prevent respiratory arrest and delayed intubation 
 
 
The goal of improving the medical management of OP poisoning was followed within 
two different streams of intervention.  However, these were related through a common 
emphasis on knowledge translation. Also both used a community based participatory 
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approach leading to practical interventions that held the promise of improved patient 
care. The findings suggest that progress has been made, but many other areas for 
future work have been equally highlighted.  
 
Taking a step back, casting the net wider, and analyzing the OP poisoning problem 
through a conceptual framework such as the Haddon matrix, it is apparent that other 
avenues may also be worthy of intervention and action. Perhaps a much better and 
more costeffective solution lies just around the corner. I have experienced that being 
part of a collaborative research network allows for a change in direction, should it be 
necessary. It also allows for the sharing of findings with others pursuing different 
avenues of research with the common goal of reducing mortality and morbidity and 
improving wellbeing in affected populations.   
 
Thus a keen awareness of how little we still know, whilst sharing what we have found, 
is at the heart of the conclusion of this thesis. This proposition is in keeping with a 
reflection made by one of the founders of modern science, Sir Isaac Newton, who 
understood how little he understood when he said,  
 
“I do not know what I may appear to the world, but to myself I seem to have 
been only a boy playing on the seashore, and diverting myself in now and then 
finding a smoother pebble and prettier shell than ordinary, whilst the great 
ocean of truth lay all undiscovered before me”  
 
We may still be only reporting the shells and the pebbles when it when it comes to 
making improvements in the management of a complex problem such as OP 
poisoning. However, health service research and training, and participatory action 
research provides some useful tools, and a worthwhile vessel, to help us navigate the 
great ocean that lies ahead. 
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Appendix B2  Survey 
 
B2-1 – True/false statement used to measure knowledge of biomarkers in OP 
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poisoning management and oxime therapy   
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True / False Questions (answers) 
 
Please circle true or false (T / F) – Don’t worry, these questions are meant to be very 
difficult, and we don’t expect everyone to get them all correct!
 
- In organophosphorus (OP) poisoning;- 
o Acetylcholinesterase in nerve synapses is inhibited 
o Both Muscarinic and Nicotinic related signs and 
symptoms can occur 
o Atropine is effective at reversing the Nicotinic 
effects 
o Oximes act by reversing the inhibited 
acetylcholinesterase enzyme 
o Oximes are equally effective in all types of OP 
poisoning 
 
- Regarding acetylcholinesterase inhibition, which of the 
following are true? 
o Acetylcholinesterase that is irreversibly inhibited by 
OP is know as “aged” acetylcholinesterase 
o Irreversible inhibition of the Muscarinic receptor 
can occur 
o Acetylcholinesterase undergoes ageing with 
carbamate poisoning  
o With higher OP concentrations in the blood, 
oximes will be less effective 
o OP inhibited acetylcholinesterase can undergo 
spontaneous reactivation  
 
- Regarding biomarkers of exposure in OP poisoning 
o Red blood cell acetylcholinesterase and plasma 
acetylcholinesterase are the same enzyme  
o Both red blood cell acetylcholinesterase and 
plasma acetylcholinesterase can be measured in 
the blood 
o Complete inhibition of red blood cell 
acetylcholinesterase is incompatible with life 
o Patients with inhibition of plasma 
acetylcholinesterase are always symptomatic  
o Plasma acetylcholinesterase is more closely 
correlated with clinical signs of OP poisoning than 
red blood cell acetylcholinesterase 
 
- On the second day post ingestion of OP poison the AChE 
level is low and shows no change when measured before 
and after a bolus of pralidoxime. This could be due to;-  
o A high proportion of “aged” acetylcholinesterase 
o Not enough atropine being given 
o Not enough pralidoxime being given 
o The patient has ingested a low dose of OP 
o The patient took carbamates rather than OPs 
 
- Regarding pralidoxime’s effect on inhibited AChE in OP 
poisoning 
o Oxime therapy is more effective when given earlier 
than later in OP poisoning 
o Poisoning with chlorpyrifos is more likely to 
respond than dimethoate poisoning 
o The maximum inhibition of AChE is likely to occur 
after several days in a patient with fenthion 
poisoning 
o 4 days following the ingestion of chlorpyrifos 
pralidoxime will be ineffective  
o AChE inhibition in profenophos poisoning responds 
well to oximes 
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Survey on treatment of Organophosphorus insecticide (OP) 
Poisoning 
 
Please answer the following questions by selecting (underline or circle) the appropriate response   
 
General 
 
1) Do you believe oximes are effective in the treatment of OP poisoning? 
 
Yes – in all patients / Yes – in some patients / No – not in any patients / Not sure  
Comments  …………………………………………………………………………….. 
…………………………………………………………………………………………. 
2a) In treating an adult male severely symptomatic patient (65kg) having pinpoint pupils, chest 
secretions, bradycardia and hypotension - What dose of intravenous pralidoxime, if any, would 
you prescribe? (Select from the following) ;- 
 
 None  /  1g 6 hourly  /  2g bolus + 500mg/hr continuous infusion  /  Other dose___________ 
 
2b) For what duration would you give the above dose? ;- 
None  /  for 24 hours / for 48 hours / For other time period (comment) ___________ 
 
3a) In treating an adult male mildly symptomatic patient (65kg) who is getting atropine but has 
no respiratory or cardiovascular compromise - What dose of intravenous pralidoxime, if any, 
would you prescribe? (Select from the following) ;- 
 
 None  /  1g 6 hourly  /  2g bolus + 500mg/hr continuous infusion  /  Other dose___________ 
 
3b) For what duration would you give the above dose? ;- 
None  /  for 24 hours / for 48 hours / For other time period (comment) ___________ 
 
4a) In treating an adult male asymptomatic patient (e.g. 60kg) who is not getting atropine -What 
dose of intravenous pralidoxime, if any, would you prescribe? (Select from the following) ;- 
  
None  /  1g 6 hourly  /  2g bolus + 500mg/hr continuous infusion  /  Other dose___________ 
 
4b) For what duration would you give the above dose? ;- 
None  /  for 24 hours / for 48 hours / For other time period (comment) ___________ 
 
5) Do think an acetylcholinesterase level (AChE) will be useful in helping guide treatment with 
oximes? Yes / No / Not sure 
Comments  …………………………………………………………………………….. 
…………………………………………………………………………………………. 
…………………………………………………………………………………………. 
6) If this test was available and affordable. Would it be useful in your practice of treating OP 
poisoning? Yes / No 
How would it help you?  …………………………………………………………………………….. 
……………………………………………………………………………………………………….. 
7) Roughly how many OP patients have you treated during your working career? (please choose) 
<5 5-20 21-50 51-100 >100 
8) Approximately how may AChE lab results have you seen ? (please choose) 
0 1-5 5-20 21-50 51-100 
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Scenario 1 – day 1 
 
A 21 year old male has taken an unknown amount of an unknown OP poison 3 hours ago. He is symptomatic with pinpoint pupils, chest secretions, bradycardia and 
tachypnoea. These toxic effects appear to be responding to atropine therapy:- 
 
a) Would you prescribe pralidoxime to this patient?   Yes / No  
Why/ Why not?......................................................................................................................................................................................................................... 
 
b) “The benefits of giving pralidoxime to this patient outweigh the risks” (circle):- 
disagree uncertain agree 
 
c) If the test were available, would you order an acetylcholinesterase (AChE) level in this patient? Yes / No 
 
Why / Why not?......................................................................................................................................................................................................................... 
d) “knowing this patient’s admission AChE level would help his management” (circle) :- 
disagree uncertain agree 
 
please answer both Scenarios  
Day 2 – 24 hours after ingestion “No oximes given”  Day 2 – 24 hours after ingestion – “Oximes given” 
 
It is now 24 hours post ingestion of poison. He was not given oximes. His clinical 
condition has improved a little but he is still on an atropine infusion. His pupils are no 
longer pinpoint, his heart rate is 96, BP 120/80 and chest is clear. 
 
a) Would you start pralidoxime at this point?   Yes / No 
 
Why / Why not?....................................................................................................... 
 
b) “The benefits of giving pralidoxime to this patient now outweigh the risks” (circle):- 
disagree uncertain agree 
 
c) If the test were available, would you order an acetylcholinesterase (AChE) level at 
this point? Yes / No  
Why / Why not?....................................................................................................... 
 
d) “knowing this patient’s AChE level now would help his management” (circle) :- 
disagree uncertain agree 
         
  
 
It is now 24 hours post ingestion. He was given oximes. His clinical condition has 
improved a little but he is still on an atropine infusion. His pupils are no longer 
pinpoint, his heart rate is 96, BP 120/80 and chest is clear. 
 
a) Would you continue pralidoxime a further 24hours ? Yes / No 
 
Why / Why not?....................................................................................................... 
 
b) “The benefits of giving pralidoxime to this patient now outweigh the risks” 
(circle):- 
disagree uncertain agree 
 
c) If the test were available, would you order an acetylcholinesterase (AChE) level 
at this point? Yes / No  
Why / Why not?....................................................................................................... 
 
d) “knowing this patient’s AChE level now would help his management” (circle) :- 
disagree uncertain agree 
 
279 
 
 
Scenario 1 - day 3 (48 hours after poison ingestion) 
 
This patient has now been on the medical ward for 48 hours. He has not received 
any pralidoxime. This morning he was weaned from his atropine infusion. He has no 
muscarinic features or cardiovascular impairment. However, he has grade 3/5 neck 
muscle weakness, mild facial weakness and diminished tendon reflexes. 
  
a) Would you start pralidoxime at this point (48hrs) in this patient?   Yes / No 
 
Why / Why not?....................................................................................................... 
 
b) “The benefits giving pralidoxime to this patient now outweigh the risks” (circle):- 
disagree uncertain agree 
 
c) If the test were available, would you order an acetylcholinesterase (AChE) level at 
this point? Yes / No  
 
Why / Why not?....................................................................................................... 
 
d) “knowing this patient’s AChE level now would help his management” (circle) :- 
disagree uncertain agree 
         
 
This patient has now been on the medical ward for 48 hours. He has been 
receiving pralidoxime. This morning he was weaned from his atropine infusion. He 
has no muscarinic features or cardiovascular impairment. However, he has grade 
3/5 neck muscle weakness, mild facial weakness and diminished tendon reflexes. 
 
a) Would you continue to prescribe pralidoxime to this patient for a further 24 
hours?  
Yes / No 
 
Why / Why not?....................................................................................................... 
 
b) “The benefits giving pralidoxime to this patient now outweigh the risks” (circle):- 
disagree uncertain agree 
 
c) If the test were available, would you order an acetylcholinesterase (AChE) level 
at this point in this patient? Yes / No  
 
Why / Why not?....................................................................................................... 
 
d) “knowing this patient’s AChE level now would help his management” (circle) :- 
disagree uncertain agree 
 
Scenario 1 (day 3 - 6 hours later than above) 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the above scenario oximes were given initially and stopped after 48 hours. 6 
hours after stopping oximes all the measured clinical parameters remained the 
same but the patient said he felt worse and slightly weak:-  
 
a) Would you re-start pralidoxime at this point? Yes / No 
Why / Why not?....................................................................................................... 
 
b) “The benefits giving pralidoxime to this patient now outweigh the risks” (circle):- 
disagree uncertain agree 
c) If the test were available, would you order an acetylcholinesterase (AChE) level 
at this point in this patient? Yes / No  
Why / Why not?....................................................................................................... 
d) “knowing this patient’s AChE level now would help his management” (circle) :- 
disagree uncertain agree 
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Scenario 2  
 
An 18 year old female claims to have ingested one to two mouthfuls of an unknown OP poison two hours ago. On examination she is slightly tachycardic (heart rate of 90 
beats per minute) but otherwise asymptomatic. 
 
a) Would you prescribe pralidoxime to this patient?   Yes / No  
Why/ Why not?......................................................................................................................................................................................................................... 
 
b) “The benefits of treatment with pralidoxime outweigh the risks in this patient” (circle):- 
disagree uncertain agree 
 
c) If the test were available, would you order an acetylcholinesterase (AChE) level in this patient? Yes / No 
Why/ Why not?......................................................................................................................................................................................................................... 
 
d) “knowing this patient’s admission AChE level would help her management” (circle) :- 
disagree uncertain agree 
 
please answer both Scenarios 
 
Scenario 2A – “No oximes” (day 2 – 24 hours after ingestion) 
 
Scenario 2A – “oximes given” (day 2 – 24 hours after ingestion) 
 
It is now 24 hours post ingestion of poison. This patient has not received any 
pralidoxime. Her pulse became normal soon after admission and she has remained 
asymptomatic thereafter.  
 
a) Would you start pralidoxime at this point?   Yes / No 
 
Why / Why not?....................................................................................................... 
b) “The benefits of giving pralidoxime to this patient now outweigh the risks” (circle):- 
disagree uncertain agree 
c) Would you discharge this patient home at this point? Yes / No   
Why / Why not?....................................................................................................... 
 
d) If the test were available, would you order an acetylcholinesterase (AChE) level at 
this point? Yes / No  
e) “knowing this patient’s AChE level now would help her management” (circle) :- 
 
disagree uncertain agree 
 
 
It is now 24 hours post ingestion of poison. This patient has received pralidoxime 
since admission. Her pulse became normal soon after admission and she has 
remained asymptomatic thereafter.  
 
a) Would you continue pralidoxime in this patient for a further 24 hours? Yes / No 
 
Why / Why not?....................................................................................................... 
b) “The benefits of giving pralidoxime to this patient now outweigh the risks” 
(circle):- 
disagree uncertain agree 
c) Would you discharge this patient home at this point? Yes / No  
Why / Why not?....................................................................................................... 
d) If the test were available, would you order an acetylcholinesterase (AChE) level 
at this point? Yes / No 
  
e) “knowing this patient’s AChE level now would help her management” (circle) :- 
 
disagree uncertain agree 
 
Scenario 2 (Day 3 - 48 hours after ingestion) 
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It is now 48 hours following the ingestion of poison. The patient has not 
received pralidoxime. She has remained asymptomatic. 
 
 
a) Would you discharge this patient home at this point? Yes / No    
 
Why / Why not?....................................................................................................... 
 
b) If the test were available, would you order an acetylcholinesterase (AChE) level at 
this point in this patient? Yes / No  
 
Why / Why not?....................................................................................................... 
 
c) “knowing this patient’s AChE level now would help her management” (circle) :- 
 
disagree uncertain agree 
 
 
 
It is now 48 hours following the ingestion of poison. The patient received 
pralidoxime for 24 hours after admission and then it was stopped. In the 
second 24 hours she did not receive any medical treatment, and has 
remained asymptomatic. 
 
a) Would you discharge this patient home at this point? Yes / No    
 
Why / Why not?....................................................................................................... 
 
b) If the test were available, would you order an acetylcholinesterase (AChE) level 
at this point in this patient? Yes / No  
 
Why / Why not?....................................................................................................... 
 
c) “knowing this patient’s AChE level now would help her management” (circle) :- 
 
disagree uncertain agree 
 
 
General comments about these scenarios / any complaints or things your didn’t understand;- 
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Appendix C  Supplementary material for train-the-trainer study 
 
Appendix C1  Resuscitation training intervention – overview of workshops 
 
Appendix C2  Instructor workshop (‘training the trainers’) – course outline 
Appendix C3  Resuscitation Training “Instructor Manual” 
Appendix C4  Peripheral hospital resuscitation workshop – course content and 
outline 
Appendix C5  Supporting material for trainers & checklists of performance 
Appendix C6  MCQ test used at assessments  
Appendix C7  Script for resuscitation scenario & picture of assessment room 
Appendix C8  Marking schedule for video assessment 
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Appendix C1  Resuscitation training intervention – overview of workshops 
 
 
 
Overview of assessments 
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Phase Ia - Initial Resuscitation Workshop – Provider 
course & selection of trainers, Nov 28th – 29th 2008 
 
Pre course Inauguration for Consultants and Day 1 participants  
    
Friday 28th November - Innauguration and Dinner (Nuwaraweva Resthouse) 
    
19:00  Registration    
19:30 
10 
mins 
Welcome of distinguished guests 
and participants 
Dr Athupattu, Provincial 
Director of Health Services – 
North Central Province (NCP) 
19:40 
20 
mins 
Partnerships with provincial 
authorities to improve health 
care service delivery in the 
peripheries of NCP  
Professor Andrew Dawson – 
South Asian Clinical Toxicology 
Research Collaboration 
(SACTRC) Program Director 
20:00 
20 
mins 
Introduction and objectives of 
the resuscitation training 
program 
 Dr Bishan Rajapakse 
“Resuscitation Training” project 
coordinator 
20:20 
15 
mins 
Keynote delivery on the 
"Importance of the development 
of the health system in the 
peripheries" 
Hon Peshara Jayarathne - 
Provincial Minister of Health - 
NCP 
20:35 
10 
mins 
Academic Agenda for the 
resuscitation workshop 
Dr Bishan Rajapakse 
“Resuscitation Training” project 
coordinator 
20:45 5 mins 
Words from the Peripheral 
hospital doctors 
Nominated Peripheral hospital 
doctor 
20:50 
10 
mins Vote of Thanks 
Dr Dhammika De Silva, 
Medical Officer Planning, Office 
of the Provincial Director of 
Health Services (PDHS) 
20:40   Dinner 
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Day 1 – resuscitation program  (first 10 participants) 
Saturday 29th November - Workshop session 1 (Auditorim RDHS) 
    
7:30 20mins 
Introduction - Overview and 
prevention of cardiac arrest 
Dr Prasanga Palihawadana . 
(Consultant Anesthetist, CA) 
7:50 40mins 
Lecture 1 - Airway management, 
ventilation and Intubation 
Dr Prasanga Palihawadana 
(CA) 
8:20   Morning Practical Session 1 (rotate between stations) 
Simultaneously 
run (25 mins each 
station -  5 mins 
change time) 
Station A1 & A2 
Basic Airway (airway opening 
techniques, adjuncts, BVM 
ventilation) 
Station B1 & B2 Advanced Airway (intubation) 
9:15 45mins 
Lecture 2 - "Advance Life 
Support Algorithm" Dr Asoka Gunaratne (CA) 
  30mins 
Lecture 3 - "Tachycardia, 
Bradycardia algorithm" 
Dr Colin Page (Emergency 
Physician, EP) 
 20mins Demonstration Scenario 
Consultant trainers and 
some participants  
10:50 15mins Morning Tea Break 
11:05 20mins 
Lecture 4 – “Post Resuscitation 
Care” 
Dr Lushantha Padmasiri 
(CA) 
11:25 2 hours Practical Session 2 - rotate through 4 skills stations 
Simultaneously 
run (25 mins each 
station -  5 mins 
change time) 
1- Asystole/PEA scenario 
Dr Prasanga Palihawadana 
(CA) 
2- VT/ VF scenario Dr Asoka Gunaratne (CA) 
3- Tachycardia/ Bradycardia 
Scenario Dr Colin Page (EP) 
4 - Post resuscitation care 
scenario 
Dr Lushantha Padmasiri 
(EP) 
13:30 1 hour Lunch Break   
14:30 45mins Post test - MCQ Classroom 
15:15 1 hour Post test practical Scenarios 
(Conducted in Two places 
simultaneously) 
    Afternoon Tea (refreshments served in between assessments) 
16:30 10mins Closing comments Entire Group 
16:40 30mins Instructor de-briefing session 
Nuwaraweva Resthouse 17:00   Instructors - Free time 
 
Pre-course introduction for Day 2 participants 
Sat 29th November - Welcome Dinner: Sunday participants (Nuwaraweva 
Resthouse) 
    
20:00 5 mins 
Introduction and aims of “Train 
the Trainer” project 
Dr Bishan Rajapakse - project 
co-ordinator 
20:05 5 mins 
Official Welcome to peripheral 
hospitals doctors  
Dr Dhammika De Silva, MO 
Planning office of the PDHS, 
NCP 
20:10 
15 
mins 
Guest Lecture - "The importance 
of resuscitation in the peripheral 
hospital setting" 
Dr Herath (Anuradhapura – 
CA) or other Consultant 
Trainer 
20:35 5 mins 
Words from the Peripheral 
hospital doctors 
Nominated Peripheral hospital 
doctor 
20:40   Dinner 
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Day 2 – (repeat course for day 2 participants, another 10, total of 20 receiving course 
over 2 days) 
 
Sunday 30th November - Workshop session 2 (Auditorim RDHS) 
    
7:30 20mins 
Introduction - Overview and 
prevention of cardiac arrest Dr Prasanga Palihawadana 
7:50 40mins 
Lecture 1 - Airway management, 
ventilation and Intubation Dr Prasanga Palihawadana 
8:20   Morning Practical Session 1 (rotate between stations) 
Simultaneously 
run (25 mins each 
station -  5 mins 
change time) 
Station A1 & A2 
Basic Airway (airway opening 
techniques, adjuncts, BVM 
ventilation) 
Station B1 & B2 Advanced Airway (intubation) 
9:15 45mins 
Lecture 2 - "Advance Life 
Support Algorithm" Dr Asoka Gunaratne 
  30mins 
Lecture 3 - "Tachycardia, 
Bradycardia algorithm" Dr Colin Page 
 20mins Demonstration Scenario 
Consultant trainers and 
some participants  
10:50 15mins Morning Tea Break 
11:05 20mins 
Lecture 4 – “Post Resuscitation 
Care” Dr Lushantha Padmasiri 
11:25 2 hours Practical Session 2 - rotate through 4 skills stations 
Simultaneously 
run (25 mins each 
station -  5 mins 
change time) 
1- Asystole/PEA scenario Dr Prasanga Palihawadana 
2- VT/ VF scenario Dr Asoka Gunaratne 
3- Tachycardia/ Bradycardia 
Scenario Dr Colin Page 
4 - Post resuscitation care 
scenario Dr Lushantha Padmasiri 
13:30 1 hour Lunch Break   
14:30 45mins Post test - MCQ Classroom 
15:15 1 hour Post test practical Scenarios 
(Conducted in Two places 
simultaneously) 
    Afternoon Tea (refreshments served in between assessments) 
16:30 10mins Closing comments Entire Group 
16:40 30mins Instructor de-briefing session 
Nuwaraweva Resthouse 17:00   Return to Colombo 
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Phase 1b - Reinforcement workshop for “trainers” 
(n=8), 21st December 2008 
 
Overview of Training for subsequent workshops: 
 
Nov 28-30   Phase Ia Initial Resuscitation workshop 
Dec 21    Phase Ib (reinforcement workshop) – current  
Jan 16-18 –  Phase Ic workshop (How to be a trainer) 
February  Phase II resuscitation training at peripheral (‘hub’) hospitals 
 
 
Agenda for Workshop  
 
7:45 – 8:15    Pre-Test 
8:15 – 9:45   Review of resuscitation material & pre-test  
9:30 – 10:00  Morning Tea 
 
10-13:00   Skills stations (x3) 
 - Airway management (approach to an unresponsive patient & Intubation) 
 - Megacode station 1 
 - Megacode station 2 
 
13:00- 14:00   Lunch  
1:45 – 15:00   Further scenarios based on Lunchtime feedback 
 
 
Phase Ic – “Instructor workshop”, n=8  
 
Jan 16th – 18th 2009  (see Appendix C2) 
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Figure C1 - showing advertisement for potential peripheral hospital trainers prior to 
phase 1. Collaboration between the Provincial Director of Health Services (PDHS), 
Postgraduate Institute of Medicine (PGIM), and the South Asian Clinical Toxicology 
Research Collaboration (SACTRC)
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Appendix C2  Instructor workshop (‘training the trainers’) – course outline 
 
“Instructor workshop” (Jan 16th – 18th 2009) 
 
Friday 16th Jan 2009 – Introduction/Orientation 
 
19:00 – Introduction of Participants to Faculty 
19:15 - Objectives of Instructor course 
 Agenda for 2 days 
20:00 -  Feedback from last 2 courses – group discussion 
20:30 -  Dinner faculty and participants 
 
 
Saturday 17th Jan 2009 (Day 1) 
 
(SG) Small Groups - 3 to 4 instructor candidates per Consultant trainer 
(EG) Entire Group – 16 instructor candidates 
 
8:00  Lecture : Becoming a Trainer - Teaching strategy – Dr Mudiyanse 
 Rasnayaka (EG - 30mins) (Consultant Paediatrician) 
Lecture: Important aspects of setting up a scenario – Dr Mabel Vasnaik 
(Consultant Anaesthetist) 
 
8:30 Demonstration of  “Skills station 1-Basic airway management and initial 
response to an unresponsive patient”. Demonstration of how to teach this skills 
station to instructor candidates  
  
 Group discussion – Questions and Answers about skills station and module 
 from the entire group  
 
8:45 Practice of “Skills station 1”. Instructor candidates practice teaching Pre-
interns participants under observation of Consultant Instructors, who provide 
guidance as necessary. 
 
9:45 Demonstration of Skills station 2 – Advanced Airway Management 
 (intubation) 
 Questions and Answers 
 
10:00 Practice of “Skills station 2” 
 
11:00  Morning Tea 
 
11:30 Demonstration of Skills station 3 – Ventricular Tachycardia and Ventricular 
 Fibrillation scenarios 
 Question and Answers 
 
11:45 Practice of Skills station 3 
 
12:45 Lunch 
13:45 Demonstration of Skills station 4 – Pulseless Electrical Activity & Asystole 
 Scenarios 
 Questions and Answers 
14:00 Practice of Skills station 4 
15:00 Afternoon Tea 
16:00 Group Discussion – Feed back of Demonstration Participants to the Instructor 
 Candidates and consultant Trainers 
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 Free Practice in Skills stations most in need for improvement 
17:00 Close 
 
Sunday 18th Jan 2009 – Day 2 
 
8:00 Demonstration of Skills station 5 – Tachycardia and Bradycardia Algorithms 
 How to use the Resuscitation Mannequin – Rhythm Generator 
 Questions and Answers 
 
8:15 Practice of “Skills station 5” 
9:15 Demonstration of Skills station 6 – Post Resuscitation care and Transport 
 Questions and Answers 
9:30 Practice of Skills station 6  
10:30 Morning Tea 
 
Practice workshop with volunteer participants (11:00 to 3:30) 
 
Consultant Instructors fill out checklist for Instructor candidates as they teach. 
Feedback and encouragement also given 
 
Each Instructor Candidate is assigned a skills station to teach (because there are 4 per 
group some will teach two skills stations) 
 
11:00 Show DVD to Participants 
i. Overview of resuscitation 
ii. Airway management 
iii. Intubation video (NEJM) 
 Answer any questions from the Demonstration Participants 
11:30 “Instructor Candidates” teach skills station 1 and 2 to Demonstration 
Participants 
 
12:30  Show DVD to Participants 
i. ALS Algorithm 
ii. Tachycardia/ Bradycardia 
iii. Post Resuscitation care & Intubation 
13:00 Lunch 
14:00 Instructor Candidates teach station 2-6 to Demonstration Participants 
 
15:30  Afternoon Tea 
15:45 De-brief and group feedback from Demonstration Participants. Individual 
 feedback from Consultant instructors 
 
16:30 Session Close – plans for Phase 2
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Appendix C3  Resuscitation Training “Instructor Manual” 
 
 
 
 
      
 
 
Resuscitation Training 
“Instructor Manual” 
 
 
 
 
A collaboration between SACTRC 
and the Provincial Director of Health 
Services NCP  
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Resuscitation Training Instructor Manual 
How to use this booklet 
 
This booklet has been designed to aid the instructor workshops with details of the 
course agenda (subject to change), as well as a resource for Trainers during and after 
their instructor workshop.  
 
The sections of the booklet are instructor course agenda, adult learning behavior, skills 
station descriptions, competence checklists and sample pre-test MCQ’s 
Goals of the instructor course 
The focus of the course is on “how to teach”. The final goal is to create a trainer who is 
able to deliver and promote the resuscitation module’s objectives :-  
 
1. Recognition of a critically ill patient – and calling for help 
2. Use of a system for assessing a critically ill patient - ABCDE 
3. Importance of Basic life saving maneuvers 
4. Update of Advanced life support algorithms for the arrested patient 
a. The Nov 2005 guidelines (ILCOR) 
5. “Communication” in Resuscitation 
a. Calling for senior support early 
b. Communication and leadership during an arrest 
c. Post arrest communication with family and other staff 
6. Post Resuscitation care  & Inter-hospital Transfer  
7. Practical “Hands on” training  
a. Simulation in real life scenarios using CPR mannequins 
b. Assessment with constructive feedback 
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Instructor Course 
 
Residential Training 
 
This will be a two day residential training starting with an inauguration session. At the 
inauguration session we will deliver the objectives of the Instructor Workshop and 
explain the focus of this workshop, which is to train the participants “how to teach” 
and how to “become trainers”. The dinner is also an opportunity for faculty to meet 
the participants, which will help facilitate discussion and feedback during the ensuing 
training sessions.  
 
The Training Module 
 
The training module that we are teaching the “trainers” how to teach is called the 
“Peripheral Hospital Training Module” which is a module covering advanced life 
support which has been accredited by the PGIM and also similar content of the 
National Training module for Sri Lanka.  
 
This module makes use of a DVD that contains lecture material, and resuscitation 
mannequins that will be used to carry out training from at total of 6 skills stations to 
cover the practical aspects of the necessary training in advanced life support.  
 
It was designed to be used by non-specialist staff who are trained to instruct others in 
resuscitation, hence the use of pre-recorded lectures in the DVD format. 
 
A pilot study showed a positive shift in practice after the deliver of a similar module to 
participants of a similar resuscitation course.  
 
Structure of the “Instructor Course” 
 
This course will start with a limited number of presentations on adult learning 
behaviour, and follow on with a detailed training in how to deliver each of the 6 skills 
stations which make up the bulk of the “Peripheral Hospital Training Module”. Finally 
on the second day the trainers will deliver the entire Module to peripheral hospital 
doctors from the NCP under supervision of the Consultant Instructors. This will be the 
same module that they are expected to teach on their own at peripheral hospital 
training rooms starting in February 2009, 
 
Skills Station Training 
 
Each skill station will be individually demonstrated to the entrire goup by Faculty and 
discussed to make the specific key learning points clear to the trainers.  
 
The trainers will be divided into groups of 4 
 
For each group there will be: 
1. 2 consultant instructors, 
2. 1 mannequin with auxiliary equipment 
3. 1 Skills station instructor guide  
4. 4 Simulated course participants (Pre-intern Doctors) 
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The role of the consultant instructor will be to facilitate each of the 4 Trainers to train 
take the Pre interns through the skills station in the manner it was shown to them in the 
entire group.  
 
The consultant instructors is watching to make sure the “Trainer” is able to:- 
1. Demonstrate the learning contents of the skills station properly 
2. Engage the participants in Simulation and Scenario based learning 
3. Assign roles to participants (e.g. “Team leader”) effectively 
4. Give constructive criticism and feedback to participants 
 
The consultant instructor is also expected to make sure that each of the 4 trainers has 
an opportunity to teach the skills station (at least in part) to the pre-intern participants.  
 
We have assigned two consultant instructors per station with a view to having one 
primary instructor, who has been ideally trained as an “instructor” in a standardised 
resuscitation course (e.g. ACLS, ALS, APLS or EMST) where they will be familiar with 
this adult learning theory and practice, to give feedback on teaching strengths and 
weaknesses, and a secondary instructor to give feedback issues pertaining 
resuscitation.  
 
 
 
Putting it all together – Running a resuscitation Training session  
 
For each group there will be: 
1. 2 consultant instructors, 
2. 1 mannequin with auxillary equipment 
3. 1 Skills station instructor guide  
4. 4 peripheral hospital participants  
 
It is assumed that by the time we reach this segment of the instructor course all the 
trainers will be very familiar with each of the individual skills stations, and would have 
had practice in teaching each of the skills stations to participants.  
 
This segment is about practicing the synthesis of this knowledge on how to teach the 
individual skills stations into the delivery of the actual training module, which involves 
the following skills to be developed: 
 
1. Delivery of a DVD lecture and encouragement of questions at the end 
2. Making sure that all the participants in each skills station get equal 
opportunity to practice scenarios 
3. How to handle different levels of ability within the participant group  
4. Keeping to time and schedule 
5. Ensuring adequate Breaks 
 
At this stage of the instructor course each trainer should be equipped to deliver all 6 
skills station as will be required when they are conducting the training course at the 
peripheral hospital. However, because there are 4 trainers per group they will only be 
able to deliver 1 skills station each, and 2 will be able to deliver 2 skills stations. 
 
The consultant trainer will pick a trainer to run the next skills as required. They will 
have a predetermined list for the group of 4 so that the trainers can be utilised 
sequentially. The trainers will not be told in advance which station they will be teaching, 
as all should be able to each all stations.  
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For this segment of the instructor course the Consultant instructor has the important 
role of filling out an assessment checklist on each Trainer that will be later evaluated to 
determine if they have made the adequate standard to go on to be trainers in the 
Phase III of the train-the-trainer project, or whether further remediation is necessary. 
 
Bishan Rajapakse 
Resuscitation Training Program Coordinator 
NCP Health-SACTRC 
Ph 0773504475 
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Instructor Course Agenda 
 
Instructor Workshop – Schedule and Roles 
 
It is important for all to understand their different roles for this workshop to be effective. 
Because we are creating “trainers” I have reserved the term “instructor” for “Faculty” (ie 
consultants who are doing the teaching at this workshop) 
 
I have divided the instructors into two kinds of Instructors for the purpose of running the 
skills stations and assigned different roles to each. I have also done this because of the 
varying backgrounds of our faculty. 
 
At this workshop we have instructors who either have completed at least a 2 day 
“instructor training course” or  those who haven’t completed a training course but have 
significant experience in the field of resuscitation (secondary instructors). either with 
the American heart association (AHA) advanced cardiac life support (ACLS) course, or 
UK or Australian resuscitation council’s advanced life support (ALS). And one instructor 
with extensive experience in advanced paediatric life support, himself having attended 
the instructor course (APLS), and who will be delivering the lecture program. 
 
I have divided the instructors into Primary instructors who’s role will be on the 
“teaching” aspects, and secondary instructors who role will be to make sure the content 
of the “resuscitation” education is fulfilled when we break into groups of 4 students and 
2 instructors.  
 
The aim is to have 8 instructors at the course to teach 16 participants.  
All the lectures will be given to the entire group, and all the practicals will be carried out 
with the class split into four group. Each group will have a primary and secondary 
instructor.  
 
List of current faculty  
(Those who have not yet confirmed are shown in brackets) 
 
Lecture Program – Mudiyanse Rasnayake / Mabel Vasnaik 
 
Skills station Primary Instructors :- 
IP1 – Maybel Vasnaik (ACLS instructor – Bangalore) 
IP2 – Donnie Woodyard (ACLS instructor – USA) 
IP3 – Shakunthala Murthy (ACLS instructor –Bangalore) 
IP4 – Jessica Spedding (ALS instructor – UK) 
 
Skills station Secondary Instructors:- 
IS1 – Mudiyanse Rasnayake (APLS instructor – Australia & Sri Lanka) 
IS2 – Sushila Ranasinghe (Resuscitation Training – Peradeniya Sri Lanka) 
IS3 – Chris Nickson (Resuscitation Training – Perth Australia 
IS4 – (to be confirmed) 
 
Schedule Overview 
 
Pre Workshop session – Friday 16th Jan Evening) 
Overview lecture – Dr Bishan Rajapake 
Lecture on “Why resuscitation Training is important – Dr Mabel Vasnaik 
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Day 1 – AM (Saturday 17th Jan) 
Lecture on Lecturing and DVD lecturing 
Theory on adult education 
Practice of lecturing (dvd lecturing) 
 
Lecture on Skills stations and Scenarios  
 
Day 1 – PM 
Demonstration on Skills stations and Scenarios  
Practice of Skills stations and Scenarios  
 
Day 1 – evening 
Specific description of skills stations 3-6 
 
Day 2  - (Sunday 18th Jan) whole day  
 
“Practice workshop” 
 
DVD lecture to participants 
Skills station 1-2 
 
Morning Tea 
 
DVD lecture 4-6 
Skills station 3-6 
 
Lunch 
 
Participants – post test MCQ 
Trainers – get lecture and demonstration on how to run a scenario assessment, mark 
and give feedback 
 
Post Scenario assessments 
 
Close 
 
 
Detailed Schedule (Subject to change)  
 
Pre workshop session – (see above) 
 
Day 1 - AM 
8:00  Lecture :  How to give a lecture (including delivering a DVD lecture )  
9:00 Demonstration of giving a “DVD based lecture”. Demonstration of how to  make 
use of set, environment, dialog, closure.  
 
 Faculty acting as both Trainers and Participants  
  
10:00 Morning Tea 
 
10:45 Practice of “Giving a DVD lecture”.Trainers’ practice teaching Pre-interns 
 participants under observation of Consultant Instructors, who provide  guidance as 
necessary. 
 
 
Layout (*group splits into 4) 
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Key for table: 
PN – Prospective trainer (Participant number) 
IP – Primary Instructor 
IS – Secondary Instructor 
DP – Demonstration Participant (Pre-intern) 
 
Numbers 
PN : 1-16 
IP : 1-4 
IS : 1-4 
DP : 1-8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Practical session – Practice of giving a DVD Lecture 
 
Instructor roles : 
Primary instructor – guiding the situation  
Secondary instructor – filling assessment form on giving a lecture 
 
Station Equipment : DVD player, Instructional DVD 
 
 A B C D 
Trainer 
(performer) 
PN1, 2,3,4 PN 5, 6,7,8 PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 1 IS 2 IS 3 IS 4 
Demonstration 
participant 
DP 1, 2 DP 3, 4  DP 5, 6 DP 7, 8 
 
Station “A” 
Front table (with screen) 
Station “C” 
Station “B” 
Station “D” 
RDHS MAIN AUDITORIUM - 
ANURADHAPURA 
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For this practical the primary and secondary instructors will observe the Trainers 
deliver the DVD lectures to the demonstration participants, and facilitate each of the 4 
trainers to do this in their station within the allocated time.  
 
Schedule (cont.) 
 
11:30 Lecture: How to teach resuscitation using “Skills stations and Scenarios” 
 
12:30 Lunch  
 
13:30 Demonstration: How to teach resuscitation using “Skills stations and 
 Scenarios  
 Demonstration of “Skills station 1 & 2” by Faculty – both acting as Trainers 
 and participants.  
 Group discussion afterwards 
 
14:30 Practice of “Skills station 1 & 2”. (Group splits into 4) 
 Trainers’ practice teaching Pre-interns participants under observation of 
 Consultant Instructors, who provide  guidance as necessary. 
 
Practical session – Teaching using skills stations and scenarios 
 
Instructor roles : 
Primary instructor – guiding the situation  
Secondary instructor – filling assessment form on how to teach a skills station 
 
Station Equipment : (equip for skills stations 1 & 2) Mannequin, OPA, Suction, ETU, 
Intubateable Mannequin, Airway head, Laryngoscope, ET Tube, introducer, Syringe,  
 
 A B C D 
Trainer 
(performer) 
PN 5, 6,7,8 
 
PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
PN1, 2,3,4 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 3 IS 4 IS 1 IS 2 
Demonstration 
participant 
DP 1, 2 DP 3, 4  DP 5, 6 DP 7, 8 
 
For this practical the primary and secondary instructors will observe the Trainers teach 
the content of skills station 1 & 2 (initial approach to an unresponsive patient not 
breathing, basic and advanced airway management) to the demonstration participants. 
They will also facilitate each of the 4 trainers to do this in their station within the 
allocated time.  
 
15:45 Afternoon Tea   
 
16:00 Demonstration: How to teach resuscitation using “Skills stations and 
Scenarios  
 Demonstration of “Skills station 3 & 4” by Faculty – both acting as Trainers and 
 participants.  
 
 Discussion 
 Free Practice in Skills stations most in need for improvement 
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17:00 Day 1 - Close 
 
Saturday 17th Jan 2009 – Evening 
 
19:00  Presentation -  “Revision of Training objectives – and Agenda for the next 
 days practice training session” (10 mins) 
 
 Feedback from Trainers to Consultant Instructors on Day 1 proceedings – 
 strengths and  weaknesses of sessions (20mins) 
  
 Demonstration and Informal Practice – Review of Skills stations 3 & 4 
 (30mins) 
Demonstration of how to teach using the defibrillator and how to use the rhythm 
generator 
 Opportunity to Practice  
 
20:30 Dinner for faculty and participants 
 
 
Sunday 18th Jan 2009 – Practice workshop 
 
12 Peripheral hospital Doctors who have not attended previous workshops are the 
participants to this Training module. They will be divided into groups of 4. The “trainers” 
will then teach the module according to the following schedule 
 
Consultant Instructors fill out checklist for prospective trainers as they teach. Feedback 
and encouragement also given after each skills stations 
 
Each Instructor Candidate is assigned a skills station to teach (because there are 4 per 
group some will teach two skills stations) 
  
Day 2 – Practice Resuscitation workshop 
 
Group is split in to 4 from the beginning  
There are 12 peripheral hospital doctor participants (PHP 1-12) 
 
 8:00 – 9:00   DVD lectures (deliver presentations 1-3) 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form on giving a lecture 
Secondary instructor – filling assessment form on giving a lecture 
 
Station Equipment : DVD player, Instructional DVD 
 
 A B C D 
Trainer 
(performer) 
PN 1, 2, 3, 4 PN 5, 6, 7, 8 PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 1 IS 2 IS 3 IS 4 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
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For this session the primary and secondary instructors will observe and assess the 
Trainers deliver the DVD lectures 1-3 to the demonstration participants. Only one 
trainer will be able to be observed in the group and if time permits a second person can 
be asked to run through the skills with the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates 
clockwise by one station) 
 
 9:00 - 9:30   Practical 1 (Part 1 - teach skills station 1) 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form on running a skills 
station  
Secondary instructor – filling assessment form on running a skills station  
 
Station Equipment : Skills station 1 (initial approach & Basic Airway Management) 
 A B C D 
Trainer 
(performer) 
PN 5, 6, 7, 8 PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
PN 1, 2, 3, 4 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 4 IS 1 IS 2 IS 3 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
 
For this session the primary and secondary instructors will observe and assess the 
Trainers deliver the skills station 1 to the demonstration participants. Only one trainer 
will be able to be observed in the group and if time a second person can be asked to 
run through the skills with the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates 
clockwise by one station) 
 
 9:30 - 10:00   Practical 1 (Part 2 - teach skills station 2) 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form on running a skills 
station  
Secondary instructor – filling assessment form on running a skills station  
 
Station Equipment : Skills station 1 (initial approach & Basic Airway Management) 
 A B C D 
Trainer 
(performer) 
PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
PN 1, 2, 3, 4 PN 5, 6, 7, 8 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 3 IS 4 IS 1 IS 2 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
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For this session the primary and secondary instructors will observe and assess the 
Trainers deliver the skills station 2 to the demonstration participants. Only one trainer 
will be able to be observed in the group and if time a second person can be asked to 
run through the skills with the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates 
clockwise by one station) 
 
10:00 - 10:30  Tea break 
 
10:30 – 11:30  DVD Lectures (deliver presentations 4-6) 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form on giving a lecture 
Secondary instructor – filling assessment form on giving a lecture 
 
Station Equipment : DVD player, Instructional DVD  
 
 A B C D 
Trainer 
(performer) 
PN 13, 14, 15, 
16 
PN 1, 2, 3, 4 PN 5, 6, 7, 8 PN 9, 10, 11, 
12 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 2 IS 3 IS 4 IS 1 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
 
For this session the primary and secondary instructors will observe and assess the 
Trainers deliver the DVD lectures 3-6 to the demonstration participants. Only one 
trainer will be able to be observed in the group and if time permits a second person can 
be asked to run through the skills with the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates 
clockwise by one station) 
 
 11:30 – 12:00 Practical 2 (Part 1 teach skills station 3) 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form on running a skills 
station  
Secondary instructor – filling assessment form on running a skills station  
 
Station Equipment : Skills station 3 (Management of cardiac arrest - shockable 
algorithm VT/ VF)  
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 A B C D 
Trainer 
(performer) 
PN 1, 2, 3, 4 PN 5, 6, 7, 8 PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 1 IS 2 IS 3 IS 4 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
 
For this session the primary and secondary instructors will observe and assess the 
Trainers deliver the skills station 3 to the demonstration participants. Only one trainer 
will be able to be observed in the group and if time a second person can be asked to 
run through the skills with the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates 
clockwise by one station) 
 
 12:00 – 12:30 Practical 2 (Part 2 teach skills station 4) 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form on running a skills 
station  
Secondary instructor – filling assessment form on running a skills station  
 
Station Equipment : Skills station 4 (Management of cardiac arrest – non-shockable 
algorithm asystole/ PEA)  
 
 A B C D 
Trainer 
(performer) 
PN 5, 6, 7, 8 PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
PN 1, 2, 3, 4 
 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 4 IS 1 IS 2 IS 3 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
 
For this session the primary and secondary instructors will observe and assess the Trainers 
deliver the skills station 4 to the demonstration participants. Only one trainer will be able to be 
observed in the group and if time a second person can be asked to run through the skills with 
the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates clockwise 
by one station) 
 
 12:30 – 13:00 Practical 2 (Part 3 teach skills station 5) 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form on running a skills 
station  
Secondary instructor – filling assessment form on running a skills station  
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Station Equipment : Skills station 5 (Management of Tachyarrhythmia’s and 
Bradyarrhythmias)  
 
 A B C D 
Trainer 
(performer) 
PN 9, 10, 11, 
12 
PN 13, 14, 15, 
16 
PN 1, 2, 3, 4 
 
PN 5, 6, 7, 8 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 3 IS 4 IS 1 IS 2 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
 
For this session the primary and secondary instructors will observe and assess the 
Trainers deliver the skills station 5 to the demonstration participants. Only one trainer 
will be able to be observed in the group and if time a second person can be asked to 
run through the skills with the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates 
clockwise by one station) 
 
 13:00 – 13:30 Practical 2 (Part 4 teach skills station 6) 
 
Instructor roles : 
 
Primary instructor – guiding the situation & filling assessment form on running a skills 
station  
Secondary instructor – filling assessment form on running a skills station  
 
Station Equipment : Skills station 6 (Post resuscitation care & Transport)  
 
 
 A B C D 
Trainer 
(performer) 
PN 13, 14, 15, 
16 
PN 1, 2, 3, 4 
 
PN 5, 6, 7, 8 PN 9, 10, 11, 
12 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 2 IS 3 IS 4 IS 1 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
 
For this session the primary and secondary instructors will observe and assess the 
Trainers deliver the skills station 6 to the demonstration participants. Only one trainer 
will be able to be observed in the group and if time a second person can be asked to 
run through the skills with the participant (see bolded PN numbers).  
 
(Trainer Group rotates anticlockwise by one station, and Secondary instructor rotates 
clockwise by one station) 
 
 13:30 - 14:30  Lunch 
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 14:30 -15:30   Lecture by Faculty on how do run an   
    assessment  
 
(whilst participants are carrying out a MCQ Post test assessment in another 
room) 
 
Lecture : How to perform assessments  
 
 15:30 - 16:30  Scenario Post test 
 
Instructor roles : 
Primary instructor – guiding the situation & filling assessment form 
Secondary instructor – filling assessment form on carrying out an assessment  
 
Station Equipment : Skills station 6 (Post resuscitation care & Transport)  
 
 A B C D 
Trainer 
(performer) 
PN 13, 14, 15, 
16 
PN 1, 2, 3, 4 
 
PN 5, 6, 7, 8 PN 9, 10, 11, 
12 
1° Instructor 
(evaluator) 
IP 1 IP 2 IP 3 IP 4 
2° Instructor 
(evaluator) 
IS 2 IS 3 IS 4 IS 1 
Peripheral 
Hospital doctor 
PHP 1, 2, 3 PHP 4, 5, 6  PHP 7, 8, 9 PHP 10, 11, 
12 
 
For this session the primary and secondary instructors will observe and assess the Trainers get 
the participants to work take part in a “mega-code” and mark and give appropriate feedback. 
Each trainer will be given a chance to be primary examiner for one participant, and the others 
will watch an provide feedback  
 
 16:30  Session Close 
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Adult Learning Behaviour 
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Becoming a Trainer 
Dr Rasnayaka M Mudiyanse, Senior Lecturer in Paediatrics 
 Department of Paediatric, Faculty of Medicine, University of Peradeniya, Sri Lanka 
This chapter is prepared by summarizing and extracting essential information from the 
‘Pocket Guide to Teaching for Medical Instructors’ of the BMJ group.     
 
Teaching and learning 
Understand the Learners 
Qualities of a Good Trainer 
Basic Principals of Teaching 
Teaching and Learning 
 
Teaching is defined as planned experience, which brings about a desired change in 
behavior. Learning is defined as ‘a relative permanent change in an individual’s 
behavior resulting from experience’. In real life we gather experience and continue to 
learn. However in teaching, experience is provided in an organized manner with a 
greater efficiency. Learning experience can be pleasant or unpleasant. Even though 
we learn from both experiences, tendency with unpleasant experience is to avoid or 
defense response.  Neither of these responses is helpful for achieving teaching goals 
and therefore should be avoided. Negative remarks, shaming, condemning and even 
finding and highlighting errors can be consider as unpleasant experience. In practice 
teachers tend to point out what is wrong even though it may constitute only a small part 
of the performance. Therefore appreciation of correct performance would be essential 
for effective teaching. This will be discussed further at the section on giving feedback.  
The domains of learning includes  
 
Knowledge 
Skills 
Attitudes (being considerate, responsible, arrogant, patronizing) 
Relationships (being able to communicate, delegate, lead) 
 
All four component of learning would be essential for effective performance.  
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Knowledge 
 
Knowledge is acquired in six stages 
Knowledge – collection of facts 
Comprehension – Use the knowledge in different situations 
Application – Learner relies upend his/her knowledge to do it in real life of 
simulated situation 
Analysis – Learner attempt to observe in the light of his/her prior knowledge 
Synthesis - Analysis leads to a new level of understanding 
Evaluation – whole process and the outcome is reflected and judge leading to 
next course of action 
Skills  
 
There are four stages involved 
Perception – learner become aware of the skill and its steps. ( skill training 
stage 1 & 2 )  
Guided response – Learner is actively involved ( skill training stage 3 & 4) 
Mastery – able to perform the skill competently. This is achieved by practice 
Autonomy – Further practice will achieve a stage when the skill is performed 
with little conscious thoughts 
Attitudes 
 
The learning of attitudes involves four stages 
Perceiving – attitudes like safety, teamwork, sensitivity should be introduced at 
the beginning of the course.  
Complying – usually learners will comply whether they agree or not 
Accepting- Achieved by consistent teaching, role modeling and subsequent 
testing.  
Internalization – Reservations are dropped and attitudes become part of the 
learner 
Relationships 
 
In many situations actual interventions are carried out by team effort. Therefore 
relationships need special attention in training workshops.  
Decisions – Friendly or unfriendly 
Tension – Agreeing/disagreeing 
Reintegration – Providing support 
Communication – Asking for and giving information 
Control – Asking for and giving opinion 
Evaluation – Asking for and giving guidance 
All these features are present in a creative group.  However the key to success is 
depend on the ability to resolve tensions and disagreements. This requires a variety of 
roles in a training course; timekeeper, organizer and a team leader. 
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Understand the learner 
 
In an adult education course like NLS or APLS student that we have to entertain 
different students with diverse knowledge, experience, skills, attitudes, expectation, 
motivation and ability. Therefore becoming a teacher in a NLS or APLS course would 
be a new challenge even for an experience teacher.  Students in NLS or APLS course 
are expecting respect for their experience and knowledge.   
Teachers should adopt a supportive attitude towards students, especially when they 
have to play a role of mentor.  The needs of the student should be addressed. 
Maslow’s hierarchy of needs describe the needs of a students. 
Physiological needs – sleep, rest, food 
Security needs – does he feel confident in expressing his opinion. 
Belonging needs – Does the candidate feel accepted by the group and 
teachers. 
Esteem needs – Confidence about own abilities and competence  
Cognitive needs – Understand the content and mastering the concepts 
Self actualization – Is the students potentials maximized.  Does the candidate 
feel that he is progressing?  
Adult learns best when  
The content is relevant and has meaning and purpose – at introduction 
Learner is actively involved – interactive lectures 
Objectives are defined and goals are set – by negotiation with leaner 
Positive feedback is given – recognize good thing and things need 
improvements and how to improve also 
Reflection on learning experience is encouraged – though summaries 
Even though most of the adult learners are motivated and enthusiastic, you may come 
across some difficult learners.  They can be classified as talker’s, non talkers and 
destroyers.  
 
Enthusiastic talkers   can be made use of by giving them a turn to summarize the 
points discussed. If the discussion is deviated, micro summaries are useful to 
recapitulate and redirect the discussion.  Some time talkers can get in to satellite 
discussions within the group. Teacher may have to stop the main discussion and listen 
to the satellite discussion and link it with main discussion. Alternatively teacher may 
call the particular talker by name to get them back in to the discussion.  
 
Non talkers are not equal to non learners.  Nervous student need support and 
encouragement. Teacher should avoid negative, derogatory or destructive responses. 
If the student fails to answer a question, redirection or rephrasing the initial question 
may help to avoid embarrassment in front of peers. Teacher may control the situation 
for example “Sorry I did not phrase the question well”. Repeating and summarizing the 
candidates ideas may make them feel more comfortable. Questions related his field of 
work should be given to a nervous candidate as he/she will be more comfortable to 
answer them.   
 
Third category; destroyers can be extremely destructive to learning.  They are rare. 
They consider themselves as having adequate knowledge but fail to share with others, 
and resist changing or accepting the opinion of the group.  Occasionally candidates 
may be argumentative or rude. This type of learners should be dealt with individually by 
a senior teacher in private.  
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Qualities of a Good Trainer 
 
Teacher should be a role model. During a training course their behavior is observed 
and followed by students. .  Appreciation is more effective way of enhancing learning 
and changing attitudes. 
 
Asking questions 
Asking questions can facilitate teaching by inducing interactions, allowing student to 
reflect on their own experiences and providing a feed back to the teacher. However 
ambiguous and confusing questions, not allowing students to answer or ignoring their 
response can have negative impact on teaching. Questions should be planned in 
advance. Intension should not be highlighting lack of knowledge or failures.  
Lower level of questions can lead to single word answers whereas higher level of 
questions can lead to a discussion or debate. Too low level questions can be 
patronizing and too higher level questions can be threatening.  Lower level questions 
are useful in lectures when quick repetition of data is required.  Questions can be 
phrased to address the deferent stages of knowledge. 
 
Knowledge – Knowing is tested by asking to name, list, describe, write, what, when, 
how, how many. 
Comprehension – Compare, distinguish, show, try to prove, interpret, and explain 
Application/analysis – What conclusions, what are the consequences, how could you 
Synthesis – Design, create, solve this, what do you suggest 
Evaluate – Evaluate this set of data, according your opinion.., What do you think.. 
 
Positive feedback 
 
Objective of teaching is to create confidant and capable student. Therefore, giving 
feedback should be carefully planned to achieve the objective. Natural tendency of a 
teacher is to observe failures/ inadequacies and to give a feedback considering only 
the wrong part, ignoring the correct part which may be a major portion of the 
performance.  
This cultural inclination of highlighting inadequacies is not helping for effective teaching 
and could be overcome by following scheme outlined below. 
 
Ask the learner to tell what went well and what part he is pleased with his 
performance. This helps to develop self reliance and confidence. Teacher 
should insist to identify good things. Everybody has something good about 
them and they should realize it.  
Encourage the group to tell what went well and good things about the 
performance. Drifting to point out failures should be discouraged at this stage.  
The teacher/trainer should tell good things about the performance 
Ask the learner what points and how he wish to improve if he/she has repeat 
the performance  
Ask the group to suggest points to improve and how to improve them. At this 
stage also listing what is wrong is not acceptable and trainer should insist on 
suggestions for improvements.  
Teacher also suggests points to improve and how to improve 
At the end of the session summarize good points and suggestions for 
improvements  
This whole process is called positive feedback.  This process has helped the learner 
to identify his/her strengths and capabilities and where improvements are needed and 
 311 
 
 
NCP Health – SACTRC Resuscitation (Instructor Manual) 
Appendix C3 
how to achieve them. Highlighting where went wrong without teaching how to improve 
becomes a negative feedback and will not help in learning process.  
Supporting attitude is very important 
Basic Principals of Teaching 
 
Basic principles of teaching are applicable in lectures, skill teaching, scenario teaching 
or in conducting discussion groups. They includes 
 
Environment 
Set  
Dialogue 
Closure  
 
Environment – This includes space, seating arrangement, lighting, noise, 
ventilation, temperature, humidity and any other movements that may disturb or 
facilitate teaching/learning. Quality of equipments (manikins or audiovisual s) is 
also very important. Giving attention to environment, organizing them in 
advance is a responsibility of the instructor and it is essential for an effective 
teaching session.  
 
Set – Mood of the learners will be set by the environment as well as by 
explaining the objectives, value and usefulness of the session at the 
introduction. Explaining the expected role of the student  (Eg - Whether they 
should interact or carefully listen) during the teaching session is useful.  It is 
important to explain the peculiarities of using manikins in teaching skills and 
case scenarios. Manikins will not show any changes or responses to indicate 
progress or improvement of a disease condition. Therefore during skill training 
or case scenarios the student will have to depend on the information given by 
the instructor regarding changes of the condition of parameters. However 
teacher may give false information in order to facilitate next step of planned 
training. For example when the student has achieved good chest expansion 
teacher may say the there was no chest expansion. This situation should be 
explained to the student in advance to avoid confusion.  
 
Dialogue – Actual teaching take place during dialogue. The content should be 
clear and precise to cover the essentials for the course and delivered within the 
allocated time.  Interactions with the audience to keep the interest and 
engagement of student also important. For good quality dialogue practice by 
the teacher is essential. 
 
Closure – Closure includes the time for questioning followed by summery and 
directing the group for next session.  Objective of the summery should be to 
emphasis the key messages.  
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Lectures 
 
Environment – special attention for audiovisual equipments, noise disturbances 
and quality of slides.   
Set – Good environment can set the mood. Interest and enthusiasm can be 
created by giving an introduction highlighting the importance of the topic and 
presenting the lay out the lecture. Asking a question to reflect the experience of 
students can create enthusiasm.   
Dialogue – This is the body of the lecture. The content should be complete, 
precise, clear and relevant to the course. Audiovisual aids such as computer 
projectors, overhead projectors, and flipcharts can be used. Content of a text 
slides should be limited to 3-5 points. Maximum is 7 line and 7 words in each 
line.  Heading should be limited to 5 words.  Picture slides can be incorporated 
to highlight important points relevant to the topic. However it should not distract 
the audience from the topic.  During the lecture questions can be directed to 
facilitate interaction.  Questions should be clear and precise and should allow 
any body to answer. Taking answers positively will encourage others to 
participate in the discussion. Audience activities such as brain storming and 
buzz groups are useful to create enthusiasm and participation.  Brainstorming is 
when a group is encouraged to express their opinion on a specific 
question/issue and the opinion is written down without any form of feedback.  At 
the end the lecturer should be able to demonstrate a pattern. Buzz group; small 
groups within a group is asked to discuss a specific subject in middle of lecture 
for few minutes. At the end they are asked to present what they have 
discussed.  This method is useful to create energy and enthusiasm. A 
demonstration at the end or in the middle of a lecture is a useful component in 
practical courses.  
Closure – Closure include question time followed by a summery.  It is best to 
keep the summery to the end so that you will be able to give conclusions and 
the take home message.  
 
Skill Stations 
 
Environment – All the equipments should be available, functioning and familiar 
to the teacher. Instructor should check all the equipments before starting the 
teaching session.  
 
Set – By explaining the usefulness and the expected role of the student.  Goals 
of the session should be explained.  Four stages of skill training should be 
explained.  
 
Dialogue – This includes four stage skill training.  
 
Stage one; Silent demonstration by the teacher – This is done at the speed of a 
real situation.  It is important to avoid talking as students tend to look at the 
teachers moth when the teacher is talking rather than steps of actual skill. 
 
Stage two; Demonstration with a commentary. At this stage teacher will explain 
the skill while performing it. Skill is broken in to several steps and explained.  
Students are encouraged to ask questions and clarify doubts.  
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Stage three; Teacher performs the skill while the student is giving the 
commentary. At this stage teacher can confirm that the student has understood 
the procedure. Further questioning is encouraged. 
 
Stage four; student will perform the skill under supervision and positive critique 
by the teacher 
 
Stage five; Practice- This may take place after the formal teaching session. 
Usually the group is divided in to two at stage three and four to ensure 
adequate time for all the students. 
 
Closure – Entire group is brought together and allow time for questions and 
summarizes the important points in the skill and stress the importance of 
practice. Practice help to master the skill and achieve autonomy when skills are 
performed almost subconsciously.  
 
Case Scenarios 
 
Case scenario is a form of improvised role-play in which the management of case is 
practiced using a manikin and suitable equipments. Student is expected to make 
decisions according to the guided responses from the instructor.   In role-play and case 
scenario participants are expected to act out roles that represent in real life. It helps to 
teach situations more closely to real clinical situations in life and helps to put 
knowledge, skills, attitudes and relationships together.   
 
Teaching scenarios help to simulate situations closer to real life. Teamwork can be 
practiced and experienced teacher could reproduce an almost realistic challenges.  
 
Environment – Environment, equipments and layout should be as realistic as 
possible. Improvisations should be minimized. Manikins allow procedures to 
practice. However as they can’t give a physiological feedback student have to 
depend on the instructor for assessment of the condition of the patient or 
response to treatment. This situation helps teacher to guide the students and 
create learning points. When real patients or actors are used as models they 
should be made up and trained to simulate the condition. However procedures 
can’t be practiced.  
 
Set – the group should be briefed together and the performing students should 
be given separate briefing.  It is important to ensure that the student who is 
going to perform clinical intervention has understood the scenario by asking him 
to repeat the description before he starts the scenario. Peculiarities of using 
manikins and responses of the instructor should be explained at the beginning.   
 
Dialogue- teacher retain the control by passive responses ( giving response on 
learners request)  or by active responses ( Teacher initiated responses). By 
these responses teacher retain the control of the direction and outcome of the 
case.  
 
Closure – Closure should include debriefing when the participant is allowed to 
express how he felt during and after role play in scenario.  Evaluation about the 
performance with the positive feedback recognizing good things and strengths 
and pointing out areas to improve and how to improve as explained under the 
topic ‘ giving feedback ‘ will help to enhance the learning experience.  Question 
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time and summery are also essential components for closure in a case 
scenario.  
 
Assessment  
 
Instructors assess students formally when the student knows that he/she is been 
assessed or informally when the student is unaware that he/she is assessed. Formal 
assessment can be done by using a checklist of score sheet (see appendix).  
 
Assessment can be of two types; formative and summative. When the assessment is 
done during the course and inform the student the areas to improve it is called 
formative assessment. This is done in a formal way at the initial pre-course 
assessment or informally during the course. Summative assessment is done by a final 
test. Usually knowledge is tested by MCQ and knowledge psychomotor skills and 
behavior Is tested by case scenario.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 315 
 
 
NCP Health – SACTRC Resuscitation (Instructor Manual) 
Appendix C3 
 
 
 
Appendix A : Skills station Guides 
 
 
 316 
 
 
NCP Health – SACTRC Resuscitation (Instructor Manual) 
Appendix C3 
                   
Airway Management Skill Station (1 instructor, up to 6 
students - approximately 30 minutes) 
  
Key teaching objectives  
By the end of this session, the participant will:  
Show competency and confidence in the principles of establishing and maintaining a 
patent airway and providing adequate ventilation in an airway training manikin  
  
Equipment at station 
ResusciAnne Skillreporter mannequin 
Oropharyngeal Airway, Suction, Oxygen 
Ambu mask and bag 
 
Instructor Information  
The instructor should: 
  
Assess the ability of all participants to maintain an airway and achieve effective 
ventilation of a manikin measured against predetermined competencies  
   
Allow participants the opportunity to discuss and / or practice airway management and 
ventilation techniques using an endotracheal tube 
  
”Discuss” the equipment and techniques used for endotracheal intubation including the 
use of cricoid pressure  
  
This skill station is divided into 2 sections; the first section is the most important. 
  
1. All participants must receive practical instruction and undergo  
 assessment of their competency in the following:  
  
• Basic airway opening manoeuvres  
- Head tilt / chin lift  
- Jaw thrust  
• Insertion of airway adjuncts  
- Oropharyngeal airway  
- Nasopharyngeal airway   
• Use of suction  
- With expired air +/- supplementary oxygen  
  
• Ventilation using a self-inflating bag-mask with supplementary oxygen   
and reservoir  
- One person technique  
- Two person technique  
- Review of ratio of compression to ventilation ratio pre intubation followed by a rate of 
approximately 10 ventilations/minute (with no pause between compressions for 
ventilations) post intubation 
  
2. All participants should be offered practical  
instruction in, and have the opportunity to practice the skills of advanced airway 
management and ventilation including:  
• Endotracheal intubation   
• Ventilation via the endotracheal tube using a self-inflating bag with supplementary 
oxygen should be demonstrated.  
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Instructor Information  
  
Set the mood, establish usefulness and state learning objectives for the session.  
One method of teaching that you may choose to use is the four-stage approach of:  
  
Stage 1:  Instructor demonstrates the skill, at normal speed, without explanation  
Stage 2:  Instructor demonstrates the skill more slowly, with explanation  
Stage 3:  Instructor demonstrates the skill while a participant provides explanation  
Stage 4:  Participant demonstrates the skill, with explanation  
  
The practical skills of airway management and ventilation should be taught around a 
simple scenario.  In order not to confuse the participants, this is best achieved by 
simulating a patient with a respiratory arrest, thereby eliminating the need for chest 
compressions.  The scenario can be broken down into 4 elements:  
 
Initial approach   
Airway assessment  
Basic airway opening manoeuvres  
Ventilation with ambu bag 
Confirmation of ventilation  
  
Arrival of basic adjuncts   
Use of suction  
Sizing and insertion of oro- and nasopharyngeal airway  
Confirmation of ventilation  
  
Arrival of additional equipment  
Assembly of self-inflating bag-mask, reservoir and supplementary oxygen  
Ventilation using one and two person techniques  
Confirmation of ventilation  
   
If time permits, allow participants to practice their skills.  Also allow participants to ask 
questions and reflect on the session content before terminating the session with a 
succinct review of all the major points covered.  
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Skills station 2 – Advanced airway management – 
intubation (1 instructor, up to 6 students - 30 minutes) 
  
Key teaching objectives  
By the end of this session, the participant will:  
Show competency and confidence in intubating an airway training manikin and 
coordinating colleagues to support this procedure before during and after the intubation 
including the application of appropriate cricoid pressure 
 
Equipment at station 
ResusciAnne Skillreporter mannequin, Airway Trainer (intubating mannequin) 
Oropharyngeal Airway, Suction, Oxygen 
Ambu mask and bag, Laryngoscope, ET Tube, Introducer, Stethescope 
 
Instructor Information  
The instructor should: 
  
Assess the ability of all participants to intubate a ventilation of a manikin measured 
against predetermined competencies  
   
Allow participants the opportunity to discuss and / or practice airway management and 
ventilation techniques using an endotracheal tube 
  
”Discuss” the equipment and techniques used for endotracheal intubation including the 
use of cricoid pressure  
  
This skill station is divided into 2 sections – Preparation, and Intubation 
 
1. All participants must receive practical instruction and undergo  
 assessment of their competency in the following:  
  
1. Preparation for intubation (10 min discourse + interactive discussion) 
 
a) Decision to intubate 
• failure to ventilate spontaneously  
• Unprotected or threatened airway 
o Secretions  
o Low level of consciousness for whatever cause (usually GCS < 8 as a 
guide) 
b) Preparation for intubation – explanation of necessary conditions:  
 
1) Checking that all essential equipment necessary for intubation in an ideal situation is 
there and present in working order. (Can use acronym – PC MALES)  
 
1. P ulse Oximetry  
2. C apnography 
3. M ask (ie. ambu mask & bag –valve checked in skills station 1) ESSENTIAL 
4. A irwary (Oropharyngeal–correct size explained in skills station 1) -ESSENTIAL 
5. L aryngoscope (check working light bulb) - ESSENTIAL 
6. E ndotracheal Tube (check size and that cuff has no leak) - ESSENTIAL 
7. S uction (Yankers suction – check suction working) - ESSENTIAL 
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2) Checking there is adequate staff to carry out intubation. Intubator has to assign 
these roles to others in the group so all understand what they are doing 
- 1 - Intubator 
- 2 - Assistant to hand ET tube 
- 3 - Person to apply cricoid pressure 
 
2. Endotracheal Intubation (5 min demonstration – 15 mins practice) 
 
a) Variations on holding Larygnoscope  
b) Assigning roles to team members before starting (see above) 
c) Correct positioning – Head extension & slight neck flexion (“sniffing the 
morning air”) 
d) Instructing to “start cricoid pressure now” 
e) Suction of oropharynx  
f) Insertion of larygnoscope and pushing the tongue to the left side and lifting up 
– not using Laryngoscope as a “lever” against the upper lip or teeth.  
g) Communication to the team of either “good view of cords” or “cannot see the 
cords” and explanation of whether they are either “going to intubate” or “go 
back to Ambu ventilation” 
h) Insertion of tube to correct depth – approx 22cm at the lip in an adult male 
(Vocal cords sit between two black lines)  
i) Inflation of cuff and ventilation via the ET tube using an Ambu bag 
j) confirmation of correct tube placement and instruction to “release cricoid 
pressure” 
 
NB –if difficulty with intubating within 30 seconds the participant must go back to the 
ambu ventilation to decrease unnecessary hypoxia (and communicate this to other 
team members), followed by a further attempt 
 
3. Confirmation of correct positioning of tube and post intubation care 
a) ET intubation 
1 – direct visualization for Tracheal intubation (ET tube going through cords) 
2 – Chest rising with ventilation & Auscultation – equals BS in 4 places (both axillae  
 
 
Instructor Information  
 
The first section on preparation for intubation should be a basic overview and 
interactive discussion. The practical skills surrounding the actual skill of intubation 
should be practiced around a simple scenario of a patient with a respiratory arrest to 
get participants in the mind set of working under emergency conditions.  
 
Eg “Mr De Silva is a 58 year old man who has arrived with a low level of consciousness 
and is not breathing spontaneously. He still has a pulse. We are now going to place a 
definitive airway” 
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The fours stage learning model can be used:-  
   
Stage 1:  Instructor demonstrates the skill, at normal speed, without explanation  
Stage 2:  Instructor demonstrates the skill more slowly, with explanation  
Stage 3:  Instructor demonstrates the skill while a participant provides explanation  
Stage 4:  Participant demonstrates the skill, with explanation  
    
Allow participants to practice their skills rotating through the different roles of intubation 
e.g. Intubator, assistant, cricoid pressure, so that participants in the group who are not 
actively intubating can also be doing something productive such as being a part of the 
intubating Team.  Also allow participants to ask questions and reflect on the session 
content before terminating the session with a succinct review of all the major points 
covered.  
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Initial Resuscitation/ PEA / Asystole Skills Station (1 
instructor, up to 6 students, approximately 30 minutes) 
 
Key teaching objectives  
By the end of this session, the participant will be able to:  
• Assess the collapsed patient, using an A B C D E approach  
• Perform effective cardiac compressions & ventilations  
• Practice the algorithm for PEA/Asystole including Atropine administration  
• Recognise the need for addressing the reversible causes of cardiac arrest   
  
Equipment at station 
ResusciAnne Skillreporter mannequin 
Drug trolley, IV Fluids, Oxygen (intubation equipment optional)  
Rhythm generating device or Power point presentation/computer program 
  
Instructor Information:  
Within this skill station there are three key teaching sections:  
 a)    Initial assessment using an A B C D E approach   
 b)    Correct performance of CPR   
 c)    Recognition of Asystole and PEA and no need for defibrillation   
 
The practical skills of using an A B C D E approach, CPR and defibrillation will be  
taught around the scenario described below. 
 
Clinical case  
"Mr Silva is a 58 year old man who had been complaining of central chest pain 2 hours 
previously. He has a history of hypertension and is on a “blood pressure pill”. In trying 
to identify the pill you notice the bottle is empty. His wife tells you that there have been 
a lot of problems at home lately. On arrival he had a weak pulse of 60bpm, and BP was 
90/60. His respiratory rate was 30. When you see him, his is distressed and 
disorientated".  
 
For ease of teaching, the scenario should be broken down to reflect each section and  
the four stage teaching approach must be used.     
Stage 1 Instructor demonstrates the skill, at normal speed, without explanation  
Stage 2 Instructor demonstrates the skill more slowly, with explanation   
Stage 3 Instructor demonstrates the skill while a participant provides  
explanation  
Stage 4 participant demonstrates the skill with explanation  
  
A team approach should be used where the instructor is the team leader calling others 
for help and co-ordinates others to perform a resuscitation. The participants who are 
not actively involved could critique, and in turn be critiqued when they are being active 
 
 
 
 
 
 
 
Section A: Initial assessment using an A B C D E approach   
The patient is still conscious but critically ill with rapid breathing and bradycardia and 
hypotension. 
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The ECG shows bradycardia 
 
Instructor information   
The defibrillator is not available during the initial assessment.  
Here the instructor just speaks aloud how they would approach this patient in terms of their 
airway, breathing and circulation.  
 
During participant practice  (stage 4), the participants are nominated to take the role of 
team leader. Here instructors may like to alter the scenario between participants to 
encourage them to think about their clinical decision-making.  
  
  • Assess responsiveness   
  • Airway (e.g. patency, debris) and administer high flow oxygen  
  • Breathing adequacy (e.g. respiratory rate, expansion, percussion, breath 
sounds, SpO2 e.g..)   
  • Circulatory status (e.g. pulse, blood pressure, capillary refill, urine output, look 
for evidence of haemorrhage (drains, PR bleeding) – IV fluids, management of 
bradycardia  
  • Disability (conscious level) (e.g. AVPU, pupils)  
  • Exposure  
  
Section B : Correct performance of CPR   
Clinical case progression  
-The patient becomes unresponsive, and there is NO carotid pulse palpable, but the 
cardiac monitor still shows a Bradycardia  
  
  • Call for help  
  • Open airway  
  • Check breathing and circulation  
  • Call resuscitation team and send for defibrillator  
  • Deliver effective chest compressions  
• Instructs assistant to commence bag-mask ventilation  
• Correct ratio 30:2  
• Follow algorithm – ie Atropine, and Adrenaline 
  
Section C: Recognition of Asytole and the Non-shockable limb of the algorithm   
Clinical case progression  
-CPR 30:2 is in progress.  The defibrillator arrives – nurse alerts doctor that it is here. 
(Instructor can use different members of the group to role play). They rhythm has now 
changed to:- 
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Instructor information   
Emphasise “team leadership” in running the arrest.    
Also emphasise going through the list of “reversible cause of cardiac arrest” and that 
this applies to both Shockable and Non-shockable rhythms  
  
1 participant can take on team leader while 2 participants should perform the chest 
compression / ventilation. The other participants can help the team leader focus on 
running the cardiac arrest, but take on other roles such as being the scribe etc. The 
scenario can be stopped at any point to get comments from the participants who are 
not running the arrest for “critique”. The different participants should be rotated through 
all roles during the course of the station.    
     
  Instructor Information – points for discussion / further demonstration  
 
1. Early assessment addressing ABC’s with treatment potential role of poisong in 
this case (one of the reversible causes)  
2. Calling the resuscitation team  
3. The role of the precordial thump (in this case –“No role”) 
4. Combined assessment of the breathing and circulation  
5. Minimise interruption to chest compressions  
6. The role of prevention of arrest by early resuscitation 
7. Understanding what PEA is and how there can be electrical activity without a 
pulse 
8. Understanding Asytole (and how fine, low amplitude VF is treated as asystole) 
  
Allow participants to ask questions and reflect on the session content before  
terminating the session with a succinct summary of all the major points covered.  
   
Summary   
• Rapid and effective patient assessment  
• Provision of effective ventilation and compressions  
• Recognition of PEA and Asystole  
• Non- Shockable limb of the ALS treatment algorithm  
• Theory and practice of safe defibrillation.   
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Initial Resuscitation/Defibrilation/V-fb/VT Skills Station 
(1 instructor, 6 students, approximately 30 minutes) 
 
Key teaching objectives  
By the end of this session, the participant will be able to:  
• Assess the collapsed patient, using an A B C D E approach  
• Perform effective cardiac compressions and ventilations  
• Recognise the need for defibrillation   
• Perform safe defibrillation   
  
 Equipment at station 
ResusciAnne Skillreporter mannequin 
Drug trolley, IV Fluids, Oxygen (intubation equipment optional)  
Rhythm generating device or Power point presentation/computer program 
Defibrillator 
 
Instructor Information:  
Within this skill station there are three key teaching sections:  
 a)    Initial assessment using an A B C D E approach   
 b)    Correct performance of CPR   
 c)    Recognition of VF and safe defibrillation   
 
The practical skills of using an A B C D E approach, CPR and defibrillation will be  
taught around the scenario described below. 
 
Clinical case  
"Mr Sunil is a 56 year old man with a history of hypertension and Diabetes admitted to 
the ward with acute severe chest pain.  He has been given aspirin, nitroglycerin 
sublingually and morphine.  You are the house officer doing the night shift when you 
are called to see the patient as he has developed worsening chest pain." 
 
 For ease of teaching, the scenario should be broken down to reflect each section and  
the four stage teaching approach must be used.     
Stage 1 Instructor demonstrates the skill, at normal speed, without explanation  
Stage 2 Instructor demonstrates the skill more slowly, with explanation   
Stage 3 Instructor demonstrates the skill while a participant provides  
explanation  
Stage 4 participant demonstrates the skill with explanation  
  
A team approach should be used where the instructor is the team leader calling others 
for help and co-ordinates others to perform a resuscitation. The participants who are 
not actively involved could critique, and in turn be critiqued when they are being active 
 
 
Section A: Initial assessment using an A B C D E approach   
The patient is still conscious but critically ill with chest pain 
 
Instructor information   
The defibrillator is not available during the initial assessment.  
Here the instructor just speaks aloud how they would approach this patient assign their airway, 
breathing and circulation.  
 
During participant practice  (stage 4), the participants are nominated to take the role of 
team leader. Here instructors may like to alter the scenario between participants to 
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encourage them to think about their clinical decision-making.  
  
  • Assess responsiveness   
  • Airway (e.g. patency, debris) and administer high flow oxygen  
  • Breathing adequacy (e.g. respiratory rate, expansion, percussion, breath 
sounds,  
  SpO2)  
  • Circulatory status (e.g. pulse, blood pressure, capillary refill, urine output, look 
for evidence of haemorrhage (drains, PR bleeding))  
  • Disability (conscious level) (e.g. AVPU, pupils)  
  • Exposure  
  
Section B : Correct performance of CPR   
Clinical case progression  
-The patient becomes unresponsive  
  
  • Call for help  
  • Open airway  
  • Check breathing and circulation  
  • Call resuscitation team and send for defibrillator  
  • Deliver effective chest compressions  
• Instructs assistant to commence bag-mask ventilation  
• Correct ratio 30:2  
• Continue until monitor/defibrillator attached  
  
Section C: Recognition of VF and safe defibrillation   
Clinical case progression  
-CPR 30:2 is in progress.  The defibrillator arrives. The following rhythm is seen 
 
 
   
Instructor information   
Emphasise “safety” to all participants and be prepared to intervene to stop the scenario  
if necessary.  
  
2 participants should perform the chest compression / ventilation during  
stages 1 - 3 so that the other 4 participants can focus on defibrillation.  Participants 
can take over ventilation and chest compression roles during stage 4.  
  
During defibrillation – emphasise the need to minimise delays in chest compression.  
  
• Correctly apply paddles / gel pads (if available), monitoring leads whilst CPR  
continues  
• Select correct energy level (biphasic / monophasic)  
• Stop CPR and identity VF on monitor  
• Remove free flowing oxygen  
• Warn team to stand clear,   
• Charge defibrillator, rapid visual check, confirm VF, deliver shock  
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• Immediately resume CPR without rechecking rhythm  
• Indicate that CPR should be continued for 2 minutes prior to checking rhythm  
  
  
Instructor Information – points for discussion / further demonstration  
• Calling the resuscitation team  
• The role of the precordial thump  
• Combined assessment of the breathing and circulation  
• Minimise interruption to chest compressions  
• Transthoracic impedance (effect of gel pads, paddle pressure etc)  
• Environmental hazards / risks  
• Biphasic / monophasic waveforms  
• ‘Dumping’ the energy from charged paddles  
• Safety ( Participants call “stand back”. Charge paddles on patient or in the 
defibrillator 
Don’t wave paddles in the air, caution with oxygen. No need to remove cardiac monitor 
leads) 
  
Allow participants to ask questions and reflect on the session content before  
terminating the session with a succinct summary of all the major points covered.  
   
Summary   
• Rapid and effective patient assessment  
• Provision of effective ventilation and compressions  
• Recognition of VF   
• Shockable limb of the ALS treatment algorithm  
• Theory and practice of safe defibrillation.   
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Tachycardia/Cardioversion/Bradycardia Skills station 
 
Instructor will review how to read a rhythm strip: 
1. Is there any electrical activity? 
2. What is the ventricular (QRS) rate? 
3. Is the QRS width normal or prolonged? 
4. Is atrial activity present? (If so what is it? Normal P waves? Other atrial activity?) 
5. How is atrial activity related to ventricular activity? 
 
Tachycardia 
 
Key teaching objectives 
• Recognition of broad complex tachycardia and narrow complex tachycardia 
• Principles of treatment, indications for chemical/electrical cardioversion 
• Mechanics of safe synchronized cardioversion 
 
Show examples of  Supraventricular tachycardia, rapid atrial fibrilation, ventricular 
fibrillation, ventricular tachycardia asking students to describe whether it is narrow/wide 
complex, regular or irregular 
Review indications for synchronized cardioversion 
Explain how to set up for synchronized cardioversion, paddle placement. 
 
Stress importance of not shocking during vulnerable ventricular repolarization phase- 
"T" wave as this could result in the deadly vfib rhythm 
 
Present 2-3 scenarios and choose a participant to go through each scenario: 
 
25 year old woman with no prior medical history presents with palpitations, and 
lightheadedness. Patient appears anxious. 
 
Vital Signs; BP 115/85 HR 180 RR 20 O2 saturation 98% 
 
ABC approach    
Oxygen, IV access, monitor   
Monitor shows SVT.   
Student should go through algorithm, first recognizing that this patient is stable with a 
narrow complex regular tachycardia 
Then discuss treatment options:  vagal maneuvers (ask participants to give examples: 
carotid sinus massage, valsalva etc)  
Vagal maneuvers fail. 
Next option: adenosine 6mg IV push (discuss how this medicine has a short half-life on 
the order of seconds and should be given with a stopcock with a saline flush- so as to 
facilitate delivery to the heart quickly), may repeat 12mg x2.  Another option is 
verapamil 5mg IV push.   
need 12 lead ekg   
 
2nd case: 
63 year old man with h/o DM, HTN, 2 days post op from surgery- noted to have 
tachycardia.  pt, c/o some Chest pain and palpitations. 
HR 145, BP 80/40 RR22, o2 sat 98% 
ABC approach    
Oxygen, IV access, monitor   
Monitor shows irregularly irregular 
Participant should recognize that patient is unstable- needs immediate synchronized 
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cardioversion 
If synchronized cardioversion performed.  symptoms resolve, hr 110, bp 110/75 
now participant can reassess algorithm: now stable with narrow complex irregular 
tachycarida--> atrial fibrillation 
treatment options: rate control: digoxin, b-blocker 
<48 hours: consider amiodarone.  
 
3rd case: 
65 y.o man with h/o multiple myocardial infarction p/w presyncopal symptoms, 
palpitations 
 
Hr 170 bp 160/100 rr 20 
ABC approach, iv access, o2 monitor 
monitor shows ventricular tachycardia 
participant recognizes, stable, broad complex, regular tachycardia--> V Tach 
 
Management: amiodarone 300mg IV 
 
Bradycardia 
 
Objectives 
Recognise bradycardia and differentiate between the different degrees of heart block 
• Understand the principles of treating bradycardia 
• Understand the indications for cardiac pacing 
• Be aware of the different methods available for cardiac pacing 
 
Choose 3 participants (one as a team leader, the other 2 as assistants) guide them 
through the following scenario.  prior to starting review algorithm and discuss what is 
meant by adverse signs: bp <90, Hr< 40, heart failure, vent arrythmias, also review risk 
factors for asystole) 
 
Clinical Scenario for Bradycardia simulation 
You are called to see a 60 year old patient who has developed complete heart block 
(CHB) after an acute inferior myocardial infarction.   
  
Clinical Course  
• Initially – reduced conscious level.  
Airway: clear;  
Breathing: RR 14 min-1, fine basal crackles,  C: P 40-50 min BP 70/40, CRT 4 sec; D: 
verbal response; E: nil  
• Unresponsive to atropine.    
• Patient collapses – Initial rhythm PEA (CHB 40-50 min-1); continue until relevant 
reversible causes  
excluded  
• VF followed by return of spontaneous circulation after 2nd shock; P 80 min-1; BP 
90/40; starts to breathe  
  
Interventions – Key treatment points in bold to emphasize 
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Initial approach  
 
Complete heart block  
ABCDE approach    
Oxygen, IV access    
Recognise compromised bradycardia    
Atropine 0.5 mg (further increments up to 3 mg)    
Request transcutaneous pacing    
Cardiac arrest management  
PEA Check patient (breathing / circulation)    
Call resuscitation team / help    
2 min CPR (30:2)   
Airway / ventilation / oxygen   
Attach ECG monitoring (if not already)       
Give first adrenaline 1 mg IV    
Recognise and treat relevant reversible causes    
       (drugs / electrolyte disturbances)  
# (further cycle as required)   
 
VF Check monitor / confirm rhythm   
1st shock (150-200 J biphasic or 360 J monophasic)    
2 min CPR (continuous chest compression / ventilation)   
VF Check monitor / confirm rhythm   
Give further adrenaline after 3-5 min*    
Minimise interruptions in CPR    
2nd shock (150-360 J biphasic or 360 J monophasic)   
2 min CPR (continuous chest compression / ventilation)   
NSR Check monitor / confirm rhythm   
Check patient (signs of life / pulse)   
Post resuscitation care Comments  
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Post Resuscitation Care Skills station 
 
Instructor will review important elements of post resuscitation care: 
Indications for Intubation 
Post Intubation Management 
Ongoing reassessment and monitoring of patient 
 
 Indications for Intubation: 
1)Airway Protection Ask yourself  can they talk? Can they swallow and manage 
secretions? 
What is the level of consciousness? 
GCS <9 indicate “potential” airway compromise due to lack of pharyngeal muscle tone 
& reflexes 
 
2) Failure to maintain Ventilation/Oxygenation:  
Is the SaO2 <90% on High Flow O2 or PaO2<60 on FiO2>40%? 
Is the PaCO2 >55 if baseline is normal, or >10 increase from baseline 
What is the Respiratory Rate and can this rate be maintained? 
 
3) Expected decline in Clinical Status (Instructor should spend time discussing need for 
early intubation if you expect that a patient’s status is likely to decline during transport) 
Deterioration/Impending Compromise 
Transport 
Airway protection during procedures (ie. endoscopy) 
         
Post intubation Management 
 
 1) Confirm intubation (end tidal CO2, calorimeter, Chest x-ray) 
 2) Secure tube 
 3) Post Intubation Medications (sedation, paralysis) 
Diazepam 0.2 mg/kg 
Lorazepam 4-6 mg 
Midazolam 0.1 mg/kg bolus, then 0.1 mg/kg/hr 2-5 mg/hr  (Drip 50 mg in 250 cc 
NS, Start at 10-25 cc/hr) 
Propofol .5-1 mg/kg then 25-100 mcg/kg/min, start at 10 cc (100 mg)/hr which 
correlates with 1 mg/kg/hour 
Vecuronium .1 mg/kg then .03 mg/kg  q25-45 min or 1-2 mcg/kg/min 
4) Patient position: if possible place head of bed at 30 degrees 
5) Nasogastric tube 
6) ABG 
7) Cuff pressure 
8) foley catheter 
     
Ongoing assessment and Monitoring 
• all patients after resuscitation should have close monitoring of vital signs, and 
be placed on a continuous cardiac monitor 
• foley catheter should be placed and urine output should be monitored 
      3)  approach all changes in vital signs in a systematic fashion as described below: 
 
Bradycardia 
Assume hypoxia and therefore tube displacement until proven otherwise 
 
Desaturation (mnemonic DOPE) 
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Displaced tube 
 
Obstruction-pass suction catheter through tube 
 
Pneumothorax 
 
Equipment failure-take off vent and bag patient 
 
 if all of the above have been evaluated, consider shunt physiology 
 
Hypotension 
·        Pneumothorax 
·        Decreased Venous Return from positive pressure ventilation, disconnect from 
vent for 30-60 seconds and observe for increased Blood Pressure and decreased heart 
rate.  Consider reducing PEEP and decreasing Tidal Volume.  Auto-PEEP in 
obstructive airway disease. 
·        Excessive hyperventilation-  
·        Induction Agents-diagnosis of exclusion, give fluid bolus 
·        Cardiogenic-fluid bolus 
 
Present scenarios and choose a participant to go through each scenario: 
 
Mr. Chandradasa, a 62 old man, with a history of Hypertension, Diabetes presented 
with CHF exacerbation subsequently developed PEA underwent resuscitation had 
return of spontaneous circulation- and now has been intubated.  What steps are you 
going to take to manage this patient post intubation?   
Student should discuss post intubation care as outlined above (securing tube, 
sedation, nasogastric tube) as well as ongoing assessment and monitoring of the 
patient.   
 
Now present another student with a change in the hemodynamics of the patient-  
 
“A nurse comes to you and says, Doctor, Mr. Chandradasa BP is 70/40 and his Heart 
rate is 130”  Have the student go through the differential of Hypotension (as discussed 
above) and discuss what they may do to correct the problem.   
 
In this case the patient could be off the vent and receiving bag-mask ventilation but the 
ventilation is excessive.  Instructor can simulate a Nurse who is bagging the 
patient excessively and see if the student notices and instructs the nurse to decrease 
rate of ventilation in which case the hemodynamics improve. 
 
Now present another student with a desaturation in Mr. Chandradasa.  Help them go 
through the differential of desaturation (DOPE mnemonic) and describe what they 
would do to rule out items in the differential.  (i.e recheck tube placement, in line 
suction to rule out obstruction,  repeat physical exam and/or CXR to look for 
pneumothorax, and taking the patient off the vent and performing bag mask ventilation 
to evaluate for equipment failure)  Instructor should emphasize to students the 
importance of  taking patient off ventilator in this situation as well as during any need 
for repeat resuscitation. 
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Scenario 2 – Patient Transfer 
 
This scenario is to make sure that doctors do the basics before transferring patients to 
another Hospital 
 
1) Organise the transfer with receiving hospital – e.g. Consultant or ICU SHO/MO in 
General or Teaching hospital. Important to communicate 
a. Name, Age, Sex 
b. Condition of the patient – Especially Airway Status – (e.g. intubated or 
not, Bag mask ventilated or not, level of oxygen delivery-prongs mask 
etc, and GCS)  
c. Reason for Transfer (e.g. Intubated or no facilities, critical illness) 
d. Plan for transfer (e.g. With or without medical staff, bag mask ventilated 
or mechanical ventilation, Fluids running, Catheter or other tubes insitu) 
e. Expected duration of trip and time of arrival in their institution 
2) Re asses and monitoring of patient prior to transfer 
3) IV Access and start fluids if necessary 
a. Enough fluids if necessary & Long Journey and  
4) Oxygen Delivery Plan 
a. Is Nasal prongs adequate ? 
b. If via mask – is oxygen supply adequate? 
c. Do they need to be intubated? 
5) Medical staffing Plan 
a. Is Solo transfer adequate 
b. If no resources for accompanying patient what precautions have been 
taken 
i. Position patient on side? Airway adjunct? 
6) Position of Patient 
a. Supine in intubated or well patient 
b. On side if airway threatened and not intubated 
7) DOES THE PATIENT NEED TO BE INTUBATED PRIOR TO TRANSFER 
a. See indication for intubation above 
b. If in doubt Call the person at the receiving hospital and Ask for their 
advice stating: 
i. Patients age & sex, co-morbidites 
ii. Airway status (secretions or not), respiratory rate, Saturations, 
Chest movements, and GCS 
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8) Have you written a detailed transfer note with all the vital signs at the time of 
transfer? 
a. Transfer notes are a good way of remembering vital information 
 
Instill in the student that the most important reversible causes of cardio respiratory 
arrest are HYPOXIA and HYPOVOLAEMIA  - this frequently occurs after interhospital 
transfer which are both preventable by good care and forward planning., and taking 
precaution 
 
A good strategy is “PLAN for the WORST situation, and then HOPE for the 
BEST” 
 
Mr Tikirbanda  is a 58 year old farmer who presented with sudden onset left sided 
paralysis. He also has slurred speech and he is only responsive to verbal stimulation. 
His pulse is 60, BP 120/80 and RR 24, and saturations are unavailable.  
 
You suspect a stroke and want to organize a transfer to the General hospital which is 1 
hour away.  
 
Whilst dong this the nurse tells you that Mr Tikirbanda’s breathing patter has changed, 
now more rapid and there is some drooling. He does not respond to your voice, but is 
easily stimulated by a sternal rub, and localized the pain, and also give you a groan. 
His eyes are now closed but open with the pain also  
 
Get participant to act out the scenario: 
 
Instructor pretends to be the Doctor on the Receiving station and has a conversation 
with the MO in the language of their choice.  
 
Participant is led through the phone call, and has to demonstrate management of 
ABCD, and a plan for transfer. 
 
Also go through to the stage of transfer onto a trolley an position of the Mannequin 
(Patient) 
Patient transfer should occur with at lest 3 people with one for the head 
Patient should be managed on the side 
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Appendix B : Competence checklists 
 
(for instructors to mark “trainers”) 
 
 
Trainer Competence Assessment - overall 
This checklist is to be carried out by Consultant Instructors to ensure that the Trainers 
demonstrate adequate skills in teaching resuscitation. Theses are based on “General 
observations” of Trainer particularly in the first part of the workshop - Skills Station 
Training, and “Objective assessment” in the Teaching of a scenario based skills station 
in the Peripheral Hospital Training Module. 
 
Consultant Instructor Name:      Date: 
Trainer being Assessed:       Setting of 
observation: General Observations   / Objective Assessment 
 
Competency Successful 
(comments) 
Needs 
Remediation 
Plan / advice 
given 
Communication - 
Communicates ideas and 
concepts clearly, 
maintains positive rapport 
with learners. uses 
appropriate nonverbal 
communication skills, 
uses appropriate 
terminology for audience 
   
Manage Technology – 
Uses technology 
associated with teaching 
(such as manikins, rhythm 
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generators and other 
teaching aids) and uses 
audio/video technology 
effectively 
Stimulation and 
Motivation – Provides a 
stimulating learning 
environment that 
maintains the interest of 
students. Encourages 
interaction from 
participants. 
   
DVD presentation – able 
to make sure that 
participants understand 
the main points of the 
DVD presentations 
   
Questioning and 
Feedback - Interacts with 
participants with 
appropriate questions to 
evaluate their 
understanding and 
thinking process. Gives 
feedback appropriately, 
particularly when  skill is 
not being learned 
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Lecture – Feedback Form 
 
Name of the lecturer -……………………………Name of the Evaluator-………….. 
 
Topic - ……………………………………………Time starting -------------, End … 
 
Set and environment 
 Did not 
achieved 
Achieved Good 
1. Check and adjust lay out    
2. Check equipments    
3. Welcome and introduce self    
4. Sets the mood    
5. Establishes the usefulness    
6. States learning objectives    
7. Overall performance of SET    
 
Dialogue 
 Did not 
achieved 
Achieved Good 
1. Presents material in a clear, logical 
sequence 
   
2. Uses visual aids appropriately    
3. Ensure voice projection    
4.Address/involves the audience    
5. Uses the eye contact appropriately    
6. Demonstrates enthusiasm    
7. Uses humour appropriately    
8. Uses personal/ audience experience    
9. Asks appropriate questions    
10. Responds positively to answers    
11. Keeps to time    
12. Attitude/behavior encourages learning 
and interactions 
   
13. Overall performance of Dialogue    
 
Closure 
 Did not 
achieved 
Achieved Good 
1. Invites and answer questions    
2. Returns to learning objectives and 
summarizes 
   
3. Terminate the session    
4. Overall performance of closure    
 
General Comments (what do you feel if you are a trainee ) 
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Skill Teaching – Feedback Form 
 
Name of the Taecher -……………………………Name of the Evaluator-…………… 
 
Topic - ……………………………………………Time starting -------------, End … 
 
Set and environment 
 Did not 
achieved 
Achieved Good 
1. Check and adjust lay out    
2. Check equipments    
3. Ensure all the candidates can see    
4. Welcome and introduce self    
5. Sets the mood    
6. Establishes the usefulness    
7. Clarifies the role of learners and teacher    
8. States learning objectives    
9. Overall performance of SET    
 
Dialogue 
 Did not 
achieved 
Achieved Good 
1. Describe 4 stage method of teaching skills     
2. Demonstrate the skill without commentary    
3. Demonstrate the skill with commentary    
4. Demonstrate the skill with candidate 
commentary 
   
5. Candidate demonstrate with appropriate 
commentary 
   
6. Keep check on safety    
7. Relate skill to the other aspects of the 
course 
   
8. Enables practice if time allows    
9. Attitudes/behavior encourages learning 
and interactions 
   
10. Overall performance of Dialogue    
 
Closure 
 Did not 
achieved 
Achieved Good 
1. Invites and answer questions    
2. Returns to learning objectives and 
summarizes 
   
3. Terminate the session    
4. Overall performance of closure    
 
General Comments  
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Scenario Assessment – Feedback Form 
 
Name of the Teacher -……………………………Name of the Evaluator  
 
Topic - ……………………………………………Time starting -------------, End … 
 
Set and environment 
 Did not 
achieved 
Achieved Good 
1. Check and adjust lay out    
2. Check equipments    
3. Check whether assistant is familiar with 
scenario and his/her role 
   
4. Welcome and introduce self    
5. Sets the mood    
6. Establishes the usefulness    
7. Clarifies the role of the teacher and learner    
6. States learning objectives    
7. Overall performance of SET    
 
Dialogue 
 Did not 
achieved 
Achieved Good 
1. Brief candidate    
2. Allows questions    
3. Checks understanding    
4. interact constructively    
5. Keeps check on safety    
6.Keeps to time    
7. Attitudes and behavior encourage learning 
and interaction 
   
8. Overall performance of dialogue    
 
Closure 
 Did not 
achieved 
Achieved Good 
1. Asks the candidates to Waite out side 
confirm results with the colleague 
   
2. Reaches a correct decision    
3. Inform the candidate of the satisfactory 
result 
   
OR    
4. Counsel the candidate of the need for reset    
8. Terminate the session    
9. Overall performance of closure    
 
General Comments  
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Appendix C4  Peripheral hospital resuscitation workshop – course content and 
outline 
 
 
Peripheral Hospital training session: course 
components  
 
 
Component 
  
Topic 
 
DVD lectures   
  
Introduction: Resuscitation Training Module 
overview 
  NEJM (online video) –  “How to intubate” 
  ALS Treatment algorithm 
  Tachycardia algorithm & cardioversion 
  Bradycardia(algorithm(&(cardiac(pacing(
 
Skills stations  
  Basic Airway management 
  Advanced Airway management 
 
Scenario Stations  
  Initial Resuscitation – PEA/Asystole 
  Resuscitation/Defibrillation – VF/VT 
  
Tachycardia/ Bradycardia algorithms -  
cardioversion & pacing 
  Post resuscitation care 
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Peripheral Hospital Training Session: course agenda 
 
 
 
 
Program for Training Session 
 
8:00 - 9:30am 
 
Pre- assessment (MCQ and Scenarios) 
 
9:30 - 10:15am 
 
Lectures on Airway management 
 
10:15 - 10:45am Morning Tea 
10:45 - 10:45am 
 
Practical sessions on Airway management  
(Skills station 1 and 2) 
 
11:45 - 12:20pm 
 
Lectures on management of cardiac arrest & using the 
current algorithms for arrhythmias 
 
12:20 - 13:00pm Lunch 
13:00 - 15:00pm 
 
 
 
Practical sessions: 
Managing PEA/Asystole (skills station 3)  
VT/VF/cardiac arrest (skills station 4) 
Tachycardia and Bradycardia (skills station 5) 
Post resuscitation care and Transport (Skills station 6) 
 
15:00 –15:15pm Afternoon Tea 
 
15:15-16:30pm 
 
Post – Assessment (MCQ and Scenarios) 
 
16:30-16:45pm 
 
 
Closing comments  
(Fill in feedback forms) 
 
 
Appendix C5  Supporting material for trainers & checklists of performance 
 
The resource manual, the DVDs and the “Instructor Manual” have been given to you to 
be used as help before during and after the training sessions. Please use the 
Instructor Manual and Skills Checklist to guide you during the training sessions.  
 
 
Objectives of the Training module  
 
Use the DVD lectures and Skills stations to teach princples outlined in manual:- 
 
• Recognition of a critically ill patient – and calling for help 
• Use of a system for assessing a critically ill patient - ABCDE 
• Importance of Basic life saving maneuvers 
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• Update of Advanced life support algorithms for the arrested patient 
o The Nov 2005 guidelines (ILCOR) 
• “Communication” in Resuscitation 
o Calling for senior support early 
o Communication and leadership during an arrest 
o Post arrest communication with family and other staff 
• Post Resuscitation care  & Inter-hospital Transfer  
• Practical “Hands on” training  
o Simulation in real life scenarios using CPR mannequins 
o Assessment with constructive feedback 
 
 
4 stage teaching approach for skills stations 
 
Stage 1 – Instructor demonstrates the skill, at normal speed, without explanation 
Stage 2 – Instructor demonstrates the skill more slowly, with explanation 
Stage 3 – Instructor demonstrates the skill while a participant provides exlanation 
Stage 4 – participant demonstrates the skill with explanation  
 
Example of above approach is included in the Trainer’s DVD 
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Resuscitation Pack for participants and participant hospitals 
 
1) A4 Colour laminated Algorithm card and Bradycardia/Tachycardia algorithm 
card (for resuscitation trolley or bag) 
2) Wall poster of Advanced life support Algorithm  
3) Training DVD 
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Checklist for Trainers 
 
DVD lectures 
 
Lecture topics: 
  Introduction 
  Airway management 
  Intubation 
  ALS algorithm 
  Tachycardia/ bradycardia 
  Post-resuscitation care  
 
 
Skills station 1 – Airway management 
 
Airway Opening maneuvers and Adjuncts: 
  Head Tilt   
  Chin Lift 
  Jaw Thrust 
  Yankers suction 
  Inserts correctly sized Oropharyngeal airway  
  Inserts correctly sized Nasopharyngeal airway  
 
Bag mask Ventilation:- 
  Assembly of self inflating Ambu bag and mask 
  Correct positioning and seal of facemask 
  Effective ventilations (causing chest to rise) 
  Rate of ventilation 8-10/mins (not >12) 
  Ventilating intubated patient (again rate 8-10/mins) 
  Single vs. two person technique 
  Confirmation of ventilation 
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Skills station 2 – Advanced airway management 
 
Preparation and Equipment Check 
  Assigns roles 
  Ideal equipment and monitoring (PCMALES) 
  Check laryngoscope light is working 
  Check ET tube – inflates cuff with syringe 
  Pre oxygenates (states they would only bag patient if no spontaneous breathing 
– understands that if patient was breathing themselves bagging may worsen 
situation) 
  Correct positioning (“sniffing the morning air”) 
 
Intubation: 
  Suctions first  
  Holds laryngoscope in properly (in Left hand) 
  If takes longer than 30 seconds – should abort and go back to bagging before 
second attempt 
  Intubates (states whether they saw the cords or not for the team to hear) 
  Checks ETT position (breath sounds/ gastric bubbling/ capnography/ etc) 
  Instructs person doing Cricoid pressures to “Start cricoid now” (prior to 
intubating) “remove cricoid” at appropriate times  
  Applies Cricoid pressure appropriately (when assisting intubation)  
 
 
Skills station 3 - PEA/ Asystole 
 
Initial approach: 
  Called for help/ resus team 
  Assesses responsiveness 
  Uses ABCDE approach 
  High flow oxygen 
  Initiates CPR when recognizes patient unresponsive 
 
CPR: 
  Correct hand position (centre of chest) 
  Straight arms 
  Compression depth 4-5cm, approx 1/3 of chest 
  Allows complete relaxation  
  Allows same time for compression as for relaxation 
  Starts with chest compressions rather than giving breaths  
  Rate 100 per minute 
  Ratio 30:2  
  Gives 2 breaths after chest compression (each taking 1 second for breath) 
  Checks for pulse and rhythm after 2mins of CPR (5 cycles) 
  Minimises interruptions to compressions 
  If patient comes back to life – states they would put in recovery position 
 
PEA/ asystole: 
  Recognition of PEA 
  Recognition of asystole 
  Recognises that defibrillation is not indicated 
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Skills station 4 – VF/VT/Defibrillation 
 
Initial approach: 
  Called for help/ resus team 
  Assesses responsiveness 
  Uses ABCDE approach 
  High flow oxygen 
  Initiates CPR when recognizes patient unresponsive 
 
CPR: 
  Correct hand position (centre of chest) 
  Straight arms 
  Compression depth 4-5cm, approx 1/3 of chest 
  Allows complete relaxation  
  Allows same time for compression as for relaxation 
  Starts with chest compressions rather than giving breaths  
  Rate 100 per minute 
  Ratio 30:2  
  Gives 2 breaths after chest compression (each taking 1 second for breath) 
  Checks for pulse and rhythm after 2mins of CPR (5 cycles) 
  Minimises interruptions to compressions 
  If patient comes back to life – states they would put in recovery position 
 
Defibrillation 
  Recognises pulseless VT/ VF (when CPR stopped) 
  Recognises indication for defibrillation and minimizes delay 
  Correctly applies paddles/ gel pads/ monitoring 
  Selects correct energy level (biphasic/ monophasic) 
  Checks and removes hazards (e.g. free-flowing oxygen) 
  Warns team to stand clear 
  Charges defibrillator, rapid visual check, confirms VT/VF, delivers shock 
  Immediately resumes CPR for 2 minutes before rechecking rhythm 
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Skills station 5 – Bradycardia / Tachycardia/ Cardioversion 
 
 
 
Initial approach: 
  Called for help/ resus team 
  Assesses responsiveness 
  Uses ABCDE approach 
  High flow oxygen 
  Initiates CPR when recognizes patient unresponsive 
 
Bradycardia: 
  Recognition of adverse signs of bradycardia 
  Recognition of rhythms that have risks for asystole 
  Indication for transcutaneous pacing 
  Indication for drugs (e.g. atropine, adrenaline) 
 
Tachycardias 
  Recognition of an “unstable” tachycardia 
  Indications for, and how to perform synchronized cardioversion 
  Distinguishes between broad and narrow complex tachycardias 
  Distinguishes between regular and irregular tachycardias 
  Understands role of vagal maneuvers and drugs 
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Skills station 6 – Post-resuscitation care and transport 
 
Post-resuscitation care: 
  Indications for intubation 
  Confirms ETT position and secures ETT 
  Post-intubation medications 
  Supportive care and monitoring (NGT, IDC, cuff pressure, ABG) 
  Management of bradycardia, desaturation (DOPE), hypovolemia 
 
Patient transfer: 
  Organises transfer with receiving hospital – name, age, sex, condition of 
patient, reason for transfer, ETA 
  Consider need for procedures (e.g. intubation) prior to transfer 
  Ongoing assessment and monitoring 
  IV fluids 
  Oxygen delivery 
  Medical staffing plan 
  Patient positioning 
  Documentation 
 
Assessments 
 
Assessments 
  Pre-course MCQs 
  Post-course MCQs 
  Post-course scenario 
 
 
Appendix C6  MCQ test used at assessments  
 
For all answers choose the single best choice 
 
1. Ten minutes after an 85-year-old woman collapses, paramedics arrive and start 
CPR for the first time. The monitor shows fine (low-amplitude) VF. Which of the 
following actions should they take next?  
  
a. Perform at least 5 minutes of vigorous CPR before attempting defibrillation  
b. Insert an endotracheal tube, administer 2 to 2.5 mg adrenalin in 10 mL NS through 
the tube and then defibrillate  
c. Deliver up to 3 precordial thumps while observing the patient’s response on the 
monitor  
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d. Deliver about 2 minutes or 5 cycles of CPR, and deliver a 360-J monophasic or 
equivalent- current biphasic shock  
 
2. Which of the following facts about identification of Ventricular fibrillation is true?  
  
a. A peripheral pulse that is both weak and irregular indicates VF  
b. A sudden drop in blood pressure indicates VF  
c. Artifact signals displayed on the monitor can look like VF  
d. Turning the signal amplitude (“gain”) to zero can enhance the VF signal  
  
3. A 60-year-old man (weight = 50 kg) with recurrent VF has converted from VF again 
to a wide- complex non-perfusing rhythm after administration of Adrenalin 1 mg IV and 
a 3rd shock. Which of the following drug regimens is most appropriate to give next?  
  
a. Amiodarone 300 mg IV push  
b. Lidocaine 150 mg IV push  
c. Magnesium 3 g IV push, diluted in 10 mL of D5W  
d. Procainamide 20 mg/min, up to a maximum dose of 17 mg/kg  
 
4. A cardiac arrest patient arrives in the ED with PEA at 30 bpm. CPR continues, 
proper tube placement is confirmed, and IV access is established. Which of the 
following medications is most appropriate to give next?  
 
a. Calcium chloride 5 mL of 10% solution IV  
b. Adrenalin 1 mg IV  
c. Synchronized cardioversion at 200 J  
d. Sodium bicarbonate 1 mEq/kg IV  
 
5. Which of the following causes of PEA is most likely to respond to immediate 
treatment?  
  
a. Massive pulmonary embolism  
b. Hypovolemia  
c. Massive acute myocardial infarction  
d. Myocardial rupture   
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6. Which of the following drug-dose combinations is recommended as the initial 
medication to give a patient in asystole?  
  
a. Adrenalin 3 mg IV  
b. Atropine 3 mg IV  
c. Adrenalin 1 mg IV   
d. Atropine 0.5 mg IV  
 
7. Which of the following causes of out-of-hospital asystole is most likely to respond to 
treatment?  
  
a. Prolonged cardiac arrest  
b. Prolonged submersion in warm water  
c. Drug overdose  
d. Blunt multisystem trauma  
 
8. Effective bag-mask ventilations are present in a patient in cardiac arrest. Now, 2 
minutes after adrenalin 1 mg IV is given, PEA continues at 30 bpm. Which of the 
following actions should be done next?  
  
a. Administer atropine 3 mg IV  
b. Initiate transcutaneous pacing at a rate of 60 bpm  
c. Start a dopamine IV infusion at 15 to 20 µg/kg per minute  
d. Give adrenalin (1 mL of 1:10 000 solution) IV bolus  
 
9. Which of the following actions helps deliver maximum current during defibrillation?  
  
a. Place alcohol pads between the paddles and skin  
b. Reduce the pressure used to push down on the defibrillator paddles  
c. Apply conductive paste to the paddles  
d. Decrease shock energy after the 2nd shock  
  
10. Which of the following actions is NOT performed when you “clear” a patient just 
before defibrillator discharge?  
  
a. Check the person managing the airway: body not touching bag mask or tracheal 
tube, oxygen  
not flowing directly onto chest  
b. Check yourself: hands correctly placed on paddles, body not touching patient or bed  
c. Check monitor leads: leads disconnected to prevent shock damage to monitor  
d. Check others: no one touching patient, bed, or equipment connected to patient  
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11. You prepare to cardiovert an unstable 48-year-old woman with tachycardia. The  
monitor/defibrillator is in “synchronization” mode. The patient suddenly becomes  
unresponsive and pulseless as the rhythm changes to an irregular, chaotic, VF-like 
pattern. You charge to 200 J and press the SHOCK button, but the defibrillator fails to 
deliver a shock. Why?  
  
a. The defibrillator/monitor battery failed  
b. The “sync” switch failed  
c. You cannot shock VF in “sync” mode  
d. A monitor lead has lost contact, producing the “pseudo-VF” rhythm  
  
12. A woman with a history of narrow-complex PSVT arrives in the ED. She is alert and 
oriented but pale. HR is 165 bpm, and the ECG documents SVT. BP is 105/70 mm Hg. 
Supplemental oxygen is provided, and IV access has been established. Which of the 
following drug-dose combinations is the most appropriate initial treatment?  
  
a. Adenosine 6 mg rapid IV push  
b. Adrenalin 1 mg IV push  
c. Synchronized cardioversion with 25 to 50 J  
d. Atropine 1 mg IV push  
 
13. A 34-year-old woman with a history of mitral valve prolapse presents to the ED 
complaining of palpitations. Her vital signs are as follows: HR = 165 bpm, resp = 14 per 
minute, BP = 118/92 mm Hg, and O2 sat = 98%. Her lungs sound clear, and she 
reports no shortness of breath or dyspnea on exertion. The ECG and monitor display a 
narrow-complex, regular tachycardia. Which of the following terms best describes her 
condition?  
  
a. Stable tachycardia  
b. Unstable tachycardia  
c. Heart rate appropriate for clinical condition  
d. Tachycardia secondary to poor cardiovascular function  
 
14. A 75-year-old man presents to the ED with a 1-week history of lightheadedness, 
palpitations, and mild exercise intolerance. The initial 12-lead ECG displays atrial 
fibrillation, which continues to show on the monitor at an irregular HR of 120 to 150 
bpm and a BP of  70/40mm Hg. Which of the following therapies is the most 
appropriate next intervention?  
  
a. Call a cardiologist for assistance  
b. Lidocaine 1 to 1.5mg/kg IV bolus  
c. Amiodarone 300 mg IV bolus  
d. Immediate cardioversion 
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15. A 25-year-old woman presents to the ED and says she is having another episode 
of PSVT. Her medical history includes an electrophysiologic stimulation study (EPS) 
that confirmed a reentry tachycardia, no Wolff-Parkinson-White syndrome, and no 
preexcitation. HR is 180 bpm. The patient reports palpitations and mild shortness of 
breath. Vagal maneuvers with carotid sinus massage have no effect on HR or rhythm. 
Which of the following is the most appropriate next intervention?  
  
a. DC cardioversion  
b. IV diltiazem  
c. IV propranolol  
d. IV adenosine  
 
 
16. Endotracheal intubation has just been attempted for a patient in respiratory arrest. 
During bag-mask ventilation you hear stomach gurgling over the epigastrium but no 
breath sounds, and oxygen saturation (per pulse oximetry) stays very low. Which of the 
following is the most likely explanation for these findings?  
  
a. Intubation of the esophagus  
b. Intubation of the left main bronchus  
c. Intubation of the right main bronchus  
d. Bilateral tension pneumothorax  
  
17. Which of the following statements correctly describes the ventilations that should 
be provided after endotracheal tube insertion, cuff inflation, and verification of tube 
position?  
  
a. Deliver 8 to 10 ventilations per minute with no pauses for chest compressions  
b. Deliver ventilations as rapidly as possible as long as visible chest rise occurs with 
each breath  
c. Deliver ventilations with a tidal volume of 3 to 5 mL/kg  
d. Deliver ventilations using room air until COPD is ruled out  
 
18. When intubating during an arrest which of the following is INCORRECT 
a. Only intubate if you have been properly trained and have adequate experience 
b. Stop chest compressions while intubation is being carried out 
c. Pre-oxygenation with high concentration oxygen should always be performed when 
possible 
d. After the patient is intubated the ratio of chest compression to ventilations is 30:2 
 
19. Regarding bag-mask ventilation which of the following is correct? 
a. Ambu bags are universal in size so that the same one can be used effectively for all 
patients 
b. The rate of ventilation should be approximately 10 ventilations per min in an arrest 
situation, but this rate should be increased if the patient is hypoxic 
c. Effective ventilation cannot be achieved unless there is a good seal between the 
face mask and the patient’s face  
d. When oxygenating a patient prior to intubation one should actively ventilate the 
patient, even if the patient is breathing himself 
e. If you are performing bag mask ventilation, you do not need to have an airway 
adjunct such as an oropharangeal airway in place 
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20. Which of these statements about IV administration of medications during attempted 
resuscitation is true?  
  
a. Give adrenalin via the intracardiac route if IV access is not obtained within 3 minutes  
b. Follow IV medications through peripheral veins with a fluid bolus  
c. Do not follow IV medications through central veins with a fluid bolus  
d. Run normal saline mixed with sodium bicarbonate (100 mEq/L) during continuing 
CPR  
 
21. A patient with a heart rate of 40 bpm is complaining of chest pain and is confused. 
After oxygen, what is the first drug you should administer to this patient while a 
transcutaneous pacer is brought to the room?  
  
a. Atropine 0.5 mg  
b. Adrenalin 1 mg IV push  
c. Isoproterenol infusion 2 to 10 µg/min  
d. Adenosine 6 mg rapid IV push   
 
22. Which of the following rhythms is a proper indication for transcutaneous cardiac 
pacing?  
  
a. Sinus bradycardia with no symptoms  
b. First degree AV block 
c. Complete heart block with pulmonary edema  
d. Asystole that follows 6 or more defibrillation shocks  
 
23. A patient with an HR of 30 to 40 bpm complains of dizziness, cool and clammy 
extremities, and dyspnea. He is in third-degree AV block. All treatment modalities are 
present. What would you do first?  
  
a. give atropine 1 mg IV  
b. give adrenalin 1 mg IV push  
c. start dopamine infusion 2 to 10 μg/min   
d. begin immediate transcutaneous pacing, sedate if possible  
 
 
24. In a conscious patient all of the following are signs of a patient being critically ill  
EXCEPT for: 
a. A sudden fall in GCS < 2 
b. HR <40 or >140 
c. RR <5  RR>36 
d. Fever of > T 38.5 
e. Systolic BP <90 
 
25. Regarding “Circulation” in an arrest situation which is correct? 
a. Patients are unlikely to need IV fluids in an arrest 
b. CPR and fluid resuscitation are unlikely to save the life of someone with Ventricular 
Fibrillation until a DC shock is given 
c. The best place to put an IV cannula in arrest is over the radial side of the wrist 
d. Even if a no central pulses are felt, it is still useful to check blood pressure during 
resuscitation of a cardiac arrest 
e. After ROSC (return of spontaneous circulation) with a pulse felt peripherally, there is 
never any reason to check the blood pressure  
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Rhythm Recognition 
Identify the Following Rhythms (write the single best choice) 
 
26.    
 
 
a. Normal Sinus Rhythm  
b. Sinus Tachycardia  
c. Sinus Bradycardia  
d. Atrial Fibrillation  
e. Atrial Flutter  
f. Reentry Supraventricular Tachycardia  
g. Monomorphic Ventricular Tachycardia  
h. Polymorphic Ventricular Tachycardia  
i. Ventricular Fibrillation  
j. Second-Degree Atrioventricular Block  
h. Third-Degree Atrioventricular Block  
   
27.   
 
 
  
  
a. Normal Sinus Rhythm  
b. Sinus Tachycardia  
c. Sinus Bradycardia  
d. Atrial Fibrillation  
e. Atrial Flutter  
f. Reentry Supraventricular Tachycardia  
g. Monomorphic Ventricular Tachycardia  
h. Polymorphic Ventricular Tachycardia  
i. Ventricular Fibrillation  
j. Second-Degree Atrioventricular Block  
h. Third-Degree Atrioventricular Block   
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28.    
 
 
 
a. Normal Sinus Rhythm  
b. Sinus Tachycardia  
c. Sinus Bradycardia  
d. Atrial Fibrillation  
e. Atrial Flutter  
f. Reentry Supraventricular Tachycardia  
g. Monomorphic Ventricular Tachycardia  
h. Polymorphic Ventricular Tachycardia  
i. Ventricular Fibrillation  
j. Second-Degree Atrioventricular Block  
h. Third-Degree Atrioventricular Block   
  
  
29.   
 
  
a. Normal Sinus Rhythm  
b. Sinus Tachycardia  
c. Sinus Bradycardia  
d. Atrial Fibrillation  
e. Atrial Flutter  
f. Reentry Supraventricular Tachycardia  
g. Monomorphic Ventricular Tachycardia  
h. Polymorphic Ventricular Tachycardia  
i. Ventricular Fibrillation  
j. Second-Degree Atrioventricular Block  
h. Third-Degree Atrioventricular Block    
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30.   
 
 
  
a. Normal Sinus Rhythm  
b. Sinus Tachycardia  
c. Sinus Bradycardia  
d. Atrial Fibrillation  
e. Atrial Flutter  
f. Reentry Supraventricular Tachycardia  
g. Monomorphic Ventricular Tachycardia  
h. Polymorphic Ventricular Tachycardia  
i. Ventricular Fibrillation  
j. Second-Degree Atrioventricular Block  
h. Third-Degree Atrioventricular Block    
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Answers 
 
1. d 
2. c 
3. a 
4. b 
5. b 
6. c 
7. c  
8. a 
9. c 
10. c 
11. c 
12. a 
13. a 
14. d 
15. d 
16. a 
17. a 
18. d 
19. c 
20. b 
21. a 
22. c 
23. d 
24. d 
25. b 
26. g 
27. h 
28. e 
29. i 
30. j 
 
 
 
Appendix C7  Script for resuscitation scenario & picture of assessment room 
 
Scenario 
 
“When you go behind the screen you will see a mannequin in a hospital bed– we want 
you to imagine this is a 50 year old man who has collapsed and is unresponsive. You 
see this patient when you are walking to your clinic.  
 
When I say start I want you to do as you would in real life. During the scenario I will 
answer any questions you have about the patient’s condition, which you cannot work 
out for yourself and that you “look for”. But I do not want you to talk to me -  You are 
alone. The only equipment you have is what you see around you.”  
 
[read scenario twice. Press record on the video camera] 
 
“Just one moment as I announce your ID for the video” 
[say PHP No….  Scenario 1] 
 
“Do what you would do in real life – continue doing so until I tell you to stop. Start 
NOW” 
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[start stopwatch, play on computer also] 
 
End of Scenario 
 
Assessor steps in and says “And help arrives!!” 
 
 
Evaluator instructions (scripted responses):  
 
Action Response 
Checks for pulse Say “there is no pulse” 
Checks for breathing There is no chest movement 
If participant starts to give expired air 
ventilation or attempts to give expired air 
ventilation 
“if you want to give ventilations, please 
use the Ambu bag provided” 
If patient asks for details of the patient, 
e.g. “what is the patient’s name” or “how 
old is he” 
“You do not know his name, he is a 50 
year old male who has collapsed”   
I would like a “………” e.g. Monitor The only equipment you have 
immediately available is what you see 
around you. You are alone. Do as you 
would in real life 
I would like some help Help is on its way 
 
After 1 min of the participant performing single rescuer CPR the evaluator stops them 
and thanks them – immediately go on to scenario 2.  
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Time prompts 
 
Time Prompt 
IF no CPR started by 1 min “I want you to start cardiopulmonary 
resuscitation on this patient please” 
After 1 min of initiation of compressions Say “And help arrives”. Please come out 
of the room” [ie. step behind the screen]” 
  
 
 
 
Setting: 
 
RA Skill trainer Mannequin in standard hospital bed.  
No pulse, No breathing.  
Ambu bag and mask is on the bedside table next to patient (not on bed) 
 
Screen covering mannequin from starting point of participant – all scenario briefing to 
be given out of the line of vision of mannequin, behind the screen.   
 
Assessor stands on the other side of the screen to the participant (out of sight but 
within earshot) – Assessor makes limited scripted responses as appropriate.  
 
Figure . Example of a peripheral hospital Assessment station setup 
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Equipment  
 
Essential*
1) CPR recording Mannequin (see below) 
2) Hospital Bed & Mattress x1 
3) Ambu bags x2 
4) Laryngoscope and x2 blades (Mac 3 and Mac4 
5) ET tube with introducer 
6) Oxygen mask and tubing 
7) Poster with ALS algorithm x2  
 
Non*essential*(but*valuable*for*simulation*)*
8) Drip stand 
9) Hospital bedside table 
10) Old saturation monitor 
11) Old defibrillation unit (Better to have a functional defibrillator but this might be 
economically challenging) 
 
 
 
 
 
 
1
 
Mannequin requirements 
 
• Full body (for realism) 
• Continuous real time feed back for ventilation and compression (LED lights) 
• Skill reporting (ability to generate a print-out of the performance, or store this 
data on a computer.) 
• A head piece that allows airway opening manoeuvres and INTUBATION 
• A body that can simulate arrhythmias and defibrillation. A computer scenario 
program that comes with the mannequin so that data can be recorded an 
stored on a computer 
2
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Appendix C8  Marking schedule for video assessment 
 
 
Scenario 1 - Guide to entering data in spreadsheet (29-5-09)
PHP: Assessor:- 
Pre  / Post  (Circle appropriate) Date of assessment:-
Time of assesment:-
No Item
Grade or Time (mins / Seconds):-
Comments:-
(enter or circle appropriate)
1 Video file Name
2 Start time - (at waist)
3 Timecalls for help (mm:ss)                             / didn't call =0
4 Time compressions started (mm:ss)
5 Time ventilation started (mm:ss)
6
Time informed "Start CPR" - if 
participant doesn’t initiate
                            /  not informed =0
7 Time of last ventilation (mm:ss)
8 Check Responsiveness: Shouts  Y=1  /  N=0
9 Check Responsiveness: Shakes 1-Safe Shake / 2-No Shake / 3-Dangerous shake
10
Initial airway opening - (circle all 
that apply)
1-Head tilt / 2-Chinlift / 3-Jaw thrust / 4-Nil
11 Check for obstruction Y=1  /  N=0
12
Initial breathing check performed? 
(Circle which apply)
1=Yes (with airway opened)                                
2=Yes (airway not opened)                                        
0=Not performed
13
If Yes, which components of 
breathing check carried out? (circle 
all that apply)
1-Look / 2-Listen / 3-Feel / 0-Nil
14 Initial Pulse Check (part a) 1-Yes (< 10s) / 2-Yes (> 10s) / 0-not performed
15
Initial Pulse Check (part b) circle all 
that apply
1-Central Pulse / 2-Peripheral pulse / 3-No pulse 
check
16
Ratio of Compression:Rescue breath 
(choose closest ratio)
1-30:2      2-15:2   3-5:1    4-Other (        )
17
Number of "attempted" 
ventilations (after 1st set of 
compressions)
18
Airway opening prior to ventilation 
(after 1st set of compressions)
1-Head tilt / 2-Chinlift / 3-Jaw thrust / 4-Nil
17 Facemask Technique 1-"E-C" used / 2-Other Technique / 3-Upside down
19 Rescue Breaths "prior" to CPR? Y=1  /  N=0
20 Number of rescue breaths?
21 Attempted mouth to mouth? Y=1  /  N=0
22 Precordial Thump given? Y=1  /  N=0
23 General Comments
